CN101932595B - 噬菌体φmru多核苷酸和多肽及其应用 - Google Patents
噬菌体φmru多核苷酸和多肽及其应用 Download PDFInfo
- Publication number
- CN101932595B CN101932595B CN200880109156.6A CN200880109156A CN101932595B CN 101932595 B CN101932595 B CN 101932595B CN 200880109156 A CN200880109156 A CN 200880109156A CN 101932595 B CN101932595 B CN 101932595B
- Authority
- CN
- China
- Prior art keywords
- cell
- polypeptide
- phage
- sequence
- methane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 213
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 187
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 184
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 93
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 93
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 92
- 238000000034 method Methods 0.000 claims abstract description 106
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 540
- 108010021006 Tyrothricin Proteins 0.000 claims description 224
- 229960003281 tyrothricin Drugs 0.000 claims description 224
- NLJVXZFCYKWXLH-DXTIXLATSA-N 3-[(3r,6s,9s,12s,15s,17s,20s,22r,25s,28s)-20-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,22,25-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,18,21,24,27-nonaoxo-12-propan-2-yl-1,4,7,10,13,16,19,23,26-nonazabicyclo[26.3.0]hentriacontan Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)N1)=O)CC(C)C)C(C)C)C1=CC=C(O)C=C1 NLJVXZFCYKWXLH-DXTIXLATSA-N 0.000 claims description 214
- 210000004027 cell Anatomy 0.000 claims description 175
- 150000001413 amino acids Chemical group 0.000 claims description 102
- 239000002773 nucleotide Substances 0.000 claims description 70
- 125000003729 nucleotide group Chemical group 0.000 claims description 70
- 241000894006 Bacteria Species 0.000 claims description 32
- 150000001875 compounds Chemical class 0.000 claims description 23
- 239000008194 pharmaceutical composition Substances 0.000 claims description 20
- 230000004927 fusion Effects 0.000 claims description 19
- 239000003112 inhibitor Substances 0.000 claims description 18
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 16
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 16
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims description 16
- 238000000926 separation method Methods 0.000 claims description 15
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 10
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 10
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 9
- 241000319304 [Brevibacterium] flavum Species 0.000 claims description 7
- 230000000968 intestinal effect Effects 0.000 claims description 7
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 5
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 4
- 239000000090 biomarker Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 abstract description 64
- 239000013604 expression vector Substances 0.000 abstract description 48
- 244000005700 microbiome Species 0.000 abstract description 44
- 230000006698 induction Effects 0.000 abstract description 9
- 239000002245 particle Substances 0.000 abstract description 8
- 239000000969 carrier Substances 0.000 abstract description 6
- 230000000149 penetrating effect Effects 0.000 abstract description 4
- 241001648836 Methanobrevibacter ruminantium Species 0.000 description 147
- 108090000623 proteins and genes Proteins 0.000 description 84
- 239000012634 fragment Substances 0.000 description 70
- 229940024606 amino acid Drugs 0.000 description 60
- 235000001014 amino acid Nutrition 0.000 description 60
- 239000000523 sample Substances 0.000 description 40
- 235000018102 proteins Nutrition 0.000 description 32
- 102000004169 proteins and genes Human genes 0.000 description 32
- 102000004190 Enzymes Human genes 0.000 description 29
- 108090000790 Enzymes Proteins 0.000 description 29
- 230000014509 gene expression Effects 0.000 description 29
- 230000004048 modification Effects 0.000 description 29
- 238000012986 modification Methods 0.000 description 29
- 229940088598 enzyme Drugs 0.000 description 28
- 238000002474 experimental method Methods 0.000 description 28
- 239000013612 plasmid Substances 0.000 description 25
- 230000008859 change Effects 0.000 description 24
- 238000005516 engineering process Methods 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 22
- 230000000295 complement effect Effects 0.000 description 22
- 239000000824 cytostatic agent Substances 0.000 description 22
- 230000001085 cytostatic effect Effects 0.000 description 22
- 150000007523 nucleic acids Chemical group 0.000 description 22
- 241001465754 Metazoa Species 0.000 description 20
- 108700026244 Open Reading Frames Proteins 0.000 description 20
- 238000009396 hybridization Methods 0.000 description 20
- 108090000856 Lyases Proteins 0.000 description 19
- 102000004317 Lyases Human genes 0.000 description 19
- 238000003786 synthesis reaction Methods 0.000 description 19
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 18
- 108091034117 Oligonucleotide Proteins 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 108091028043 Nucleic acid sequence Proteins 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 16
- 238000010168 coupling process Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 238000003752 polymerase chain reaction Methods 0.000 description 16
- 238000005336 cracking Methods 0.000 description 15
- 238000003780 insertion Methods 0.000 description 15
- 230000037431 insertion Effects 0.000 description 15
- 102000039446 nucleic acids Human genes 0.000 description 15
- 108020004707 nucleic acids Proteins 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 239000002585 base Substances 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 241001515965 unidentified phage Species 0.000 description 13
- 230000001580 bacterial effect Effects 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 230000008878 coupling Effects 0.000 description 12
- 238000005859 coupling reaction Methods 0.000 description 12
- 230000012010 growth Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 11
- 230000027455 binding Effects 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- -1 methyl compound Chemical class 0.000 description 11
- 108091026890 Coding region Proteins 0.000 description 10
- 230000004071 biological effect Effects 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000005520 cutting process Methods 0.000 description 10
- 230000000977 initiatory effect Effects 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 230000001629 suppression Effects 0.000 description 10
- GSXRBRIWJGAPDU-BBVRJQLQSA-N tyrocidine A Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)=O)CC(C)C)C(C)C)C1=CC=C(O)C=C1 GSXRBRIWJGAPDU-BBVRJQLQSA-N 0.000 description 10
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 9
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 9
- 235000011180 diphosphates Nutrition 0.000 description 9
- 238000002493 microarray Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 230000002441 reversible effect Effects 0.000 description 9
- 230000004543 DNA replication Effects 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 8
- 230000009089 cytolysis Effects 0.000 description 8
- 235000015872 dietary supplement Nutrition 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- GMPYNOTVKNXELU-UHFFFAOYSA-N 1-bromoethanesulfonic acid Chemical compound CC(Br)S(O)(=O)=O GMPYNOTVKNXELU-UHFFFAOYSA-N 0.000 description 7
- 101710126949 Lysin Proteins 0.000 description 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 7
- 102000035195 Peptidases Human genes 0.000 description 7
- 108091005804 Peptidases Proteins 0.000 description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 230000000692 anti-sense effect Effects 0.000 description 7
- 239000000427 antigen Substances 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 238000010367 cloning Methods 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 238000013016 damping Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 239000005431 greenhouse gas Substances 0.000 description 7
- 230000010354 integration Effects 0.000 description 7
- 108010076401 isopeptidase Proteins 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 108010013639 Peptidoglycan Proteins 0.000 description 6
- 241000282849 Ruminantia Species 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 238000001311 chemical methods and process Methods 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 235000019833 protease Nutrition 0.000 description 6
- 238000012797 qualification Methods 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- 239000011593 sulfur Substances 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 108020004705 Codon Proteins 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 229910002091 carbon monoxide Inorganic materials 0.000 description 5
- 210000002421 cell wall Anatomy 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 229940023064 escherichia coli Drugs 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 241000282994 Cervidae Species 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- 108010070675 Glutathione transferase Proteins 0.000 description 4
- 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- 241001302044 Methanothermobacter marburgensis Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 241001494479 Pecora Species 0.000 description 4
- 241000589516 Pseudomonas Species 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- 108091081024 Start codon Proteins 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 238000012412 chemical coupling Methods 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 238000007852 inverse PCR Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 102000042567 non-coding RNA Human genes 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 238000012207 quantitative assay Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 230000009870 specific binding Effects 0.000 description 4
- 239000005418 vegetable material Substances 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 244000249062 Artemisia abrotanum Species 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- 108091035707 Consensus sequence Proteins 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 108010013369 Enteropeptidase Proteins 0.000 description 3
- 102100029727 Enteropeptidase Human genes 0.000 description 3
- 241000588722 Escherichia Species 0.000 description 3
- 108010011459 Exenatide Proteins 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
- 241000588748 Klebsiella Species 0.000 description 3
- 241000202987 Methanobrevibacter Species 0.000 description 3
- 241000202985 Methanobrevibacter smithii Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001302037 Methanothermobacter wolfeii Species 0.000 description 3
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 108091092724 Noncoding DNA Proteins 0.000 description 3
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 3
- 241000192023 Sarcina Species 0.000 description 3
- 241000723873 Tobacco mosaic virus Species 0.000 description 3
- 108020004566 Transfer RNA Proteins 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000003139 biocide Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 229960001519 exenatide Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 235000014304 histidine Nutrition 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 150000002460 imidazoles Chemical class 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000002555 ionophore Substances 0.000 description 3
- 230000000236 ionophoric effect Effects 0.000 description 3
- 125000005647 linker group Chemical group 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- UYEUUXMDVNYCAM-UHFFFAOYSA-N lumazine Chemical compound N1=CC=NC2=NC(O)=NC(O)=C21 UYEUUXMDVNYCAM-UHFFFAOYSA-N 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 230000028744 lysogeny Effects 0.000 description 3
- 230000002101 lytic effect Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 description 3
- 229960001267 nesiritide Drugs 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 108091027963 non-coding RNA Proteins 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003127 radioimmunoassay Methods 0.000 description 3
- 101150074945 rbcL gene Proteins 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 108091092562 ribozyme Proteins 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- OQFSYHWITGFERZ-UHFFFAOYSA-N 2-bromoethanesulfonic acid Chemical compound OS(=O)(=O)CCBr OQFSYHWITGFERZ-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 101100301006 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) cbbL2 gene Proteins 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 241000193388 Bacillus thuringiensis Species 0.000 description 2
- 108010062877 Bacteriocins Proteins 0.000 description 2
- 108091033409 CRISPR Proteins 0.000 description 2
- 238000010354 CRISPR gene editing Methods 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 108090000565 Capsid Proteins Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 102100023321 Ceruloplasmin Human genes 0.000 description 2
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 2
- 108090000395 Cysteine Endopeptidases Proteins 0.000 description 2
- 102000003950 Cysteine Endopeptidases Human genes 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 108010059378 Endopeptidases Proteins 0.000 description 2
- 102000005593 Endopeptidases Human genes 0.000 description 2
- 241000588698 Erwinia Species 0.000 description 2
- HTQBXNHDCUEHJF-XWLPCZSASA-N Exenatide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 2
- 241000589565 Flavobacterium Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 108010019494 Histatins Proteins 0.000 description 2
- 102000006492 Histatins Human genes 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 241000588744 Klebsiella pneumoniae subsp. ozaenae Species 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930182504 Lasalocid Natural products 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241000202972 Methanobacterium bryantii Species 0.000 description 2
- 241000205276 Methanosarcina Species 0.000 description 2
- 241001302035 Methanothermobacter Species 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000080590 Niso Species 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 108020004518 RNA Probes Proteins 0.000 description 2
- 239000003391 RNA probe Substances 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 241000223252 Rhodotorula Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 241001655322 Streptomycetales Species 0.000 description 2
- 101710172711 Structural protein Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 108010023617 abarelix Proteins 0.000 description 2
- AIWRTTMUVOZGPW-HSPKUQOVSA-N abarelix Chemical compound C([C@@H](C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 AIWRTTMUVOZGPW-HSPKUQOVSA-N 0.000 description 2
- 229960002184 abarelix Drugs 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- BDNDRNLSLGGULA-UHFFFAOYSA-N actaplanin Chemical compound C=1C2=CC=C(O)C=1C1=C(OC3C(C(O)C(O)C(CO)O3)O)C=C(O)C=C1C(C(=O)OC)NC(=O)C1NC(=O)C2NC(=O)C2NC(=O)C(C=3C=C(C(=C(O)C=3)C)OC=3C(O)=CC=C(C=3)C(N)C(=O)N3)NC(=O)C3CC(C=C3)=CC=C3OC(C=3OC4C(C(O)C(O)C(CO)O4)O)=CC2=CC=3OC(C(=C2)Cl)=CC=C2C1OC1CC(N)C(O)C(C)O1 BDNDRNLSLGGULA-UHFFFAOYSA-N 0.000 description 2
- 108010020588 actaplanin Proteins 0.000 description 2
- 229950002379 actaplanin Drugs 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 238000003766 bioinformatics method Methods 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 101150004101 cbbL gene Proteins 0.000 description 2
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- 238000002788 crimping Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 238000007877 drug screening Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 125000000487 histidyl group Chemical class [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- USSYUMHVHQSYNA-SLDJZXPVSA-N indolicidin Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)CC1=CNC2=CC=CC=C12 USSYUMHVHQSYNA-SLDJZXPVSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000012177 large-scale sequencing Methods 0.000 description 2
- BBMULGJBVDDDNI-OWKLGTHSSA-N lasalocid Chemical compound C([C@@H]1[C@@]2(CC)O[C@@H]([C@H](C2)C)[C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC=2C(=C(O)C(C)=CC=2)C(O)=O)C[C@](O)(CC)[C@H](C)O1 BBMULGJBVDDDNI-OWKLGTHSSA-N 0.000 description 2
- 229960000320 lasalocid Drugs 0.000 description 2
- RGLRXNKKBLIBQS-XNHQSDQCSA-N leuprolide acetate Chemical compound CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 RGLRXNKKBLIBQS-XNHQSDQCSA-N 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 230000001320 lysogenic effect Effects 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 210000004493 neutrocyte Anatomy 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 239000003791 organic solvent mixture Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- GNHOJBNSNUXZQA-UHFFFAOYSA-J potassium aluminium sulfate dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GNHOJBNSNUXZQA-UHFFFAOYSA-J 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 2
- 125000006853 reporter group Chemical group 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000000979 retarding effect Effects 0.000 description 2
- 210000004767 rumen Anatomy 0.000 description 2
- 229940081969 saccharomyces cerevisiae Drugs 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OTKXWJHPGBRXCR-UHFFFAOYSA-N (2-chloro-4-nitrophenoxy)-dimethoxy-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1Cl OTKXWJHPGBRXCR-UHFFFAOYSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- SWXOGPJRIDTIRL-DOUNNPEJSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s)-1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pent Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 SWXOGPJRIDTIRL-DOUNNPEJSA-N 0.000 description 1
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 1
- NSOITZIGPJTCMQ-KCXFZFQESA-N (4r,7s,10s,13s,16s,19s,22r)-22-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-6-amino-2-[[(2s,3s)-2-[[(2s)-2-[[2-[[2-[[(2s)-2-[[(2s)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]acetyl]amino]-4-methylpentanoyl]a Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CSSC1)C(O)=O)[C@@H](C)O)C(C)C)=O)C1=CC=CC=C1 NSOITZIGPJTCMQ-KCXFZFQESA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- JWQZOTGHUDZFMU-WIDFLDSMSA-N 17034-35-4 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 JWQZOTGHUDZFMU-WIDFLDSMSA-N 0.000 description 1
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
- PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical group NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 1
- HPNRHPKXQZSDFX-UHFFFAOYSA-N 2-[[2-[[2-[[2-[[2-[[6-amino-2-[[52-[[2-[[2-[[2-[[5-amino-2-[[2-[[2-[[6-amino-2-[[1-(2-amino-3-hydroxypropanoyl)pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-butan-2-yl-31,43-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,19,22,25-tetrakis(hydroxymethyl)-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid Chemical compound N1C(=O)C(NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C2N(CCC2)C(=O)C(N)CO)C(C)C)CSSCC(C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC=2N=CNC=2)C(O)=O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(O)=O)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)C1CC1=CC=CC=C1 HPNRHPKXQZSDFX-UHFFFAOYSA-N 0.000 description 1
- ZRNSSRODJSSVEJ-UHFFFAOYSA-N 2-methylpentacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(C)C ZRNSSRODJSSVEJ-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 101150000481 AGFG1 gene Proteins 0.000 description 1
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 1
- 108010013043 Acetylesterase Proteins 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000282979 Alces alces Species 0.000 description 1
- 108010025188 Alcohol oxidase Proteins 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- MQLZLIYPFDIDMZ-HAFWLYHUSA-N Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O MQLZLIYPFDIDMZ-HAFWLYHUSA-N 0.000 description 1
- GWWSUMLEWKQHLR-NUMRIWBASA-N Asp-Thr-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O GWWSUMLEWKQHLR-NUMRIWBASA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000223651 Aureobasidium Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 239000004184 Avoparcin Substances 0.000 description 1
- MQTOSJVFKKJCRP-HHZDEWPHSA-N Azythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@H]([C@@]([C@H](O)[C@H](C)N(C)C[C@@H](C)C[C@](C)(O)[C@@H](O[C@@H]2[C@H]([C@@H](C[C@H](C)O2)N(C)C)O)[C@@H]1C)(C)O)CC)[C@@H]1C[C@](C)(OC)[C@H](O)[C@@H](C)O1 MQTOSJVFKKJCRP-HHZDEWPHSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 102100033735 Bactericidal permeability-increasing protein Human genes 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- GGPMDBMFWZWPHO-KPIITGRYSA-N C(C)(=O)N[C@H]1C(O[C@@H]([C@H]([C@@H]1O[C@@H](C(=O)O)C)O)CO)N[C@@H](C)C(=O)O Chemical compound C(C)(=O)N[C@H]1C(O[C@@H]([C@H]([C@@H]1O[C@@H](C(=O)O)C)O)CO)N[C@@H](C)C(=O)O GGPMDBMFWZWPHO-KPIITGRYSA-N 0.000 description 1
- 102100021935 C-C motif chemokine 26 Human genes 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 238000010453 CRISPR/Cas method Methods 0.000 description 1
- 241000282421 Canidae Species 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 101800003223 Cecropin-A Proteins 0.000 description 1
- 241001529572 Chaceon affinis Species 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- YAHZABJORDUQGO-NQXXGFSBSA-N D-ribulose 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)C(=O)COP(O)(O)=O YAHZABJORDUQGO-NQXXGFSBSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000008836 DNA modification Effects 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 241000186394 Eubacterium Species 0.000 description 1
- 241001137858 Euryarchaeota Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 102100039556 Galectin-4 Human genes 0.000 description 1
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 1
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 1
- KXRORHJIRAOQPG-SOUVJXGZSA-N Glu-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O KXRORHJIRAOQPG-SOUVJXGZSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- YNIMVVJTPWCUJH-KBPBESRZSA-N Gly-His-Tyr Chemical group [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YNIMVVJTPWCUJH-KBPBESRZSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- 101000871785 Homo sapiens Bactericidal permeability-increasing protein Proteins 0.000 description 1
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 1
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 108010000817 Leuprolide Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 229910052765 Lutetium Inorganic materials 0.000 description 1
- DUTMKEAPLLUGNO-JYJNAYRXSA-N Lys-Glu-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DUTMKEAPLLUGNO-JYJNAYRXSA-N 0.000 description 1
- FMIIKPHLJKUXGE-GUBZILKMSA-N Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN FMIIKPHLJKUXGE-GUBZILKMSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241000579835 Merops Species 0.000 description 1
- 241000202974 Methanobacterium Species 0.000 description 1
- 241000202970 Methanobacterium formicicum Species 0.000 description 1
- 241000516657 Methanobrevibacter acididurans Species 0.000 description 1
- 241001407721 Methanobrevibacter thaueri Species 0.000 description 1
- 241000203407 Methanocaldococcus jannaschii Species 0.000 description 1
- 241001148031 Methanococcoides burtonii Species 0.000 description 1
- 241001515932 Methanolobus taylorii Species 0.000 description 1
- 241000205280 Methanomicrobium Species 0.000 description 1
- 241000205278 Methanomicrobium mobile Species 0.000 description 1
- 241000205275 Methanosarcina barkeri Species 0.000 description 1
- 241000205274 Methanosarcina mazei Species 0.000 description 1
- 241000204676 Methanosphaera stadtmanae Species 0.000 description 1
- 108700005443 Microbial Genes Proteins 0.000 description 1
- 229930191564 Monensin Natural products 0.000 description 1
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- MNLRQHMNZILYPY-MDMHTWEWSA-N N-acetyl-alpha-D-muramic acid Chemical compound OC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(C)=O MNLRQHMNZILYPY-MDMHTWEWSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 108010020856 N-terminal nucleophile hydrolase Proteins 0.000 description 1
- 101100190845 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pmp-1 gene Proteins 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108700020497 Nucleopolyhedrovirus polyhedrin Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- OHUXOEXBXPZKPT-STQMWFEESA-N Phe-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=CC=C1 OHUXOEXBXPZKPT-STQMWFEESA-N 0.000 description 1
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 229940022005 RNA vaccine Drugs 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 241000270934 Rana catesbeiana Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
- 101150027663 Rpain gene Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 239000004189 Salinomycin Substances 0.000 description 1
- KQXDHUJYNAXLNZ-XQSDOZFQSA-N Salinomycin Chemical compound O1[C@@H]([C@@H](CC)C(O)=O)CC[C@H](C)[C@@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 KQXDHUJYNAXLNZ-XQSDOZFQSA-N 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000004523 Sulfate Adenylyltransferase Human genes 0.000 description 1
- 108010022348 Sulfate adenylyltransferase Proteins 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 108010050144 Triptorelin Pamoate Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- 241001416177 Vicugna pacos Species 0.000 description 1
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000001651 autotrophic effect Effects 0.000 description 1
- JWFVWARSGMYXRN-HTQQBIQNSA-N avoparcin Chemical compound O([C@H]1[C@H](C(N[C@H](C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(N[C@H](C4=CC(O)=CC(O)=C4C=4C(O)=CC=C3C=4)C(O)=O)=O)CC3=C(O[C@@H]4O[C@@H](C)[C@H](O)[C@H](N)C4)C=C(C(=C3)Cl)OC=3C=C2C=C(C=3O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H]2O[C@@H](C)[C@H](O)[C@H](N)C2)OC2=CC=C1C=C2)C=1C=CC(O)=CC=1)=O)NC(=O)[C@@H](NC)C=1C=CC(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)=CC=1)[C@@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@H]1O JWFVWARSGMYXRN-HTQQBIQNSA-N 0.000 description 1
- 108010053278 avoparcin Proteins 0.000 description 1
- 235000019377 avoparcin Nutrition 0.000 description 1
- 229950001335 avoparcin Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 108010016341 bactenecin Proteins 0.000 description 1
- RHISNKCGUDDGEG-UHFFFAOYSA-N bactenecin Chemical compound CCC(C)C1NC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)C(CCCN=C(N)N)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(N)CCCN=C(N)N)CSSCC(C(=O)NC(CCCN=C(N)N)C(O)=O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC1=O RHISNKCGUDDGEG-UHFFFAOYSA-N 0.000 description 1
- 108010042854 bacteria histone-like protein HU Proteins 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 102000028861 calmodulin binding Human genes 0.000 description 1
- 108091000084 calmodulin binding Proteins 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 230000021523 carboxylation Effects 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 108060001132 cathelicidin Proteins 0.000 description 1
- 102000014509 cathelicidin Human genes 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- HCQPHKMLKXOJSR-IRCPFGJUSA-N cecropin-a Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)CCCCN)C1=CC=CC=C1 HCQPHKMLKXOJSR-IRCPFGJUSA-N 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 108700008462 cetrorelix Proteins 0.000 description 1
- SBNPWPIBESPSIF-MHWMIDJBSA-N cetrorelix Chemical compound C([C@@H](C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 SBNPWPIBESPSIF-MHWMIDJBSA-N 0.000 description 1
- 229960003230 cetrorelix Drugs 0.000 description 1
- JUFFVKRROAPVBI-PVOYSMBESA-N chembl1210015 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@]3(O[C@@H](C[C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C3)C(O)=O)O2)O)[C@@H](CO)O1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 JUFFVKRROAPVBI-PVOYSMBESA-N 0.000 description 1
- JQXXHWHPUNPDRT-BQVAUQFYSA-N chembl1523493 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2C=NN1CCN(C)CC1 JQXXHWHPUNPDRT-BQVAUQFYSA-N 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000012916 chromogenic reagent Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 238000007878 drug screening assay Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000010437 erythropoiesis Effects 0.000 description 1
- FCJJZKCJURDYNF-UHFFFAOYSA-N ethyl but-2-ynoate Chemical compound CCOC(=O)C#CC FCJJZKCJURDYNF-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000009415 formwork Methods 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- IUAYMJGZBVDSGL-XNNAEKOYSA-N gramicidin S Chemical compound C([C@@H]1C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1)C(C)C)=O)CC(C)C)C(C)C)C1=CC=CC=C1 IUAYMJGZBVDSGL-XNNAEKOYSA-N 0.000 description 1
- 229950009774 gramicidin s Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 108010013846 hematide Proteins 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000001261 hydroxy acids Chemical group 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 108010021336 lanreotide Proteins 0.000 description 1
- 229960002437 lanreotide Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960004338 leuprorelin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940087857 lupron Drugs 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 150000002669 lysines Chemical group 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 108700021021 mRNA Vaccine Proteins 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 125000006357 methylene carbonyl group Chemical group [H]C([H])([*:1])C([*:2])=O 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229960005358 monensin Drugs 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N monofluoromethane Natural products FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229940051921 muramidase Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229940054205 natrecor Drugs 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000003499 nucleic acid array Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000001293 nucleolytic effect Effects 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229940049547 paraxin Drugs 0.000 description 1
- TZRHLKRLEZJVIJ-UHFFFAOYSA-N parecoxib Chemical compound C1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C(C)ON=C1C1=CC=CC=C1 TZRHLKRLEZJVIJ-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 108700010839 phage proteins Proteins 0.000 description 1
- 238000001066 phage therapy Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- NONJJLVGHLVQQM-JHXYUMNGSA-N phenethicillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C(C)OC1=CC=CC=C1 NONJJLVGHLVQQM-JHXYUMNGSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- UORVCLMRJXCDCP-UHFFFAOYSA-N propynoic acid Chemical compound OC(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-N 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 108010047804 ranalexin Proteins 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 229960001548 salinomycin Drugs 0.000 description 1
- 235000019378 salinomycin Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 229950006794 secretin porcine Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000003375 selectivity assay Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 108010018381 streptavidin-binding peptide Proteins 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- VXKHXGOKWPXYNA-PGBVPBMZSA-N triptorelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 VXKHXGOKWPXYNA-PGBVPBMZSA-N 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- UDKYUQZDRMRDOR-UHFFFAOYSA-N tungsten Chemical compound [W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W][W] UDKYUQZDRMRDOR-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 229960002730 vapreotide Drugs 0.000 description 1
- 108700029852 vapreotide Proteins 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
- C12N9/641—Cysteine endopeptidases (3.4.22)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/20—Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
- Y02P60/22—Methane [CH4], e.g. from rice paddies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
Abstract
本发明包括含有噬菌体诱导、噬菌体颗粒和噬菌体基因组的噬菌体φmru还包括噬菌体多肽、编码这些多肽的多核苷酸、包含这些多核苷酸的表达载体和包含这些载体的宿主细胞。本发明还包括使用所公开的噬菌体、多肽、多核苷酸、表达载体或宿主细胞来检测、靶向、通透并抑制微生物细胞,尤其是产甲烷菌细胞的组合物和方法。
Description
相关申请
本申请要求2007年9月25日提交的美国申请号60/975,104,2007年9月22日提交的美国申请号60/989,840和2007年11月22日提交的美国申请号60/989,841的优先权,将上述所有的内容整体纳入本文作参考。
技术领域
本发明涉及将抑制分子递送至微生物细胞,具体说是产甲烷菌细胞的组合物和方法。具体说,本发明涉及新鉴定的噬菌体包括噬菌体诱导、噬菌体颗粒、噬菌体基因组、噬菌体多肽以及编码这些多肽的多核苷酸。本发明还涉及用于产生这些多肽的表达载体和宿主细胞。本发明还涉及使用所公开的噬菌体、多肽、多核苷酸、表达载体和宿主细胞来探测、靶向并抑制微生物细胞,尤其是产甲烷菌细胞的方法。
发明背景
在新西兰,农业活动是温室气体排放的主要来源。因此,减少农业温室气体排放对于新西兰完成京都议定书的义务是重要的。议定书要求在首次承诺期(2008-2012)结束前温室气体减排至1990年水平。为此,农业部门和新西兰政府成立了田园温室气体研究联合会(PGGRC)寻求降低新西兰的农业温室气体排放的方法。
PGGRC活动的一个重要部分是研究减少来自新西兰放牧反刍动物的甲烷排放量。出于两个原因,减少反刍动物甲烷排放量具有商业利益。首先,不履行京都议定书承诺将迫使政府购买碳排放额度。目前预计该项将花费三亿五千万美金。第二,甲烷的产生导致瘤胃中产生的总能量损耗8-12%。可利用这种能量来提高反刍动物的生产性能。
甲烷在瘤胃中由称为产甲烷菌的微生物产生,这种微生物属于古细菌(Archaea)界广古菌门(euryarchaeota)的一部分。多数产甲烷菌依靠CO2和H2作为它们唯一的能量来源,但是一些能使用乙酸或甲基化合物生长。瘤胃中中存在多种不同属的产甲烷古菌,但是甲烷短杆菌属中的种,尤其是反刍甲烷短杆菌(M.ruminantium)和史氏甲烷短杆菌(M.smithii)被认为是新西兰反刍动物中主要的产甲烷菌,反刍甲烷短杆菌目前是PGGRC基金资助基因组测序项目的研究对象。该项目第一次对于瘤位产甲烷菌的基因组进行测序,旨在对甲烷短杆菌(Methanobrevibacter)的生物学建立更好的理解,以发现抑制甲烷产生的靶点。
减少瘤胃中甲烷产生需要抑制产甲烷菌或使其甲烷生成通路失活。一种抑制甲烷产生的方法是将特异性抑制分子递送至产甲烷菌细胞中。可通过(例如)使用特异性靶向产甲烷菌的试剂如噬菌体达到这种目的。已对数种非瘤胃产甲烷菌的噬菌体进行表征,但是没有报道关于能够感染或裂解瘤胃产甲烷菌的噬菌体。因此,鉴定能够感染产甲烷菌细胞和/或递送抑制剂的噬菌体极具优势。
发明内容
本发明涉及一种分离的噬菌体包括本文详述的以整体或部分形式生产的噬菌体颗粒和/或噬菌体基因组,以及分离的噬菌体多核苷酸和多肽。
本发明还涉及一种分离的多肽,其包含至少一个选自SEQIDNO:1-69的噬菌体氨基酸序列。在一个具体方面,所述多肽包含选自SEQIDNO:2-5和62-68的氨基酸序列。另一方面,所述多肽包含SEQIDNO:63的氨基酸序列。在另一方面,所述多肽为片段,例如包含至少一个延伸自SEQIDNO:63中残基32-186的氨基酸序列。
本发明还涉及一种分离的多核苷酸,其包含至少一种噬菌体多肽的编码序列。在一个方面,所述多核苷酸包含至少一个选自SEQIDNO:1-69的氨基酸序列的编码序列。在一个具体方面,所述多核苷酸包含选自SEQIDNO:2-5和62-68的序列的编码序列。在另一方面,所述多核苷酸包含SEQIDNO:63的编码序列。在另一方面,所述多核苷酸包含某编码序列的片段,该编码序列编码,例如,至少一个延伸自SEQIDNO:63中残基32-186的氨基酸序列。
在另一方面,本发明涉及一种分离的多核苷酸,其包含选自SEQIDNO:74-142的噬菌体核酸序列。.在特定方面,所述多核苷酸包含选自SEQIDNO:75-78和135-141,或更具体是SEQIDNO:136的核酸序列。在另一方面,所述多核苷酸是包含例如延伸自SEQIDNO:136中核苷酸94-558的核酸序列的片段或寡核苷酸。此外,本发明包括一种分离的多核苷酸或其片段,该多核苷酸或其片段能与SEQIDNO:74-142中任一核酸序列杂交。本发明还包括一种分离的多核苷酸,该多核苷酸含有任一所述核酸序列的互补物、反向互补物、反向序列或其片段。
本发明涉及一种表达载体,其包含含有至少一种噬菌体多肽的编码序列的多核苷酸。在一个方面,所述表达载体包含至少一个选自SEQIDNO:1-69的氨基酸序列的编码序列。在一个特定方面,所述表达载体包含SEQIDNO:2-5和62-68中至少一个氨基酸序列的编码序列。在另一方面,所述表达载体包含至少一个SEQIDNO:63的氨基酸序列的编码序列。在另一方面,所述表达载体包含至少一个延伸自SEQIDNO:63中残基32-186的氨基酸序列的编码序列。
在一个具体方面,本发明涉及以完整或部分形式产生如本文详述的噬菌体的表达载体。具体说,所述表达载体可产生噬菌体颗粒、噬菌体基因组或修饰的噬菌体,包括其任何变化形式、衍生物、变体或片段。
本发明还涉及包含至少一种表达载体的宿主细胞,例如微生物宿主细胞。
本发明尤其涉及本文公开的多肽或多核苷酸的抗体。在某些方面,所述抗体针对至少一个选自SEQIDNO:1-69的多肽序列或其片段。在另一方面,所述抗体针对选自SEQIDNO:74-142的多核苷酸的至少一个片段或其互补或修饰序列。在另一方面,所述抗体包含与至少一种细胞抑制剂,例如本文详述的抗-甲烷生成化合物(如,溴代乙磺酸)、抗体和抗体片段、裂解酶、肽核酸、抗微生物肽和其他抗生素产生的一种或多种融合物或偶联物。
本发明还涉及例如SEQIDNO:1-69中至少一项的修饰的噬菌体多肽,其包括如本文所述的生物学活性变化形式、片段、变体和衍生物。本发明还涉及例如针对SEQIDNO:1-69中至少一项的修饰的抗体,其包括如本文所述的生物学活性变化形式、片段、变体和衍生物。本发明还涉及编码这些修饰多肽的多核苷酸,以及所公开多核苷酸的变化形式、片段、变体和衍生物,包含这些多核苷酸的表达载体以及包含这些载体的宿主细胞。在具体方面,本发明的组合物和方法使用这些修饰的多核苷酸或多肽,或对应的表达载体或宿主细胞。
此外,本发明涉及噬菌体多肽,如SEQIDNO:1-69中至少一种或其修饰序列,包括与至少一种细胞抑制剂,如本文详述的抗-甲烷生成化合物(如,溴代乙磺酸)、抗体和抗体片段、裂解酶、肽核酸、抗微生物肽和其他抗生素形成的融合物或偶联物。
本发明涉及一种组合物,该组合物包含分离多肽如SEQIDNO:1-69中至少一种或其修饰序列。本发明还涉及一种组合物,该组合物包含针对,例如SEQIDNO:1-69中至少一种或其修饰序列的抗体。本发明还涉及一种组合物,该组合物包含分离的多核苷酸,如SEQIDNO:74-142中至少一种或其互补或修饰序列。本发明还涉及一种组合物,该组合物包含本发明表达载体或本发明含有表达载体的宿主细胞。所述组合物可包含本文所述生物学活性变化形式、片段、变体和衍生物中的任何一种。所述组合物可包含至少一种细胞抑制剂(如,作为融合物或偶联物)并可配制成,例如,药物组合物或食品补充剂,具体是反刍动物饲料组分。
本发明还涉及作为按照所公开方法靶向和/或抑制微生物细胞,特别是产甲烷菌细胞的试剂盒的一部分的本发明组合物。该试剂盒包括:a)至少一种本文所列的组合物;以及b)任选地包括,用其(例如)靶向细胞或抑制产甲烷菌或其他微生物的细胞生长或复制的使用说明书。
本发明涉及一种产生噬菌体的方法,所述方法包括:a)在适合产生噬菌体条件下培养表达载体或含有表达载体的宿主细胞,所述表达载体包含噬菌体基因组的至少一部分;以及b)从培养物中回收该噬菌体。在特定方面,该噬菌体包含至少一个选自SEQIDNO:1-69或其修饰序列的多肽。在另一些方面,该噬菌体包含至少一个选自SEQIDNO:74-142或其修饰序列的多核苷酸。
本发明还涉及一种产生噬菌体多肽的方法,所述方法包括:a)在适合多肽表达条件下培养表达载体或含有表达载体的宿主细胞,所述表达载体包含至少一种噬菌体多肽的编码序列的至少一部分;以及b)从培养物中回收该多肽。在特定方面,所述多肽包含至少一个选自SEQIDNO:1-69或其修饰序列的氨基酸序列。
此外,本发明还涉及一种产生噬菌体多肽的方法,该多肽如SEQIDNO:1-69中至少一种,包括与至少一种细胞抑制剂,如本文详述的抗-甲烷生成化合物(如,溴代乙磺酸)、抗体和抗体片段、裂解酶、肽核酸、抗微生物肽和其他抗生素形成的融合物或偶联物。此类方法包括:a)在适合多肽表达的条件下培养表达载体或包含表达载体的宿主细胞,所述表达载体包含至少一种噬菌体多肽的编码序列;b)形成噬菌体融合物或偶联物(如,通过表达融合序列或与细胞抑制剂化学偶联);以及c)回收该融合物或偶联物。在特定方面,所述多肽包含至少一个选自SEQIDNO:1-69或其修饰序列的氨基酸序列。
此外,本发明涉及一种抑制微生物细胞(如抑制其生长或复制),具体是产甲烷菌细胞的方法,该方法包括:a)任选产生或分离至少一种噬菌体多肽;以及b)将所述细胞与所述噬菌体多肽接触。在一个特定方面,所述多肽包含至少一个选自SEQIDNO:1-69或其修饰序列的氨基酸序列。
此外,本发明还包括一种抑制微生物细胞(如抑制其生长或复制),具体是产甲烷菌细胞的方法,该方法包括:a)任选产生或分离至少一种噬菌体多肽,其还包含至少一种细胞抑制剂;以及b)将所述细胞与所述噬菌体多肽接触。在一个特定方面,所述多肽包含至少一个选自SEQIDNO:1-69或其修饰序列的氨基酸序列。
本发明还涉及一种检测和/或测定噬菌体水平或对应的噬菌体多肽或多核苷酸水平的方法,该方法包括:1)将来自对象的样品与抗体接触,所述抗体针对噬菌体多肽(如,SEQIDNO:1-69中至少一种或其修饰序列)或对应的多核苷酸;和2)检测与样品中多肽或多核苷酸形成的抗体复合物的存在或水平。此类方法还可用于检测和/或测定微生物细胞,具体是产甲烷菌细胞的水平。
本发明还涉及一种检测和/或测定噬菌体水平或对应的噬菌体多多核苷酸(如噬菌体编码序列)水平的方法,该方法包括:1)将来自对象的样品与互补多核苷酸(如与SEQIDNO:74-142中任一项或其修饰序列互补的序列)接触;以及2)测定与样品中噬菌体多核苷酸形成的杂交复合物的存在或水平。此类方法还可用于检测和/或测定微生物细胞,具体是产甲烷菌细胞的水平。
在特定方面,本发明的方法使用体内或体外表达组件。在其它方面,本发明使用重组、合成或半合成方法产生的多肽,或内源性方法产生的多肽。
本发明的其它方面和实施方式如下文所述。
附图简要说明
用本发明特定实施方式和附图作为参考对本发明进行描述。
图1A-1B.反刍甲烷短杆菌原噬菌体显示推定整合位点序列attL和attR(图1A)和预测的噬菌体功能模块和基因结构(图1B)。
图1C:用灭菌空气(氧压)进行噬菌体诱导。
图1D:用丝裂霉素C对噬菌体进行初始诱导。
图1E:诱导(氧气刺激)和未诱导的反刍甲烷短杆菌的PCR扩增产物的琼脂糖凝胶电泳。第2和第4泳道:英骏公司(Invitrogen)的1kbDNA梯标记物。第1和第3泳道分别代表使用引物对R1F-L2R对分离自诱导和未诱导的反刍甲烷短杆菌培养物的DNA进行PCR的产物。
图2.原噬菌体开放阅读框注释和注解。
图3.原噬菌体开放阅读框注释、功能预测和注解。
图4A-4B.反刍甲烷短杆菌原噬菌体序列信息,包括噬菌体的编码序列(图4A)和氨基酸序列(图4B)。
图5.噬菌体ORF2058与马尔堡甲烷杆菌(M.marburgensis)的PeiP和沃氏甲烷杆菌(M.wolfeii)的PeiW的序列比对。
图6:使用LogoBar创建的来自反刍甲烷短杆菌的信号肽序列的蛋白质序列标识,显示了核心共有信号。
图7:ORF2058对反刍甲烷短杆菌静息细胞的抑制效应。
图8:ORF2058对反刍甲烷短杆菌细胞生长和甲烷产生的抑制效应。
具体实施方式
定义
如本文所述,“改变的”编码噬菌体多肽的核酸序列包括那些具有不同的核苷酸缺失、插入或取代,得到优选编码相同或功能等同多肽的多核苷酸的核酸。编码的多肽或抗体也可以是“改变的”,并包含氨基酸残基的缺失、插入或取代,产生沉默改变并得到功能等同的多肽。只要多肽的生物学活性(如细胞结合、细胞通透或细胞裂解)或免疫学活性(如一个或多个抗体结合位点)得以保留,可在残基的极性、电荷、溶解性、疏水性、亲水性和/或两亲特性相似的基础上,有意进行氨基酸取代。例如,带负电的氨基酸可以包括天冬氨酸和谷氨酸;带正电的氨基酸可以包括赖氨酸和精氨酸;具有亲水性值相似的不带电极性头部基团的氨基酸包括亮氨酸、异亮氨酸和缬氨酸,甘氨酸和丙氨酸,天冬酰胺和谷胺酰胺,丝氨酸和苏氨酸以及苯丙氨酸和酪氨酸。
如本文所用“氨基酸序列”指寡肽、肽、多肽或蛋白质序列及其任何片段,并且指天然产生的、重组的、合成或半合成的分子。本发明的序列包含至少5、10、15、20、25、30、35、40、45、50、100、150、200、250个氨基酸,优选至少5-10、10-20、20-30、30-40、40-50、50-100、100-150、150-200或200-250或250-4000个氨基酸,并且优选保持原始序列的生物学活性(如细胞结合、细胞通透或细胞裂解)或免疫学活性(如一个或多个抗体结合位点)。当本文引用“氨基酸序列”指代天然产生多肽分子的氨基酸序列、氨基酸序列,以及类似术语时,并不意于将氨基酸序列限制为与全长分子相关的完整原始氨基酸序列。
本文所用“扩增”指产生核酸序列的其它拷贝,通常使用本发明熟知的聚合酶链反应(PCR)技术操作(Dieffenbach,C.W.和G.S.Dveksler(1995)《PCR引物,实验室手册,冷泉港出版社,纽约普莱恩维尤》(PCRPrimer,aLaboratoryManual,ColdSpringHarborPress,Plainview,NY))。
术语“抗体”应理解为最广泛的可能含义,并意于包含完整的单克隆抗体和多克隆抗体。也意于覆盖抗体片段和衍生物,只要其显示生物学活性。抗体包括免疫球蛋白分子和免疫球蛋白(Ig)分子的活性部分,即包含特异性结合抗原(与其免疫反应)的抗原结合位点的分子。这些包括但不限于:多克隆抗体、单克隆抗体、嵌合抗体、单链抗体、Fc、Fab、Fab’和Fab2片段和Fab表达文库。
抗体分子涉及IgG、IgM、IgA、IgE和IgD的任何种类,它们之间的差异在于分子中重链的特性。它们也包括亚类,如IgG1、IgG2和其它。轻链可以是κ链或λ链。本文提到抗体时包括所有类、亚类和类型。还包括嵌合抗体,例如对于不止一种来源如一种或多种小鼠、人或反刍动物序列具有特异性的单克隆抗体或其片段。还包括羊驼抗体或纳米抗体。应理解,本文中提到“抗体”或任何类似术语包括完整抗体,及其任何片段、变化形式、衍生物或变体。
如本文所用术语“生物学活性”或“功能性”指保持一种或多种结构、免疫学或生物化学功能(如细胞结合、细胞通透或细胞裂解)的多肽。
本文所用术语“细胞抑制剂”或“抑制剂”指降低或阻碍微生物细胞,尤其是产甲烷菌细胞生长或复制的试剂。细胞抑制剂可用于降低或阻碍如细胞分裂。抑制剂可减少或阻断例如DNA合成、RNA合成、蛋白质合成或翻译后修饰。抑制剂也可降低或阻断参与甲烷生成通路的酶的活性。抑制剂还可靶向细胞,以便免疫系统组件识别。抑制细胞还包括细胞杀伤和细胞死亡,例如通过裂解、凋亡、坏死等实现。有用的抑制剂包括但不限于:如本文详述的抗甲烷生成化合物(如溴代乙磺酸)、抗体和抗体片段、裂解酶、肽核酸、抗微生物肽和其他抗生素。
本文所用术语“互补的”或“互补性”指在允许的盐和温度条件下多核苷酸通过碱基配对自然结合。对于序列A-G-T,互补序列是T-C-A,反向互补是A-C-T而反向序列是T-G-A。两条单链分子间的互补性可以是部分的,即仅有一些核酸结合,或者为完全互补,即当单链分子间存在完全互补性时。核酸链间的互补程度对于核酸链间杂交的效率和强度有显著性影响。这对于依赖核酸链结合的扩增反应以及PNA分子的设计和使用尤其重要。
本文所用术语“衍生物”指噬菌体多肽的编码核酸或与之互补的核酸的化学修饰形式。此类修饰包括例如,用烷基、酰基或氨基取代氢。在优选方面,核酸衍生物编码的多肽保留天然分子的生物学或免疫学功能。
衍生多肽是通过糖基化、peg化或任何相似过程修饰的多肽,它保留了其来源序列的一种或多种生物学功能(如细胞结合、细胞通透或细胞裂解)或免疫学功能。
本文所用术语“同源”指一定程度的互补性。可以是部分同源(即,1相同)或完全同源(即,100%相同)。使用功能性术语“基本同源”指代至少部分抑制相同序列与靶核酸杂交的部分互补序列。可在低严谨性条件下使用杂交实验(Southern或northern印迹,溶液杂交等)检验对完全互补序列与靶序列杂交的抑制。基本同源的序列或杂交探针在低严谨性条件下将竞争并抑制完全同源序列与靶序列的结合。这并不是说低严谨性条件允许非特异性结合;低严谨性条件需要两条序列的相互结合是特异性(选择性)相互作用。
如本文所用术语“杂交”指核酸链通过碱基配对与互补链结合的任何过程。
本文所用“插入”或“加入”指对氨基酸或核苷酸序列进行改变,与天然产生的分子相比,导致加入一个或多个氨基酸残基或核苷酸。
本文所用“产甲烷菌”指产生甲烷气体的微生物,包括甲烷短杆菌(Methanobrevibacter)、甲烷嗜热杆菌(Methanothermobacter)、甲烷微菌(Methanomicrobium)、甲烷杆菌(Methanobacterium)和甲烷八叠球菌(Methanosarcina)。具体的产甲烷菌包括但不限于:反刍甲烷短杆(Methanobrevibacterruminantium)、史氏甲烷短杆菌(Methanobrevibactersmithii)、酸性甲烷短杆菌(Methanobrevibacteracididurans)、巢氏甲烷短杆菌(Methanobrevibacterthaueri)、布氏甲烷杆菌(Methanobacteriumbryantii)、甲酸甲烷杆菌(Methanobacteriumformicicum)、马尔堡甲烷嗜热杆菌(Methanothermobactermarburgensis)、沃氏甲烷嗜热杆菌(Methanothermobacterwolfeii)、斯氏甲烷球形菌(Methanosphaerastadtmanae)、运动甲烷微菌(Methanomicrobiummobile)、巴氏甲烷八叠球菌(Methanosarcinabarkeri)、梅氏甲烷八叠球菌(Methanosarcinamazei)、布氏拟甲烷球菌(Methanococcoidesburtonii)和泰氏甲烷叶菌(Methanolobustaylorii)。所有产甲烷菌的属和种均在此术语涵盖范围内。
本文所用“微生物细胞”指天然产生或遗传修饰的微生物细胞,包括古细菌如产甲烷菌、嗜盐微生物和嗜酸嗜热菌,以及真细菌,如蓝藻、螺旋体、变形细菌以及革兰阳性和革兰阴性细菌。
术语“修饰的”指如本文所述的更改的序列和序列片段、变体和衍生物。
本文所用“核酸序列”或“核苷酸序列”指多核苷酸序列、寡核苷酸或其片段,以及天然、重组、合成或半合成来源的DNA或RNA,它们可以是单链或双链,并可代表正义或反以链以及编码或非编码区。本发明的序列最优选包括包含至少12、15、30、45、60、75、90、105、120、135、150、300、450、600、750个核苷酸,优选至少15-30、30-60、60-90、90-120、120-150、150-300、300-450、450-600或600-750个核苷酸或至少1000个核苷酸或至少1500个核苷酸的多肽编码序列。应理解的是本文中每一处提及“核酸序列”或“核苷酸序列”将包括原始、全长序列,及其任何互补序列、片段、变化形式、衍生物或变体。
术语“寡核苷酸”指包含至少6、8、10、12、15、18、21、25、27、30或36个核苷酸或至少12-36个核苷酸或至少15-30个核苷酸的核酸序列,可用于例如PCR扩增、测序或杂交实验。如本文所用,“寡核苷酸”基本等同于“扩增物”、“引物”、“寡聚物”、“寡核苷酸”以及“探针”,如本领域通常定义的那样。
本文所用“多肽”指本发明的分离多肽,其获自任何物种,优选微生物,以及任何天然、合成、半合成或重组的来源。具体说,噬菌体多肽可获自产甲烷菌细胞,如甲烷短杆菌(Methanobrevibacter)细胞,具体是反刍甲烷短杆菌或史氏甲烷短杆菌细胞。对于重组产生,本发明多肽可获自微生物或真核细胞,例如大肠杆菌(Escherichia)、链球菌(Streptomyces)、芽孢杆菌(Bacillus)、沙门菌(Salmonella)、酵母、昆虫细胞如果蝇细胞、动物细胞如COS和CHO细胞或植物细胞。应理解的是本文中每一处提及“多肽”将包括原始、全长序列,及其任何片段、变化形式、衍生物或变体。
本文中所用单数或复数形式的术语“多核苷酸”一般指任何核酸序列,例如,任何聚核糖核苷酸或聚脱氧核糖核苷酸,它可以是未修饰的RNA或DNA,或者修饰的RNA或DNA。包括但不限于:单链和双链DNA,包括单链和双链区的DNA,单链和双链RNA以及包括单链和双链区的RNA,包含DNA和RNA的杂交分子(可为单链或(更典型的)双链或包含单链和双链区)。也包括含有RNA或DNA或者RNA和DNA的三链区。具体说,包括mRNA、cDNA和基因组DNA及其任何片段。该术语包括含有一个或多个修饰碱基如含氚碱基或非常见碱基如肌苷的DNA和RNA。本发明的多核苷酸可涵盖编码或非编码序列,或正义或反义序列或iRNA如siRNA。应理解的是本文中每一处提及“多核苷酸”或类似术语将包括全长序列,及其任何互补序列、片段、变化形式、衍生物或变体。
本文所用“肽核酸”或“PNA”指反义分子或抗-基因试剂,其包含通过肽主链连接的碱基。
本文所用术语“反刍动物”指具有瘤胃作为特殊类型消化器官的动物。反刍动物包括但不限于:牛、绵羊、山羊、水牛、麋鹿、羚羊、北美驯鹿和鹿。
本文所用术语“严谨条件”或“严谨性”指核酸、盐和温度限定的杂交条件。这些条件为本领域所熟知,可更改这些条件以鉴定或检测相同或相关的多核苷酸序列。参见例如Sambrook,J.等(1989)《分子克隆,实验室手册》冷泉港出版社,纽约普莱恩维尤(MolecularCloning,ALaboratoryManual,ColdSpringHarborPress,Plainview,NY),以及Ausubel,F.M.等(1989)新编分子生物学实验指南,约翰韦利森出版社,纽约(CurrentProtocolsinMolecularBiology,JohnWiley&Sons,NewYork,NY)。数种包含低或高严谨性的相等条件取决于以下因素,如序列的长度和特性(DNA、RNA、碱基组成)、靶点特性(DNA、RNA、碱基组成)、环境(在溶液中或固定于固体基材上)、盐和其它成分(如甲酰胺、硫酸右旋糖苷和/或聚乙二醇)的浓度和反应温度(从低于探针解链温度5℃至低于解链温度约20℃-25℃的范围内)。可改变一种或多种因素以产生不同于或等同于上述条件的低或高严谨性。
术语“对象”包括人或非人动物。非人动物包括但不限于:鸟类和哺乳动物,如反刍动物,具体是小鼠、兔、猫、狗、猪、绵羊、山羊、牛和马。
本文所用术语“基本纯化”或“分离”指从细胞、重组或合成环境中移出的核酸或氨基酸序列,并且至少至少60%,优选75%并最优选至少90%或至少99%不含它们在细胞、重组或合成环境中相关联的其它组分。
本文所定义“转化”指外源DNA进入并改变接受细胞的过程。可使用本领域所熟知多种方法在天然或人工条件下进行转化。转化可依赖将外源核酸序列插入原核或真核宿主细胞的任何已知方法。基于需转化的宿主细胞类型选择方法,可包括但不限于病毒感染、电穿孔、热休克、脂质转染和粒子轰击。此类“转化”细胞包括稳定转化细胞,其中插入的DNA能够作为自主复制质粒或作为宿主染色体的一部分进行复制。它们还包括在限定时间期间瞬时表达插入的DNA或RNA的细胞。
如本文所用多肽“变体”指一个或多个氨基酸改变的氨基酸序列。改变变体多核苷酸的一个或多个核苷酸。变体可导致“保守性”改变,其中取代的氨基酸具有相似结构或化学特性,如用异亮氨酸取代亮氨酸。更少见的,变体可导致“非保守性”变化,如用色氨酸替换甘氨酸。类似的小变异还可包括氨基酸缺失或插入或两者均有。使用本领域熟知计算机程序如LASERGENE软件(DNASTAR)可发现如何确定可对哪一氨基酸取代、插入或缺失而不破坏生物学或免疫学活性的指南。
本发明还涵盖保留多肽的至少一种生物学活性(如细胞结合、细胞通透或细胞裂解)或免疫学活性的变体。优选的变体是具有基本相同或功能等同序列的变体,例如与公开序列至少80%和更优选至少90%序列相同的变体。最优选的变体是与本文公开序列至少95%,至少97%,至少98%,至少99%,至少99.5%,至少99.8%或至少99.9%序列相同的变体。如下所述通过对需比较的两条序列比对、确定比对部分的相同残基数目、除以本发明(查询)序列总残基数并乘以100,从而确定相同性百分数。有用的比对程序是AlignX(载体NTI)。
发明详述
甲烷在反刍动物前肠中由产甲烷菌产生,它是瘤胃系统中碳的终末还原产物。已对甲烷产生通路的多个步骤进行了阐述,主要来自于对非瘤胃产甲烷菌的研究,但是尚不了解对于使产甲烷菌在瘤胃中生长和持续存在的适应性。反刍甲烷短杆菌(Methanobrevibacterruminantium)是新西兰反刍动物体内主要的产甲烷菌。如本文所述,已经对反刍甲烷短杆菌的基因组进行测序,显示大小约3.0Mb,GC含量为33.68%。一个出乎意料的发现是反刍甲烷短杆菌基因组包括原噬菌体序列(称为),该序列具有编码噬菌体整合、DNA复制和包装、衣壳蛋白质、裂解和溶原性转换功能的独特功能模块。
在进行高通量测序时,发现基因组的30-40kb区域在测序克隆中过度出现,因此发现反刍甲烷短杆菌噬菌体。这表明基因组的一部分以高于通常水平的拷贝数出现,这可能归因于驻留噬菌体的复制。对过度出现的区域进行研究,预测开放阅读框的详细生物信息学分析表明它含有噬菌体样基因。已证明噬菌体序列(溶原性转换)远端发现的低GC区含有预测的DNA硫修饰系统(dnd),它可能为宿主或外源DNA的提供其它修饰。本文详述了反刍甲烷短杆菌原噬菌体序列。在本发明的不同方面,可以使用原噬菌体多核苷酸和多肽作为在瘤胃中抑制产甲烷菌和/或甲烷生成的手段,并进一步阐明反刍甲烷短杆菌在甲烷形成中的作用。
因此,本发明包括噬菌体多肽,包括含有至少SEQIDNO:1-69中至少一种或其片段、变体和衍生物的那些多肽。本发明还包括这些多肽在靶向和抑制微生物细胞,尤其是产甲烷菌细胞中的应用。本发明还包括该多肽在抑制此类细胞生长或复制中的应用。可表达本发明的多肽并用于不同的实验以测定其生物学活性。该多肽可用于大规模合成和分离实验方案,例如,用于商业生产。可使用此类多肽产生抗体,以分离相应的氨基酸序列和对氨基酸序列水平进行定量测定。本发明的多肽还可用作组合物,例如药物组合物和食品补充剂,如反刍动物饲料组分。本发明的多肽还具有健康益处。在健康相关方面,产甲烷菌抑制剂可用于恢复通常以甲烷形式从个体流失的能量。在特定方面,缓释瘤胃装置可与本发明的多肽和组合物(如药物组合物和食品补充剂)联用。
本发明多肽包含选自下组的至少一个序列:(a)包含至少一个选自SEQIDNO:1-69或其片段、变体或衍生物的氨基酸序列的多肽;(b)包含至少一个选自SEQIDNO:1-69和其片段、变体的氨基酸序列的功能性结构域的多肽;以及(c)包含的选自SEQIDNO:1-69或其变体或衍生物的至少一个氨基酸序列的至少一定数目的毗连残基的多肽。在一个实施方式中,本发明包括含有SEQIDNO:1-69中至少一个氨基酸序列的分离的多肽。所有这些序列统称本发明的多肽。
本发明还包括编码至少一种噬菌体多肽,包括SEQIDNO:1-69及其片段、变体和衍生物的多核苷酸。本发明还包括这些多核苷酸在制备靶向和抑制微生物细胞尤其是产甲烷菌细胞的表达载体和宿主细胞中的应用。本发明还包括多核苷酸在抑制此类细胞生长或复制中的应用。本发明的分离的多核苷酸还可用于对或多或少的相关噬菌体进行基因组作图、物理作图和基因克隆。通过本领域熟知技术如狭缝印迹技术或微阵列技术,可使用根据本发明多核苷酸设计的探针在细胞中具有充分同源DNA和RNA序列的任何生物体中检测基因的存在和表达模式。使用本发明多核苷酸设计的引物可用于测序和PCR扩增。本发明的多核苷酸还可用作组合物,例如药物组合物和食品补充剂,如,反刍动物饲料组分。本发明的多核苷酸还具有健康益处。对于此类益处,多核苷酸可作为表达载体或含表达载体的宿主细胞提供。在特定方面,缓释瘤胃装置可与本发明的多核苷酸、载体、宿主细胞和组合物(如药物组合物和食品补充剂)联用。
本发明多核苷酸包含选自下组的至少一个序列:(a)包含至少一个选自SEQIDNO:1-69或其片段或变体的氨基酸序列的编码序列的序列;(b)至少一个选自SEQIDNO:1-69或其片段或变体的氨基酸序列的编码序列的互补序列、反向序列以及反向互补序列;(c)至少一个选自SEQIDNO:1-69或其片段或变体的氨基酸序列的编码序列中所含的开放阅读框;(d)至少一个选自SEQIDNO:1-69或其片段或变体的氨基酸序列的编码序列的功能性结构域;以及(e)含有至少一个选自SEQIDNO:1-69或其变体的氨基酸序列的编码序列的至少一定数目的毗连残基的序列。在一个方面,本发明包括包含至少一个选自SEQIDNO:1-69的氨基酸序列的编码序列的分离多核苷酸。
本发明多核苷酸包含选自下组的至少一个序列:(a)包含至少一个选自SEQIDNO:74-142或其片段或变体的核酸序列的序列;(b)至少一个选自SEQIDNO:74-142或其片段或变体的核酸序列的编码序列的互补序列、反向序列以及反向互补序列;(c)选自SEQIDNO:74-142或其片段或变体的核酸序列中所含的开放阅读框;(d)至少一个选自SEQIDNO:74-142或其片段或变体的核酸序列的编码序列的功能性结构域;以及(e)含有至少一个选自SEQIDNO:74-142或其变体的核酸序列的至少一定数目的毗连残基的序列。还提供获自任何公开序列的寡核苷酸探针和引物及其变体。所有这些多核苷酸和寡核苷酸在本文中统称为本发明的多核苷酸。
本领域熟练技术人员应当理解的是,作为遗传密码简并性的结果,可产生大量本发明多肽的编码核苷酸序列,其中某些序列与任何已知和天然产生的基因的核苷酸序列同源性很小。因此,本发明考虑到各个和每个可能的核苷酸序列变异,这些变异可通过根据可能密码子选择密码子组合而产生。根据应用于天然产生的氨基酸序列的标准细菌三联遗传密码产生这些组合,所有此类变异都被视作已具体公开。
编码噬菌体多肽或其片段或变体的核苷酸序列优选在适当选择的严谨条件下能够与天然产生序列的核苷酸序列杂交。然而,具有优势的是产生编码多肽或其片段或衍生物的、具有明显不同密码子使用的核苷酸序列。根据宿主使用特定密码子的频率,可选择密码子以提高特定原核或真核宿主中的多肽表达速率。例如,按照已知方法,可根据大肠杆菌表达优化密码子。改变多肽及其衍生物的编码核苷酸序列而不改变编码的氨基酸序列的其它原因包括产生具有更有利特性,如比天然产生序列产生的转录物具有更长半衰期的RNA转录物。
本发明还包括完全通过合成化学产生编码多肽或其片段或变体的DNA序列或其片段。在合成序列产生后,利用本领域熟知试剂,可将其插入到任何可用的表达载体和细胞系统中。而且,可使用合成化学在编码多肽或其任何变体或片段的序列中引入突变。本发明还包括在如Wahl,G.M和S.L.Berger(1987;MethodsEnzymol.152:399-407)以及Kimmel,A.R.(1987;MethodsEnzymol.152:507-511)所教导的各种严谨条件下,能与要求权利的核苷酸序列杂交的多核苷酸序列,尤其是SEQIDNO:74-149中显示的那些及其互补序列。
本领域熟知并常用的DNA测序方法可用于实践本发明的任何实施方式。这类方法可使用如DNA聚合酶I的克列诺片段,SEQUENASE(美国生物化学集团(U.S.BiochemicalCorp.),俄亥俄州克里富兰)(U.S.BiochemicalCorp,Cleveland,OH),Taq聚合酶(珀金埃尔默)(PerkinElmer),热稳定T7聚合酶(安法马西亚生物技术公司,新泽西州皮斯卡塔韦)(AmershamPharmaciaBiotechPiscataway,NJ),或者聚合酶和校对核酸外切酶的组合,如生命技术公司(LifeTechnologies)(马里兰州盖瑟斯堡)销售的ELONGASE扩增系统中找到的那些。优选地,该方法通过机器自动化进行,如汉密尔顿微型实验室2200(HamiltonMicroLab2200)(内华达州雷诺汉密尔顿)(Hamilton,Reno,NV),派而特热循环仪(PeltierThermalCycler)(PTC200;MJ研究公司,麻省沃特敦)(MJResearch,Watertown,MA);ABI催化仪(ABICatalyst)以及373和377DNA测序仪(珀金埃尔默)(PerkinElmer)或基因组测序仪20TM(罗氏诊断公司)(RocheDiagnostics)。
可使用部分核苷酸序列并利用本领域所知检测上游序列如启动子和调控元件以及下游元件如终止子和非编码RNA结构的方法,对多肽的编码核酸序列进行扩展。例如,可使用的一种方法“位点限制性”PCR使用通用引物以获取与已知基因座相邻的未知序列(Sarkar,G.(1993)PCRMethodsApplic.2:318-322)。具体说,在接头序列引物和已知区域特异性引物存在的条件下对基因组DNA进行首次扩增。然后对扩增序列进行第二轮PCR,其中使用相同的接头引物和在第一引物内的另一特异性引物。用合适的RNA聚合酶对每一轮PCR产物进行转录,用逆转录酶进行测序。
另一个有用的方法是反向PCR,也称为IPCR(参见例如,OchmanH,GerberAS,HartlDL.Genetics.1988年11月;120(3):621-3)。当仅知道靶DNA的一个内部序列时,可使用反向PCR。反向PCR方法包括使用限制性核酸内切酶切割的DNA进行一系列消化和自连。此种切割在未知序列的任一末端产生已知序列。按照该方法,通过限制性核酸内切酶消化将靶DNA轻微切割成数千碱基的较小片段。然后在低浓度下诱导自连,引起磷酸主链重新形成并产生环状DNA连接产物。然后用已知核酸内切酶限制性消化靶DNA。由此在已知内部序列内产生切割,产生具有已知末端序列的线性产物。然后可利用该产物和与已知内部序列互补的引物进行标准的PCR。
市售毛细管电泳系统可用于分析测序或PCR产物的核苷酸序列的大小或对其进行确认。具体说,毛细管测序可使用可流动聚合物进行电泳分离,激光激发的四种不同荧光染料(每种对应一种核苷酸),用电荷耦合器件照相机探测发射波长。使用合适的软件(如基因组分型和序列导航者,珀金埃尔默公司)(GENOTYPERandSequenceNAVIGATOR,PerkinElmer)可将输出/光强度转化为电信号,从上样到计算机分析和电子数据显示均可在计算机控制下进行。毛细管电泳尤其优选用于对特定样品中少量存在的小片段DNA进行测序。
近年来,焦磷酸测序成为一种有用的测序方法。参见例如Ronaghi,M.等1996.通过探测焦磷酸释放进行实时DNA测序(Real-timeDNAsequencingusingdetectionofpyrophosphaterelease).Anal.Biochem.242:84-89;Ronaghi,M.等1998.基于实时焦磷酸的测序方法(Asequencingmethodbasedonreal-timepyrophosphate).Science281:363-365;Ronaghi,M.等1999.通过焦磷酸测序分析DNA二级结构(AnalysesofsecondarystructuresinDNAbypyrosequencing).Anal.Biochem.267:65-71;Ronaghi2001.GenomeRes.11卷,1期,3-11;Nyrén,焦磷酸测序历史(Thehistoryofpyrosequencing).MethodsMolBiol.2007;373:1-14。焦磷酸测序的优势是准确、灵活、平行处理并容易自动化.而且,该技术摈弃了对标记引物、标记核苷酸和凝胶电泳的需要。根据该方法,聚合酶催化将核苷酸掺入核酸链。掺入的结果是焦磷酸分子释放并由硫酸化酶转化为ATP。萤光素酶反应产生光,其间萤光素分子被氧化。在加入每种核苷酸后,进行洗涤步骤以允许反复添加。核苷酸降解酶持续降解核苷酸从而允许加入后续核苷酸。已经成功将焦磷酸测序作为平台用于大规模测序,包括基因组和巨大基因组分析(参见例如,来自454罗氏生命科学(LifeSciences/Roche)的基因组测序仪FLXTM)。
研发SOLiDTM系统用于测序(参见例如应用生物系统公司,SOLiDTM系统应用说明书,加州福斯特城)(AppliedBiosystems.ApplicationFactSheetfortheSOLiDTMSystem.FosterCity,CA)。该方法基于将染料标记的寡核苷酸依次连接于磁珠连接的克隆扩增DNA片段。在该方法中,通过测量连续连接产生DNA序列。连接反应基于探针识别而非依次加入,因此不易于累计错误。化学性质大大减少了错误插入或缺失的可能性。连接步骤和用磷酸酶处理未连接探针能防止移相。此外,经历7个循环的连接后,原始引物从模板上脱离,新引物杂交以开始对n-1位置的查询。使用这种“重置”相允许降低系统性噪声并允许更长的阅读长度。此外,使用两碱基编码以区分测量误差与真正的多态性。单一位点的改变被鉴定为随机误差,并在数据分析中可被软件去除。作为分析平台,SOLiDTM系统可应用于大规模测序,数字基因表达,ChIP和甲基化研究,并在探测基因组变异上尤其有用。
在本发明的另一实施方式中,编码多肽的多核苷酸或其片段可用于重组DNA分子以在合适宿主细胞中指导多肽或其片段或变体的表达。由于遗传编码的固有简并性,可产生编码基本相同或功能等同的氨基酸序列的其它DNA序列,这些序列可用于克隆和表达噬菌体多肽。可使用本领域通常所知方法对本发明的核苷酸序列进行工程改造以根据多种原因改变氨基酸编码序列,包括但不限于为了改变克隆、加工和/或基因产物表达而进行的变化。可使用通过随机片段化进行的DNA改组以及对基因片段和合成寡核苷酸的PCR组装对核苷酸序列进行工程改造。例如,可使用定位诱变插入新的限制性位点,改变糖基化形式,改变密码子偏好,引入突变等等。
在本发明的另一实施方式中,可将天然、修饰或重组的编码多肽的核酸序列连接至异源序列以编码融合蛋白。例如,编码可被市售抗体识别的嵌合序列可能是有用的。也可工程改造融合蛋白使其在本发明的多肽和异源蛋白序列间含有切割位点,以便于切割并纯化该多肽,与异源部分分离。
在另一实施方式中,可使用本领域熟知化学方法合成完整或部分形式的多肽编码序列(参见Caruthers,M.H.等(1980)Nucl.AcidsRes.Symp.Ser.215-223,Horn,T.等(1980)Nucl.AcidsRes.Symp.Ser.225-232)。或者,可使用合成氨基酸序列或其片段的化学方法产生多肽本身。例如,可使用多种固相合成技术(Roberge,J.Y.等(1995)Science269:202-204;MerrifieldJ.(1963)J.Am.Chem.Soc.85:2149-2154)进行多肽合成,使用例如ABI43lA肽合成仪(珀金埃尔默公司)进行自动合成。可用化学方法合成多肽的各种片段,并用化学方法组合产生全长分子。
可用制备型高效液相色谱分离新合成的多肽(如,Creighton,T.(1983)蛋白质结构和分子原则,WH富瑞曼公司,纽约(ProteinsStructuresandMolecularPrinciples,WHFreemanandCo.,NewYork,NY))。通过氨基酸分析和测序可确认合成多肽的组成(如,埃得曼降解步骤(Edmandegradationprocedure;Creighton),同上)。此外,多肽或其任何部分的氨基酸序列可在直接合成中更改和/或通过化学方法与来自其它蛋白质或其部分的序列组合以产生变体分子。
为了表达生物学活性多肽,可将编码多肽或功能等同物的核苷酸序列插入合适的表达载体,即包含插入序列转录和翻译必需元件的载体。可用本领域熟练技术人员熟知的方法构建包含多肽编码序列以及合适的转录和翻译控制元件的表达载体。
这些方法包括体外重组DNA技术、合成技术和体内遗传重组。
Sambrook,J.等(2001)《分子克隆,实验室手册》冷泉港出版社,纽约普莱恩维尤(MolecularCloning,ALaboratoryManual,ColdSpringHarborPress,Plainview,NY),以及Ausubel,F.M.等(2007)新编分子生物学实验指南,约翰韦利森出版社,纽约(CurrentProtocolsinMolecularBiology,JohnWiley&Sons,NewYork,NY)对此类技术进行了描述。
可使用多种表达载体/宿主系统包含并表达本发明多肽的编码序列。它们包括但不限于:微生物体如重组噬菌体、质粒或粘粒DNA表达载体转化的细菌;酵母表达载体转化的酵母;病毒表达载体(如杆状病毒)转化的昆虫细胞系统;病毒表达载体(如,花椰菜花叶病毒CaMV;烟草花叶病毒TMV)或细菌表达载体(如,Ti或pBR322质粒)转化的植物细胞;或动物细胞系统。对于细菌,有用的质粒包括英骏公司(Invitrogen)的pET、pRSET、pTrcHis2和pBAD质粒;诺瓦基公司(Novagen)的pET和pCDF质粒以及西格玛奥德里奇公司(Sigma-Aldrich)的DirectorTM质粒。对于产甲烷菌,有用的质粒包括但不限于pME2001、pMV15和pMP1。具体说,可将大肠杆菌(Escherichiacoli)与表达载体pET一起使用。所用表达载体或宿主细胞并不限制本发明。
“控制元件”和“调节序列”是载体的非翻译区-增强子、启动子、5′和3′非翻译区--它们与宿主细胞蛋白质相互作用,进行转录和翻译。此类元件的强度和特异性可能不同。根据所使用载体系统和宿主,可使用任何数量的合适的转录和翻译元件,包括组成型和诱导型启动子。例如,当克隆进细菌系统时,可使用诱导型启动子,如BLUESCRIPT噬菌粒(司查塔基公司,加州拉霍亚)(Stratagene,LaJolla,CA)或pSPORT1质粒(生命技术公司)(LifeTechnologies)的杂交lacZ启动子等。可在昆虫细胞中使用杆状病毒多角体蛋白启动子。可将来源于植物细胞基因组(如,热休克、RUBISCO和存储蛋白质基因)的启动子或增强子或来自于植物病毒的启动子或增强子(如病毒启动子或前导序列)克隆到载体中。
在细菌系统中,可根据多肽的指定应用对许多表达载体进行选择。例如,当需要大量多肽时,可使用指导高水平表达易于纯化的融合蛋白的载体。此类载体包括但不限于:多功能大肠杆菌克隆和表达载体如BLUESCRIPT(司查塔基公司),其中可将多肽编码序列连接入载体,与β-半乳糖苷酶的氨基末端Met和后续7个残基在相同读框内,从而产生杂合蛋白;pIN载体(VanHeeke,G.和S.M.Schuster(1989)J.Biol.Chem.264:5503-5509)等。
也可采用pGEX载体(普洛麦格公司,威斯康星州麦迪逊)(Promega,Madison,WI)表达多肽与谷胱甘肽-S-转移酶(GST)的融合蛋白。通常,这类融合蛋白可溶,并容易通过以下方法由裂解细胞纯化:吸附于谷胱甘肽琼脂糖珠上,然后在游离谷胱甘肽的存在下洗脱。可设计此类系统产生的蛋白质以使其包含肝素、凝血酶或Xa因子蛋白酶切割位点,从而使感兴趣的克隆多肽可按需从GST部分释放出来。在酿酒酵母(Saccharomycescerevisiae)中,可使用包含组成型或诱导型启动子的多种载体,如α因子、醇氧化酶和PGH。参见Ausubel等(同上)和Grant等(1987)MethodsEnzymol.153:516-544的综述。
也可使用特异性起始信号达到更有效的翻译本发明多肽编码序列的目的。此类信号包括ATG启动密码子和相邻序列。当多肽编码序列、其起始密码子和上游序列插入到合适表达载体的情况下,无需另外的转录或翻译控制信号。然而,当仅插入编码序列或其片段时,需提供外源的翻译控制信号包括ATG起始密码子。而且,起始密码子应当位于正确的阅读框中,以保证完整插入物的翻译。外源翻译控制元件和起始密码子可有多种天然或合成来源。通过包括适合所用特定细胞体系的增强子可增强表达效率,如文献中所述(Scharf,D.等,(1994)ResultsProbl.CellDiffer.20:125-162)。
此外,可根据宿主细胞株调节插入序列表达或以所期望的方式加工表达多肽的能力对其进行选择。此类序列的修饰包括但不限于:乙酰化、羧化、糖基化、磷酸化、脂化和酰基化。也可使用切割多肽“前体”形式的翻译后加工以利于正确的插入、折叠和/或功能。可从美国典型培养物保藏中心(马里兰州贝塞斯达)(AmericanTypeCultureCollection(ATCC;Bethesda,MD)获取具有特定细胞机器或翻译后活性的特征性机制的不同宿主细胞,选择以保证正确的序列修饰和加工。具体宿主细胞包括但不限于:产甲烷菌细胞,如产甲烷短杆菌细胞,具体说,反刍甲烷短杆菌或史氏甲烷短杆菌细胞。感兴趣的宿主细胞还包括例如,红酵母(Rhodotorula)、短梗霉菌(Aureobasidium)、酿酒酵母(Saccharomyces)、掷孢酵母(Sporobolomyces)、假单胞菌(Pseudomonas)、欧文氏菌(Erwinia)和黄杆菌(Flavobacterium);或其它此类有机体如埃希菌(Escherichia)、乳酸杆菌(Lactobacillus)、芽胞杆菌(Bacillus)、链霉菌(Streptomyces)等。特定的宿主细胞包括尤其适于本发明使用的大肠杆菌(Escherichiacoli)、酿酒酵母(Saccharomycescerevisiae)、苏云金芽孢杆菌(Bacillusthuringiensis)、枯草芽孢杆菌(Bacillussubtilis)、变青链霉菌(Streptomyceslividans)等。
数种技术可将核酸引入体外培养的真核细胞中。它们包括化学方法(Felgner等,Proc.Natl.Acad.Sci.,USA,84:74137417(1987);Bothwell等,真核基因克隆和分析方法(MethodsforCloningandAnalysisofEukaryoticGenes),编,约翰和巴特勒出版公司,麻省波士顿(JonesandBartlettPublishersInc.,Boston,Mass.)(1990);Ausubel等,分子生物学简明实验方案(ShortProtocolsinMolecularBiology),约翰韦利森公司,纽约(JohnWileyandSons,NewYork,NY)(1992);以及Farhood,Annal.NYAcad.Sci.,716:2334(1994)),使用原生质体(Bothwell,同上)或电脉冲(Vatteroni等,Mutn.Res.,291:163169(1993);Sabelnikov,Prog.Biophys.Mol.Biol.,62:119152(1994);Bothwell等,同上;以及Ausubel等,同上),使用减毒病毒(Davis等,J.Virol.1996,70(6),37813787;Brinster等J.Gen.Virol.2002,83(Pt2),369381;Moss,Dev.Biol.Stan.,82:5563(1994);以及Bothwell等,同上),以及物理方法(Fynan等,同上;Johnston等,Meth.CellBiol.,43(PtA):353365(1994);Bothwell等,同上;以及Ausubel等,同上)。
可通过以下方法将核酸成功递送至动物组织:使用阳离子脂质体(Watanabe等,Mol.Reprod.Dev.,38:268274(1994)),直接将裸露的DNA或RNA注射入动物肌肉组织(Robinson等,Vacc.,11:957960(1993);Hoffman等,Vacc.12:15291533(1994);Xiang等,Virol.,199:132140(1994);Webster等,Vacc.,12:14951498(1994);Davis等,Vacc.,12:15031509(1994);Davis等,Hum.Molec.Gen.,2:18471851(1993);Dalemans等,AnnNYAcad.Sci.1995,772,255256.Conry等,CancerRes.1995,55(7),1397-1400)和胚胎(Naito等,Mol.Reprod.Dev.,39:153161(1994);和Burdon等,Mol.Reprod.Dev.,33:436442(1992)),肌肉内注射自我复制的RNA疫苗(Davis等,JVirol1996,70(6),37813787;Balasuriya等,Vaccine2002,20(1112),16091617)或者用“基因枪”技术皮内注射DNA(Johnston等,同上)。
用蛋白质特异性多克隆或单克隆抗体检测和测定本发明多肽表达的各种实验方案为本领域所知。例子包括酶联免疫吸附实验(ELISA)、放射性免疫(RIA)和荧光激活的细胞分选(FACS)。可使用与多肽上两个非干扰表位具有反应性的单克隆抗体进行双位点单克隆免疫实验,也可使用竞争结合实验。这些和其它实验参见Hampton,R.等(1990;血清学方法,实验室手册(SerologicalMethods,alaboratoryManual),APS出版社,明尼苏达州圣保罗)以及Maddox,D.E.等(1983;J.Exp.Med.158:1211-1216)等。
本领域熟练技术人员了解多种标记和偶联技术,可用于多种核酸和氨基酸实验。产生标记的杂交或PCR探针用于探测多核苷酸相关序列的方法包括寡核苷酸标记、缺口平移、末端标记或使用标记核苷酸进行PCR扩增。或者,可将多肽或其任何片段或变体的编码序列克隆入载体用于产生mRNA探针。此类载体为本领域所知并可购得,可在加入合适RNA聚合酶如T7、T3或SP6以及标记的核苷酸后用于体外合成RNA探针。可利用安法马西亚生物技术公司、普洛麦格公司和美国生物化学公司(AmershamPharmaciaBiotech,PromegaandUSBiochechemical)生产的多种市售试剂盒进行这些步骤。易于探测的合适报告分子或标记包括放射性核素、酶、荧光物质、化学发光物质或发色剂以及底物、辅因子、抑制剂、磁性颗粒等。
可在适于表达和从培养物中回收多肽的条件下,复制表达载体或用表达载体转化的宿主细胞。培养物可包含体外或体内表达组件。体外表达组件包括兔网织红细胞裂解物、大肠杆菌裂解物和麦芽提取物的体外表达组件,例如,英骏公司(Invitrogen)的ExpresswayTM或RiPs系统,英特龙生物技术公司(iNtRONBiotechnology)的GenelatorTM系统,诺瓦基公司(Novagen)的EcoProTM或STP3TM系统,普洛麦格公司(Promega)的快速偶联系统和凯杰公司(QIAGEN)的EasyXpress系统。产自培养物的多肽可以是分泌的或细胞内包含的多肽,这取决于序列和/或所用载体。在某些特定方面,可设计编码噬菌体多肽的表达载体使其包含指导多肽通过原核或真核细胞膜分泌的信号序列。
其它构建物可包含利于多肽纯化的氨基酸结构域。此类结构域包括但不限于:可在固化金属上进行纯化的金属螯合肽如组氨酸-色氨酸(如6X-HIS(SEQIDNO:150))模块,可在固定免疫球蛋白上进行纯化的蛋白质A结构域,以及在扩展/亲和纯化系统(因缪耐斯集团,华盛顿州西雅图)(ImmunexCorp.,Seattle,WA)中所用结构域。可用的表位标签包括HA、VSV-G、V5、HSV、GST、GFP、MBP、GAL4和β-半乳糖苷酶。有用的质粒包括含有生物素标签的质粒(如,普洛麦格公司的PinPointTM质粒),含有钙调蛋白结合蛋白的质粒(如司查塔基公司的pCAL质粒),含有链霉亲和素结合肽的质粒(如司查塔基公司的InterPlayTM质粒),含有c-myc或标签的质粒(如西格玛奥德里奇公司的免疫沉淀质粒)或含有组氨酸标签的质粒(如凯杰公司的QIAExpress质粒)。
为了利于纯化,表达载体可包含可切割的接头序列,如Xa因子或肠激酶(英骏公司,加州圣地亚哥)的特异性接头序列。例如,载体在纯化结构域和多肽间可包含一个或多个接头。一种此类表达载体能够用于表达包含本发明多肽的融合蛋白,并提供编码硫氧还蛋白或肠激酶切割位点前6个组氨酸的核酸。组氨酸残基利于在IMAC(固定金属离子亲和色谱柱,如Porath,J等(1992)Prot.Exp.Purif.3:263-281所述)上纯化,而肠激酶切割位点则提供一种从融合蛋白中纯化多肽的方法。Kroll,D.J.等(1993;DNACellBiol.12:441-453)提供了关于包含融合蛋白的载体的讨论。
可使用本领域通常所知方法产生本发明抗体,用于纯化或诊断技术。具体说,根据通常所知的实验方案,可使用多肽或多核苷酸产生抗体。此类抗体可包括但不限于:多克隆、单克隆、嵌合和单链抗体、Fab片段和Fab表达文库产生的片段。本发明尤其优选使用中和抗体(即抑制功能的那些抗体)。
为了产生抗体,可将具有免疫原性的多肽、多核苷酸或其任何片段注射入不同的宿主,包括山羊、兔、大鼠、人等,以进行免疫。根据宿主种类,可使用不同的佐剂以提高免疫应答。此类佐剂包括但不限于:福氏佐剂、矿物凝胶如氢氧化铝和表面活性物质如溶血卵磷脂、普流罗尼克多元醇、聚阴离子、肽、油乳剂、钥孔血蓝素和二硝基酚。用于人的佐剂中,尤其优选BCG(卡介苗)和短小棒状杆菌(Corynebacteriumparvum)。
用于诱导抗体的多肽或片段优选具有包含至少5个氨基酸,更优选10个氨基酸的氨基酸序列。优选的是,它们与天然蛋白质氨基酸序列的一部分相同,以及它们可包含小的天然产生分子的完整氨基酸序列。可将氨基酸短臂与另一蛋白质如钥孔血蓝素以及抗嵌合分子的抗体的短臂融合。
使用通过连续培养细胞系产生抗体分子的任何技术制备单克隆抗体。这些技术包括但不限于杂交瘤技术,人B-细胞杂交瘤技术和EBV-杂交瘤技术(Kohler,G.等(1975)Nature256:495-497;Kozbor,D.等(1985)J.Immunol.Methods81:31-42;Cote,R.J等(1983)Proc.Natl.Acad.Sci.80:2026-2030;Cole,S.P.等(1984)Mol.CellBiol.62:109-120)。如文献报道,也可通过诱导淋巴细胞在体内生产抗体,或通过筛选免疫球蛋白文库或高特异性结合试剂板块产生抗体(Orlandi,R.等(1989)Proc.Natl.Acad.Sci.86:3833-3837;Winter,G.等(1991)Nature349:293-299)。
此外,也可使用某些技术产生“嵌合抗体”,如将抗体基因组合以获得具有合适抗原特异性和生物学活性的分子(Morrison,S.L.等(1984)Proc.Natl.Acad.Sci.81:6851-6855;Neuberger,M.S.等(1984)Nature312:604-608;Takeda,S.等(1985)Nature314:452-454)。或者,可通过本领域所知方法改进用于产生单链抗体的技术,以产生特异性单链抗体。具有相关特异性但独特型组成不同的抗体可通过随机组合免疫球蛋白文库的链改组产生(BurtonD.R.(1991)Proc.Natl.Acad.Sci.88:11120-3)。
本发明相关领域的技术人员理解术语“双抗体”和“三抗体”。存在包含重链可变结构域(VH)通过短肽接头与轻链可变结构域(VL)连接的分子,该短肽接头太短以至相同链上的两个结构域间无法配对。这促使与一条或多条其它链的互补结构域配对,并促进形成具有两个或多个功能性抗原结合位点的二聚体或三聚体分子。所得的抗体分子可以是单特异性或多特异性的(如,双抗体的情况下具有双重特异性)。使用本发明涉及领域的标准方法,如Todorovska等(在癌症靶向中双抗体、三抗体和四抗体的设计和应用(Designandapplicationofdiabodies,triabodiesandtetrabodiesforcancertargeting).J.Immunol.Methods.2001年2月1日;248(1-2):47-66)所述,从两种或多种抗体产生此类抗体分子。
也可产生包含特异性结合位点的抗体片段。例如,此类片段包括但不限于:可通过胃蛋白酶消化抗体分子产生的F(ab′)2片段,以及通过还原F(ab′)2片段的二硫桥产生的Fab片段。或者,可构建Fab表达文库以快速简便的鉴定具有所需特异性的单克隆Fab片段(Huse,W.D.等(1989)Science254:1275-1281)。
可使用不同免疫实验来筛选鉴定具有结合特异性的抗体。本领域熟知使用具有确定特异性的多克隆或单克隆抗体进行竞争结合或免疫放射实验的多种实验方法。此类免疫实验通常包括测定多肽或多核苷酸和其特异性抗体间形成的复合物。优选使用与两个非干扰表位具有反应性的单克隆抗体的双位点单克隆免疫实验,但也可使用竞争性结合实验(Maddox,同上)。
本文所述噬菌体多肽具有靶向、通透和/或抑制细胞的能力,还可作为载体分子用于将其它抑制剂分子递送入微生物细胞。将化合物偶联至氨基酸的化学方法已经得以很好的发展,可将多种不同的分子类型与多肽连接。最常见的偶联方法依赖于游离氨基(α-氨基或Lys)、巯基(Cys)或羧酸基团(Asp、Glu或α-羧基)的存在。可使用偶联方法通过羧基-或氨基-末端残基将多肽连接至细胞抑制剂。在一些情况下,序列包含多个可与所选化学物质进行反应的残基。可使用该方法生产包含多于一种细胞抑制剂的多聚物。或者,可缩短或选择多肽,使反应性残基位于序列的氨基或羧基末端。
例如,在多肽合成中可使用N-α-Fmoc-Nε-1-(4,4-二甲基-2,6二氧代环亚己-1-基-3-甲基丁基)-L-赖氨酸,将报告分子如荧光素特异性掺入到赖氨酸残基(Ono等,1997)。合成后用肼处理去除4,4-二甲基-2,6-二氧代环亚己-1-基,偶联5-和6-羧基荧光素琥珀酰亚胺酯。因此,通过在多肽序列中包含赖氨酸残基,然后与合适的衍生化细胞抑制剂反应,能够完成抑制剂分子与噬菌体多肽的偶联。
还可使用EDC(盐酸1-乙基-3-(3-二甲基氨基丙基)碳二亚胺)或碳二亚胺偶联方法。碳二亚胺可激活天门冬氨酸和谷氨酸的侧链羧基基团,以及羧基末端基团,使其成为伯胺偶联的反应性位点。将活化的多肽与细胞抑制剂混合以产生最终的偶联物。如果细胞抑制剂首先被活化,那么EDC法将通过N末端α胺并且可能通过Lys侧链中的胺(如果存在的话)偶联细胞抑制剂。
间-马来酰亚胺基苯甲酰基-N-羟基琥珀酰亚胺酯(MBS)是异双功能试剂,可通过半胱氨酸将多肽连接于细胞抑制剂。半胱氨酸残基的硫醇基团参与偶联。如果所选序列不包含Cys,通常将Cys残基放置于N-或C-末端以便在高度控制条件下连接多肽与细胞抑制剂。出于合成的目的,将半胱氨酸置于多肽的N末端是有帮助的。MBS尤其适合用于本发明。
戊二醛可用作通过其氨基将两个化合物连接的双功能偶联试剂。戊二醛在多肽和细胞抑制剂之间提供了高度灵活的间隔物,以利于呈现。戊二醛是反应性非常高的化合物,与Cys、Tyr和His进行有限程度的反应。当多肽在其氨基末端仅包含一个游离氨基时,戊二醛偶联方法尤其有用。当多肽包含不止一个游离氨基时,可形成大型多聚复合物。
在一个方面,本发明的多肽可融合于(如通过框内克隆)或连接于(如通过化学偶联)细胞抑制剂,如抗微生物试剂。其中包括抗微生物肽,例如杀菌/通透性增加蛋白、阳离子抗微生物蛋白、溶菌酶、乳铁蛋白和犬科抗菌肽(cathelicidins)(如来自中性粒细胞,参见例如Hancock和Chapple,1999,Antimicrob.AgentsChemother.43:1317-1323;Ganz和Lehrer,1997,Curr.Opin.Hematol.4:53-58;Hancock等,1995,Adv.Microb.Physiol.37:135-175)。抗微生物肽还包括防御素(如,来自上皮细胞或中性粒细胞)和血小板杀微生物蛋白(参见例如,Hancock和Chapple,1999,Antimicrob.AgentsChemother.43:1317-1323)。其它抗微生物肽包括但不限于:短杆菌肽S、杆菌肽、多粘菌素B、鲎素、白细胞抗菌肽(bactenecin)(如,牛白细胞抗菌肽),牛蛙皮肤抗菌肽(ranalexin)、天蚕素A(cecropinA)、尹杜抗菌肽(indolicidin)(如牛尹杜抗菌肽)和乳酸链球菌素(如细菌乳酸链球菌素)。
抗微生物试剂还包括离子载体(ionophores),它利于离子(如钠)的穿越脂质屏障如细胞膜进行传播。尤其适合本发明的两个离子载体化合物是RUMENSINTM(礼来公司)(EliLilly)和拉沙里菌素(Lasalocid)(罗氏公司)(HoffmanLaRoche)。其它离子载体包括但不限于:盐霉素、阿伏霉素、阿瑞辛(aridcin)和阿克拉宁(actaplanin)。其他抗微生物剂包括青霉素、莫能菌素TM和阿奇霉素、甲硝唑、链霉素、卡那霉素和青霉素,以及β-内酰胺类、氨基糖苷类、大环内酯类、氯霉素、新生霉素、利福平和氟喹诺酮(参见例如Horn等,2003,AppliedEnviron.Microbiol.69:74-83;Eckburg等,2003,InfectionImmunity71:591-596;Gijzen等,1991,AppliedEnviron.Microbiol.57:1630-1634;Bonelo等,1984,FEMSMicrobiol.Lett.21:341-345;Huser等,1982,Arch.Microbiol.132:1-9;Hilpert等,1981,Zentbl.Bakteriol.Mikrobiol.Hyg.1AbtOrig.C2:21-31)。
尤其有用的抑制剂是阻断或干扰甲烷生成的化合物,包括溴代乙磺酸,如,2-溴代乙磺酸(BES)或其盐,例如钠盐。钼酸钠(Mo)是硫酸还原抑制剂,可与溴代乙磺酸一起使用。其它抗甲烷生成化合物包括但不限于:硝酸、甲酸、甲基氟、三氯甲烷、水合氯醛、亚硫酸钠、乙烯和不饱和烃、乙炔,脂肪酸如亚油酸,顺式油酸,饱和脂肪酸,如山萮酸(behenic)和硬脂酸,以及陆马嗪(lumazine)(例如,2,4-二羟基蝶啶)。其它化合物包括3-溴丙磺酸盐(BPS)、丙炔酸和2-丁炔酸乙酯。
抗微生物剂还包括裂解酶,包括噬菌体溶菌酶、内溶素、溶菌酶、溶素、噬菌体溶素、溶肠壁素、胞壁质酶和病毒溶素。有用的酶具有水解细菌细胞壁中特定键的能力。特定的裂解酶包括但不限于:葡萄糖苷酶,它水解肽聚糖中氨基糖(如N-乙酰基胞壁酸和N-乙酰基葡糖胺)间的糖苷键;酰胺酶,它切割多糖链和交联肽之间的N-乙酰胞壁酰-L-丙氨酸的酰胺连接;以及内肽酶,它水解肽间连接(如,半胱氨酸内肽酶),和内异肽酶,它攻击来自甲烷杆菌科(Methanobacteriacaea)的产甲烷菌的假胞壁质。
本文详述的ORF2058或ORF2055编码的多肽可用作瘤胃产甲烷菌特异性裂解酶。可以从新鲜裂解的反刍甲烷短杆菌细胞中制备天然的酶。或者,可将ORF2058或ORF2055克隆入表达载体并在异源宿主如大肠杆菌中表达。早前利用PeiP和PeiW完成这项工作,并且在还原条件下该重组蛋白显示对抗甲烷嗜热杆菌(Methanothermobacter)细胞的活性(Luo等,2002)。可将ORF2058或ORF2055裂解酶或任何其它裂解酶用于组合物,例如,作为反刍动物的饲料添加剂,或者可将其掺入缓释胶囊或药丸装置用于在瘤胃中长时间递送。可将裂解酶与其它产甲烷菌抑制剂组合或依次使用以避免宿主产甲烷菌适应并对酶耐受。也可在酶中使用随机和/或靶向突变以避免适应。裂解/溶原开关组件(如ORF1981和ORF1983-ORF1986)可以与裂解酶相似的方式使用。
此外,PNA也包括作为抗微生物试剂。PNA是肽-核酸杂交物,其中磷酸主链被获自N-(2-氨基乙基)-甘氨酸单位的非手性中性主链取代(参见例如优卡生物科学系列(EurekahBioscienceCollection).人端粒酶的PNA和寡核苷酸抑制剂(PNAandOligonucleotideInhibitorsofHumanTelomerase).G.Gavory和S.Balasubramanian,兰登生物科学公司(LandesBioscience),2003)。通过亚甲羰基连接将A、G、T、C碱基连接于主链的氨基氮上(P.E.Nielsen等,Science1991.254:1497-1500;M.Egholm等,Nature1993.365:566-568)。PNA以高特异性与互补序列结合,并且相对类似的DNA或RNA,PNA具有更高亲合力(M.Egholm等,同上)。与对应的DNA/DNA或DNA/RNA双链体相比,PNA/DNA或PNA/RNA杂交物具有更高的热稳定性(M.Egholm等,同上)。由于非天然酰胺主链不被核酶或蛋白酶识别,因而PNA还具有高的化学和生物学稳定性(V.Demidov等,BiochemPharmacol1994.48:1310-1313)。通常PNA的长度至少为5个碱基,并包含末端赖氨酸。可将PNAPEG化以进一步延长其寿命(Nielsen,P.E.等(1993)AnticancerDrugDes.8:53-63)。
在一个特定方面,本发明的多肽可与细胞抑制剂如抗体或其片段融合(如通过框架内克隆)或连接(如通过化学偶联)。抗体或抗体片段可靶向微生物细胞,或者特别是产甲烷菌细胞,或一种或多种细胞组件。例如,可靶向细胞表面蛋白质,如胞外受体。包括免疫球蛋白分子和免疫球蛋白(Ig)分子的免疫活性部分,即包含特异性结合抗原(与其免疫反应)的抗原结合位点的分子。
本发明的多肽在靶向微生物细胞,具体说是产甲烷菌细胞中尤其有用。在特定方面,可利用该多肽与细胞壁或膜连接或结合,通透细胞和/或抑制细胞的生长或复制。同样,可使用该多肽瞬时或长时间附着于细胞,或通透细胞壁或膜和/或在胞内环境中累积。应当理解的是,本发明的噬菌体多肽,以及对应的多核苷酸、表达载体、宿主细胞和抗体可用于靶向多种微生物,例如,反刍甲烷短杆菌和史氏甲烷短杆菌,前者是反刍动物中的主要产甲烷菌,后者是人体的主要产甲烷菌。为了实施靶向,可将微生物细胞与噬菌体多肽接触,如本文详述,所述多肽可分离自一种或多种天然资源,或产自表达载体和/或宿主细胞,或来自于合成或半合成化学方法。为了增强通透性,可将该多肽与一种或多种信号序列融合或连接(预测共有序列:
[ML]KKKK[K]{0,1}X{0,9}[IL][IFL][IL][IL][IS][LIA]X{0,4}[LIVF][LIAV][LI][ILV][LAIV][ILFV][LIVF][SAL][ILV][GSA][AS][VAI][SA]A(SEQIDNO:151),参见图6)。还参见Pérez-Bercoff,Koch,J.和Bürglin,T.R.(2006)LogoBar:利用柱状图观察蛋白质标识和缺口(LogoBar:bargraphvisualizationofproteinlogoswithgaps).Bioinformatics22,112-114。在特定方面,将该多肽以本文详述的组合物形式递送给对象,例如通过用于反刍动物的缓释装置递送。
在某些实施方式中,将该多肽与细胞抑制剂融合或连接,所述细胞抑制剂包括例如,抗-产甲烷生成化合物(如溴代乙磺酸),抗体或抗体片段,裂解酶,肽核酸,抗微生物肽或其它抗生素。多肽抑制剂以组合物的形式递送给对象以抑制微生物细胞,具体是产甲烷菌细胞的生长和/或复制。该组合物包含,例如:a)分离的噬菌体,噬菌体颗粒,噬菌体基因组或其变化形式、片段、变体或衍生物;b)分离的噬菌体多肽或其变化形式、片段、变体或衍生物;c)分离的多核苷酸或其变化形式、片段、变体或衍生物;d)包含该多核苷酸的表达载体;或e)包含该表达载体的宿主细胞。根据公开的方法,本发明的组合物可专门包装为试剂盒的一部分,用于靶向、通透和/或抑制微生物细胞,尤其是产甲烷菌细胞。该试剂盒包括至少一种本文所列组合物;以及用于靶向或通透产甲烷菌或其它微生物细胞,或抑制其细胞生长或复制的使用说明。
在另一实施方式中,本发明涉及上述任何方法所用的与药学上可接受载体联用的药物组合物。此类药物组合物可包含噬菌体多肽和细胞抑制剂的组合。或者,药物组合物可包含本文详述的表达载体或宿主细胞。可单独给予该组合物或与至少一种其它药剂,如稳定化合物联合给予,可利用任何无菌的生物相容性药学载体,包括但不限于:盐水、缓冲盐水、右旋糖和水给与该组合物。该组合物可单独给予对象或与其它药剂、药物(如抗微生物药物)或激素联合给予。
除了活性成分,这些药物组合物还可包含合适的药学上可接受的载体,包括利于将活性化合物加工成药学可用制剂的赋形剂和辅助剂。在最新版的雷明顿药物科学(Remington′sPharmaceuticalSciences)(宾夕法尼亚州伊斯顿的麦克出版公司(MaackPublishingCo.,Easton,PA))可找到制剂和给药技术的更多细节。本发明使用的药物组合物可通过任何途径给予,包括但不限于:口服、静脉内、肌肉内、动脉内、髓内、鞘内、心室内、透皮、皮下、腹膜内、鼻内、肠内、局部、舌下或直肠方式。
可使用本领域熟知的药学上可接受的载体,以口服给药合适剂量,配制用于口服给药的药物组合物。此类载体使药物组合物可以配制为片剂、丸剂、糖衣剂、胶囊剂、液体、凝胶剂、糖浆、浆液、混悬剂等,便于对象摄取。可通过以下方法获得口服用途的药物制剂:将活性化合物与固定赋形剂混合,任选将所得混合物研磨,在加入合适的辅助剂后将该混合物加工成颗粒,获得片剂或糖衣剂芯体。合适的赋形剂是糖或蛋白质填充物,如糖,包括乳糖、蔗糖、甘露醇或山梨糖醇;来自玉米、小麦、稻米、土豆或其它植物的淀粉;纤维素,如甲基纤维素、羟丙基甲基-纤维素或羧甲基纤维素钠;胶质物,包括阿拉伯胶和黄芪胶;以及蛋白质如明胶和胶原。需要的话,可加入崩解剂或增溶剂,如交联聚乙烯吡咯烷酮、琼脂、藻酸或其盐,如藻酸钠。
可口服使用的其它药物制剂包括明胶制成的压接(push-fit)胶囊,以及明胶和包衣剂(coating)(如甘油或山梨糖醇)制成的密封软胶囊。压接胶囊可包含与填充剂或粘合剂,如乳糖或淀粉;润滑剂,如滑石粉或硬脂酸镁以及任选稳定剂混合的活性组分。
在软胶囊中,活性化合物可溶解或悬浮于含有或不含稳定剂的合适液体,如脂肪油、液体或液体聚乙二醇中。
糖衣剂芯体可与合适的包衣剂,如浓缩糖溶液联合使用,其中还可包含阿拉伯胶、滑石粉、聚乙烯吡咯烷酮、卡波姆凝胶、聚乙二醇和/或二氧化钛、漆溶液和合适的有机溶剂或溶剂混合物。可将染料或颜料加入片剂或糖衣剂包衣中,用于标示产品或表征活性化合物的量,即剂量。
可用水性溶液,优选生理相容性缓冲液,如汉克斯溶液、林格溶液或生理缓冲盐水配制适合胃肠道外给药的药物制剂。水性注射悬液可包含增加悬液粘度的物质,如羧甲基纤维素钠、山梨糖醇或右旋糖苷。此外,活性化合物的悬液可制备为合适的油性注射悬液。合适的亲脂性溶剂或运载体包括脂肪油如芝麻油,或合成脂肪酸酯如油酸乙酯或甘油三酯,或脂质体。也可使用非脂质聚阳离子氨基酸聚合物进行递送。悬液可任选包含合适的稳定剂或增加化合物溶解度以制备高浓缩溶液的试剂。对于局部或鼻腔给药,在制剂中使用适合要渗透的特定屏障的渗透剂。本领域通常了解此类渗透剂。
本发明的药物组合物可以本领域所知方式制造,如,通过常规的混合、溶解、造粒、制造糖衣剂、水飞、乳化、包胶、包封或冻干工艺的方法。可以盐的形式提供药物组合物,所述盐可用多种酸形成,包括但不限于:盐酸、硫酸、乙酸、乳酸、酒石酸、苹果酸、琥珀酸等。在水性或其它质子溶剂中盐比对应的游离碱形式更易于溶解。在其它情况下,优选制剂可以是包含下列任何或所有成分的冻干粉末:1-50mM组氨酸、0.1%-2%蔗糖和2-7%甘露醇,pH范围为4.5-5.5,在使用前与缓冲液组合。药物组合物制备后,可将其放置于合适的容器中,并贴上用于治疗所示病症的标签。对于本发明组合物的给药,此标签可包含给药量、频率和方法。
适用于本发明的药物组合物包括包含有效量活性组分以达到预期目的的组合物。对于任何化合物,最初可在细胞实验中,如微生物细胞或具体说,在产甲烷菌细胞中,或在动物模型中,通常是小鼠、兔、狗或猪或反刍动物如绵羊、牛、鹿或山羊中估计治疗有效剂量。还可使用动物模型确定合适的浓度范围和给药途径。此类信息还可用于确定有用的给药剂量或途径。通常给药剂量可以是0.1-100,000微克,甚至总剂量约为1g或更多,这取决于给药途径。文献中提供了有关具体剂量和递送方法的指南,本领域实施人员可获得这些指南。与递送多肽相比,本领域熟练技术人员将使用不同制剂递送多核苷酸。相似地,多核苷酸或多肽的递送对于特定细胞、病症、位置等而言是不同的。
本领域已知基于噬菌体的疗法,并且已公开此类组合物的制备方法。已描述噬菌体疗法可用于靶向葡萄球菌(Staphylococcus)(如金黄色葡萄球菌(S.aureus))、假单胞菌(Pseudomonas)(如绿脓假单胞菌(P.aeruginosa))、大肠杆菌(Escherichia)(如大肠杆菌(E.coli))、克雷伯菌(Klebsiella)(如臭鼻克雷伯菌(K.ozaenae)、鼻硬结克雷伯氏菌(K.rhinoscleromatisscleromatis)和肺炎克雷伯菌(K.pneumonia))、变形杆菌(Proteus)、沙门氏菌(Salmonella)、志贺氏菌(Shigella)(参见例如Carlton,R.M.(1999).ArchivumImmunologiaeetTherapiaeExperimentalis,47:267-274;Liu,J.等(2004).Nat.Biotechnol.22,185-191;Projan,S.(2004).Nat.Biotechnol.22,167-168;Sulakvelidze,A.,Alavidze,Z.和Morris,J.G.(2001).AntimicrobialAgentsandChemotherapy,45(3):649-659;Weber-Dabrowska,Mulczyk,M.和Gorski,A.(2000).ArchivumImmunologiaeetTherapiaeExperimentalis,48:547-551)。噬菌体疗法比传统抗微生物剂具有先天的优势,因为噬菌体高度特异,不影响人体中正常微生物;噬菌体不感染真核细胞,不具有已知的严重副作用;噬菌体可定位于感染位置;并且噬菌体可以指数级复制,因此这种治疗仅需小剂量,成本通常很低(参见例如Sulakvelidze等,同上)。关于当前的综述,参见FischettiVA,NelsonD,SchuchR.重新使用噬菌体疗法:部分大于总和?(Reinventingphagetherapy:arethepartsgreaterthanthesum?)NatBiotechnol.2006年12月;24(12):1508-11。
基于肽和多肽的疗法已作描述,例如白介素融合毒素(denileukindifitox)、奥曲肽、伐普肽、兰瑞肽、RC-3940系列肽、达必佳、醋酸亮丙瑞林(lupron)、瑞林、西曲瑞克(参见例如,Lu等,2006,AAPSJ8:E466-472),亥莫西汀(hemocidins),司他弗平(staphopains)(参见例如,Dubin等,2005,ActaBiochemicaiPolonica,52:633-638),以及吲哚西汀(indolicidin),防御素,羊毛硫抗生素,微西汀B17(microcidinB17),富组蛋白(histatins)和吗加宁(maganin)(参见例如,Yeaman和Yount,2003,PharmacolRev55:27-55)。在Degim等,2007,CurrPharmDes13:99-117和Shai等,2006,CurrProtPeptSci,7:479-486中能够找到肽和多肽疗法的一般性指南。最近批准的基于肽的药物包括HematideTM(合成的基于肽的红细胞生成刺激剂,埃非麦克司公司(Affymax,Inc.)),艾塞那肽(Exenatide)(合成的肠促胰岛素类似物(exendin)-4,爱麦林/礼来公司(Amylin/EliLilly),Natrecor(奈西立肽(nesiritide),奈西立肽,司可奥斯公司(Scios)),普来纳西(Plenaxis)(阿巴瑞克,普瑞西斯制药公司(PraecisPharmaceuticals))和SecreFlo(促胰液素,瑞普里根公司(Repligen))。
实施者根据需要治疗对象相关的因素确定准确剂量。对剂量和给药进行调整以提供足够水平的活性试剂或维持所需效果。需要考虑的因素包括疾病状况的严重性、对象的总体健康状况、对象的年龄、体重和性别、饮食、给药的时间和频率、联合用药、对治疗的反应敏感性以及耐受/响应。根据特定制剂的半衰期和清除率,长效药物组合物可每3-4天,每周或每两周给予一次。
本发明组合物(如药物组合物)尤其有用的是缓释配方或原理。例如,瘤胃内装置包括但不限于:新西兰埃格瑞饲料公司(Agri-FeedsLtd.,NewZealand)时间胶囊TM丸范围,最初由新西兰爱吉研究公司开发(AgResearchLtd.,NewZealand),如WO95/19763和NZ278977所公开的,以及新西兰奥克兰的纽法姆公司的分支机构纽法姆健康和科学公司的CAPTEC(NufarmHealth&Sciences,adivisionofNufarmLtd.,Auckland,NewZealand),如AU35908178,PCT/AU81/100082和Laby等,1984,Can.J.Anim.Sci.64(增刊)337-8所公开的,将所有这些参考文献纳入本文作参考。作为特定的例子,该装置可包括弹簧和柱塞,迫使组合物穿过同末端的孔。
作为另一实施方式,本发明涉及作为水补充物的组合物如进水组合物,和食物补充剂如反刍动物饲料组分,用于上述任何方法。在特定方面,食物补充剂包含至少一种可食用的植物材料以及本发明的肽或多肽。或者,食物补充剂包含至少一种可食用的植物材料以及本文公开的肽或多肽,或编码本文公开的肽或多肽的多核苷酸,例如,表达载体或含有表达载体的宿主细胞的形式。具体说,组合物还包含与所得序列融合或连接的细胞抑制剂。优选的植物材料包括干草、草、谷物或粗磨粉中的任一种,例如,豆科干草、禾本科干草、玉米青贮、禾本青贮、豆科青贮、玉米粒、燕麦、大麦、酿酒谷物、啤酒谷物、大豆粗磨粉和棉籽粗磨粉。具体说,禾本青贮可用作反刍动物的食物组合物。可对植物材料进行遗传改造,使其包含本发明的一种或多种组分,如一种或多种多肽或肽、多核苷酸或载体。
在另一实施方式中,本发明多肽或多核苷酸的抗体可在监测微生物水平的实验种用于测定该微生物,尤其是产甲烷菌的存在。同上所述可以相同的方法制备用于诊断目的的抗体。诊断实验包括使用抗体和标签检测人体体液或细胞或组织提取物中多肽的方法。可使用修饰或未修饰的抗体,通过共价或非共价方式将报告分子与其结合进行标记。可使用本领域所知的多种不同的报告分子,上文对其中几个进行了描述。
本领域已知用于测量多肽或多核苷酸水平的多种实验方案(如ELISA、RIA、FACS和印迹法,如Southern、Northern、Western印迹),为测定微生物尤其是产甲烷菌的存在或水平提供了基础。通过在适合形成复合物的条件下将来自正常对象如正常人或反刍动物的体液或细胞提取物与抗体组合,从而确定正常或标准水平。利用各种方法可对标准复合物的形成量进行定量,但优选分光光度法。将对象、对照和治疗样品(如来自治疗对象的样品)中表达的多肽或多核苷酸的量与标准值进行比较。标准值和对象值之间的偏差确定了用于测定微生物存在或水平的参数。
在本发明的一个特定实施方式中,通过使用特定杂交和/或扩增技术,可将多核苷酸用于诊断目的。可使用的多核苷酸包括寡核苷酸、互补RNA和DNA分子和PNA。多核苷酸可用于检测或定量测定样品中的基因表达,其中表达与微生物的存在或水平相关。可使用诊断实验区分微生物水平的不存在、存在和改变,并在治疗干预中监测水平。
在一个方面,可利用与PCR探针的杂交鉴定核酸序列,尤其是基因组序列,其编码本发明的多肽。无论探针产生于高度特异性的区域,如5’调节区的10个独特核苷酸,或者较低特异性的区域,如3′编码区,探针的特异性以及杂交或扩增的严谨性(最大、高、中等或低)将决定该探针是否仅仅识别天然产生的序列、等位基因或相关序列。探针也可用于检测相关序列,并应该优选包含来自任何编码序列的至少50%核苷酸。本发明的杂交探针可以是DNA或RNA,并来源于核苷酸序列SEQIDNO:74-142或其互补或修饰序列,或来自于包含天然产生序列的启动子、增强元件和内含子的基因组序列。
用于产生特异性DNA杂交探针的方法包括将核酸序列克隆入载体以产生mRNA探针。本领域了解此类载体,它们可购得,并且通过加入合适的RNA聚合酶和合适的标记核苷酸可将它们用于体外合成RNA探针。可通过多种报告基团对杂交探针进行标记,这些报告基团例如放射性核素如32P或35S,或酶标记,如通过亲和素/生物素偶联系统偶联至探针的碱性磷酸酶等。多核苷酸可用于Southern或northern分析,点印迹或其它基于膜的技术;用于PCR技术;或者用于试纸条、狭缝、ELISA实验或微阵列,用来自对象活检的液体或组织检测微生物的存在和水平。本领域熟知此类定性或定量的方法。
在一个特定方面,核酸序列可用于各种标准方法标记的实验,并在适合杂交和/或扩增的条件下加入来自对象的液体或组织。孵育合适的时间后,洗涤样品,对信号进行定量并与标准值比较。如果受试样品的信号量与可比较的对照样品的信号量相比发生了显著的改变,那么样品中出现核苷酸序列水平的改变表明微生物的出现或水平。还可使用此类实验评价特定治疗方案在动物研究、临床实验或者监测对象治疗中的效果。
为了提供微生物出现或水平的诊断基础,需确定表达的正常或标准特征。通过在适合杂交和/或扩增的条件下,将来自正常对象的体液或细胞提取物与多核苷酸或其片段混合,来完成这项实验。通过比较获自正常对象的值与获自使用已知量基本纯化多核苷酸的实验中的值,可对标准水平进行定量。可将来自正常样品的标准值与来自针对微生物生长进行治疗的对象的值进行比较。利用标准值和对象值之间的偏差测定微生物的存在或水平。
一旦鉴定了微生物并开始了治疗方案,则在常规基础上进行重复的杂交和/或扩增实验以评价相对于正常对象中观察到的表达水平,对象中的表达水平是否开始降低。来自连续实验的结果可用于显示从数天到数月的治疗期间的效果。
由核酸序列设计的寡核苷酸的特定诊断应用可包括使用PCR。此类寡聚体可以是化学合成、酶学方法产生或体外产生的。寡聚体优选由两个核苷酸序列组成,一个为正义方向(5′->3′),另一个为反义方向(3′->5′),在为鉴定具体核苷酸序列或条件的优化条件下使用。在用于检测和/或定量测定紧密相关的DNA或RNA序列的较低严谨性条件下,使用相同的两种寡聚物,巢式寡聚物集合或寡聚物简并库。
可用于定量测定表达的方法包括放射性标记或生物素化核苷酸,对照核酸共扩增以及可通过插值获得实验结果插值的标准曲线(Melby,P.C.等(1993)J.Immunol.Methods,159:235-244;Duplaa,C.等(1993)Anal.Biochem.229-236)。可通过以ELISA形式进行实验加快多个样品的定量速度,其中感兴趣的寡聚物以各种稀释度出现,通过分光光度法或比色法进行快度定量。
在另外的实施方式中,源自本发明所述任何多核苷酸的寡核苷酸或更长的片段可用作微阵列中的靶点。可使用微阵列同时监测大量基因的表达水平(产生转录物图像),并鉴定遗传变体、突变和多态性。可使用该信息确定基因功能,了解疾病的遗传学基础,诊断疾病,开发并监测治疗剂活性。在一个实施方式中,根据本领域所知方法制备和使用微阵列,如PCT申请WO95/11995(Chee等),Lockhart,D.J.等(1996;Nat.Biotech.14:1675-1680)以及Schena,M.等(1996;Proc.Natl.Acad.Sci.93:10614-10619)所述。
在一个方面,可使用化学偶联步骤和喷墨打印应用设备,如PCT申请WO95/251116(Baldeschweiler等)所述在微阵列表面合成寡核苷酸。在另一方面,可使用类似于斑点或狭缝印迹的“网状”阵列(HYBRIDOT设备,生命科技公司(LifeTechnologies)),利用真空系统、热、UV、机械或化学连接步骤将cDNA片段或寡核苷酸安置和连接至基材表面。在另一方面,可手工或利用可获得的设备、材料或机器(包括多道移液器或机器人仪器;布林克曼公司,韦斯特伯里,纽约州(Brinkmann,Westbury,N.Y.))生产阵列,该阵列可包括例如24、48、96、384、1024、1536或6144或更多个点或孔(如多孔板),或从2-1,000,000的任何倍数,以便充分利用市售仪器。
为了用微阵列进行样品分析,从生物制品中抽提多核苷酸。可从任何体液(血液、尿液、唾液、痰、胃液等),培养细胞,活检物或其它组织制备物中获取生物样品。为了生产探针,使用抽提自样品的多核苷酸产生与阵列上核酸互补的核酸序列。如果微阵列由cDNA组成,则反义RNA是合适的探针。因此,在一个方面,使用mRNA产生cDNA,进而在荧光核苷酸存在下用cDNA产生片段或反义RNA探针。将这些荧光标记的探针与微阵列孵育,以使探针序列与微阵列的cDNA寡核苷酸杂交。在另一方面,用作探针的核酸序列可包含使用杂交技术领域熟知的限制酶、PCR技术和寡聚物标记试剂盒(安法马西亚生物技术公司(AmershamPharmaciaBiotech))产生的多核苷酸、片段和互补或反义序列。
在本发明的另一实施方式中,可利用本发明的多肽或其功能性或免疫原性片段或寡肽通过任何药物筛选技术筛选化合物文库。此类筛选所用片段可在溶液中游离,附加于固体支持物、携带于细胞表面或定位于细胞内部。可检测多肽和受试物间的结合复合物的形成。
公开的PCT申请WO84/03564描述了一种药物筛选技术,它可用于高通量筛选对感兴趣多肽具有合适亲和力的化合物。在该方法中,在固体基质如塑料针或一些其它表面上合成大量不同的小受试化合物。受试化合物与多肽或其片段反应,然后洗涤。然后利用本领域熟知方法检测结合的多肽。还可将纯化的多肽直接包被在板上,用于上述药物筛选技术。或者,可使用非中和抗体捕获多肽并将其固定到固体支持物上。
在另一项技术中,可使用竞争性药物筛选实验,其中能够结合多肽的中和抗体与受试化合物特异性竞争结合该多肽。以此方式,可使用该抗体检测与该抗体具有相同的一个或多个抗原结合位点的受试化合物的存在。
实施例
本文所述实施例用以解释本发明的实施方式。其它实施方式、方法和分析类型在分子诊断领域的一般技术人员技术范围内,无需在此赘述。其它本领域范围内的实施方式也应作为本发明的一部分。
实施例1:基因组大小估测
反刍甲烷短杆菌(Methanobrevibacterruminantium)菌株M1T(DSM1093)生长于BY+培养基中(基本培养基,Joblin等,1990),该培养基由[g/l]NaCl(1)、KH2PO4(0.5)、(NH4)2SO4(0.25)、CaCL2.2H2O(0.13)、MgSO4.7H2O(0.2)、K2HPO4(1)、澄清反刍液(300ml)、dH2O(360ml)、NaHCO3(5)、刃天青(0.2ml)、L-盐酸半胱氨酸(0.5)、酵母提取物(2)以及巴赫(Balch)微量元素溶液(10ml)(加入微量元素;Balch等,1979)组成,由(g/l)三乙酸腈(1.5)、MgSO4.7H2O(3)、MnSO4.H2O(0.5)、NaCl(1)、FeSO4.7H2O(0.1)、CoCl2.6H2O(0.1)、CaCl2(0.1)、ZnSO4.7H2O(0.1)、CuSO4.5H2O(0.01)、AlK(SO4)2.12H2O(0.01)、H3BO3(0.01)、Na2MoO4.2H2O(0.01)、NiSO4.6H2O(0.03)、Na2SeO3(0.02)和Na2WO4.2H2O(0.02)组成。在液氮中冷冻细胞团并用预冷的无菌臼和杵研磨,抽提基因组DNA。将细胞匀浆液包埋于琼脂糖塞中,后续操作在栓中进行以减少对基因组DNA的物理剪切。用限制性核酸内切酶进行消化,用脉冲场电泳(PFGE)分离DNA片段。
实施例2:DNA克隆和测序
安进科生物科学公司(美国麻省)(AgencourtBiosciencesCorporation(Massachusetts,USA))使用随机鸟枪克隆方案(Fleischmann等,1995),马克基因公司(美国马里兰州洛克维尔)(MacrogenCorporation(Rockville,MD,USA))使用焦磷酸测序对反刍甲烷短杆菌的基因组DNA进行测序。简单的说,通过随机物理破坏基因组DNA和电泳分离片段在大肠杆菌中构建反刍甲烷短杆菌的DNA文库。从凝胶中回收40Kb范围内的大片段,并用于产生大的插入f粘粒文库。回收2-4kb范围的DNA片段并用于产生小的插入质粒文库。培养大和小的插入文库所得的克隆,回收其f粘粒或质粒DNA并用高通量测序技术进行测序。对足够数量的克隆进行测序以达到对反刍甲烷短杆菌基因组理论上8倍的覆盖。在随机剪切的基因组DNA片段上进行焦磷酸测序,并达到理论上10倍的覆盖。
实施例3:序列组装和原噬菌体注释
比对DNA序列以找到交叠序列,并利用帕拉赛基因组组装者(ParacelGenomeAssembler)(帕拉赛公司,加利福尼亚州,美国)(ParacelInc,CA,USA)和Staden软件包(Staden等,1998),与来自标准和反向PCR的序列组合组装成毗连序列(毗连群)。使用开放阅读框(ORF)寻找器GLIMMER(基因定位插值马尔可夫模型ER)(GeneLocatorInterpolatedMarkovModelER,Delcher等,1999)分析毗连群,利用缺口BLASTP(基础本地比对搜索工具)(BasicLocalAlignmentSearchTool(Altschul等,1997)在国家生物技术信息中心(NationalCenterforBiotechnologyInformation)(NCBI)的非冗余核苷酸和蛋白质数据库中对每一ORF进行分析。通过以随机方式人工连接来自8倍草图噬菌体序列的毗连群产生“假分子”,并提交给基因组研究所(TheInstituteforGenomicResearch)(TIGR,美国华盛顿特区)(TIGR,DC,USA)进行自动注释。用GLIMMER对来自10倍焦磷酸测序组装的毗连群再次进行分析,并且用GAMOLA(复杂现场BlastDNA序列全局注释(GlobalAnnotationofMultiplexedOn-siteBlastedDNAsequences);Altermann和Klaenhammer,2003)对ORF进行自动注释。用直系同源蛋白聚类(COG)数据库根据功能对ORF进行分类(阈值1e-02)(http://www.pnas.org/cgi/content/full/102/11/3906;Tatusov等,2001)。
分别利用全局和局部比对(http://pfam.wustl.edu)以及标准和片段模式TIGRFAMHMM模型(http://www.tigr.org/TIGRFAMs)(阈值1e-02),使用PFAMHMM和TIGRFAM文库通过HMMER(http://hmmer.wustl.edu)对蛋白基序进行确定。用TRNASCAN-SE鉴定tRNA(Lowe和Eddy,1997),用KODON软件包(应用数学公司,美国得克萨斯州奥斯汀)(AppliedMaths,Austin,TX,USA)和REPUTER(Kurtz和Schleiermacher,1999)鉴定核苷酸重复。随后对自动注释进行人工校验。使用GENEWIZ(Jensen等,1999)构建可视化基因组图集,用定制的内部开发算法产生潜在的数据结构。利用内部开发的软件(PathwayVoyager;Altermann和Klaenhammer,2005),从预测的反刍甲烷短杆菌ORF组和KEGG(京都基因与基因组百科全书)(KyotoEncyclopediaofGenesandGenomes,Kanehisa等,2004)在线数据库重建通路。
实施例4:测序结果和分析
通过限制性酶消化基因组DNA和通过PFGE测定片段大小进行反刍甲烷短杆菌基因组大小的估测,表明单条染色体大小约2.5-2.9Mb。大和小插入克隆的初始测序(6倍草图覆盖)以及将序列组装为毗连群表明基因组中40Kb的区域出现频率非常高(over-represented)(>20倍),特别是在小插入物文库中。可能的原因是在用于DNA抽提的培养物的生长过程中,高拷贝数的质粒(尽管没有鉴定到染色体外DNA)或溶原性细菌噬菌体复制。因为这种巨大序列偏向,所以仅对小插入克隆进行再次测序(覆盖2倍理论基因组),从Sanger测序中产生最终的8倍覆盖。将8倍草图阶段(phase)序列组装为通过105个支架连接的756个毗连群。进一步进行焦磷酸测序,以实现额外约10倍的覆盖,将这些序列掺入组装物使毗连群的数目降至27。使用反向和长范围PCR技术的后续缺口连接过程使毗连群数目降至14,保留一个错误组装。
在高通量测序阶段,观察到序列倾向于覆盖与低G+C区(~12Kb)紧紧相邻的G+C含量显著较高区域(~50Kb)的方向。通过GAMOLA和GeneWiz对基因组序列进行分析发现了与巨大低-GC穗(spike)紧邻的显著的高-GC区。对高G+C区的详细分析揭示了存在与噬菌体相关整合酶、噬菌体末端酶大亚基、噬菌体门户蛋白、噬菌体衣壳蛋白以及预测的用作噬菌体细胞溶素的肽酶相似的基因产物(图3)。这些基因产物用作预测的反刍甲烷短杆菌原噬菌体(记做)的整体结构的锚定位点。基于DNA二级结构的分析,鉴定出可能的噬菌体整合位点attL和attR(图1A)。att位点的噬菌体整合似乎破坏了ORF1980和2069编码的推定膜蛋白,并且该基因可能具有噬菌体基因组的原始整合位点attB。
基于公认的噬菌体基因组模块化结构以及与序列相似性和功能数据库,确定的一般结构(图1B)和DNA序列(图4A)。参见例如,AltermannE,KleinJR,HenrichB.格氏乳杆菌温和噬菌体基因组的一级结构和特征(PrimarystructureandfeaturesofthegenomeoftheLactobacillusgasseritemperatebacteriophage(phi)adh).Gene.1999年8月20日;236(2):333-46;DesiereF,LucchiniS,CanchayaC,VenturaM,BrüssowH.AntonieVanLeeuwenhoek.乳酸细菌中的噬菌体和原噬菌体的比较基因组学(Comparativegenomicsofphagesandprophagesinlacticacidbacteria).2002年8月;82(1-4):73-91。成功将预测的噬菌体ORF组分类为编码噬菌体整合、DNA复制和包装、噬菌体结构蛋白以及裂解盒的模块,并且对约40%噬菌体ORF进行了功能表征。与大量直接或非直接重复侧接并且确定位于DNA复制模块内部的非编码区中的终止子样结构(244bp)被表征为推定的DNA复制起点。经预测,噬菌体基因组序列内部的数个基因位于反义链上,它们与低-GC区同时出现。有待确定的是这些基因是否使噬菌体功能失活或表明噬菌体基因组内的错误组装。
发现预测的噬菌体溶素和attR之间的低-GC区具有DNA硫修饰系统,dnd(电泳期间降解),包括II型限制性m6腺嘌呤DNA甲基转移酶和可能是dnd系统特异性的转录调节子。而且,在噬菌体基因组内部或者与噬菌体基因组侧接处鉴定到非编码RNA结构。在预测的DNA复制模块内部,鉴定到rbcL。rbcL代表来自莱茵衣藻(Chlamydomonasreinhardtii)的5′TRRNA稳定元件。该家族被认为参与了rbcL基因的稳定,rbcL基因编码1,5-二磷酸核酮糖羧化酶的大亚基。该家族的突变可导致转录物降解加速50倍。
鉴定出与噬菌体基因组侧接的三组I型内含子结构。I组催化内含子是大的自我剪切核酶。在广泛的有机体中,它们催化自身从mRNA、tRNA和rRNA前体上剪切。核心二级结构由9个配对区域组成(P1-P9)。它们主要折叠成为两个结构域-P4-P6结构域(由堆叠的P5、P4、P6和P6a螺旋组成)和P3-P9结构域(由P8、P3、P7和P9螺旋组成)。该家族的标注(mark-up)二级结构仅代表该保守核心。I组催化内含子通常具有插入环区域的长ORF。这些非编码RNA结构位于ORF1980(SEQIDNO:74)上游,ORF2065(SEQIDNO:141)和attR的下游以及ORF2069(SEQIDNO:142)上游的非编码区。
实施例5A:噬菌体基因
在反刍甲烷短杆菌基因组序列内发现原噬菌体的序列是预料之外的。此前未有关于反刍甲烷短杆菌菌株M1(DSM1093)对裂解或溶原性噬菌体易感性的报道,尽管有报道称鉴定出其它甲烷短杆菌种的噬菌体(Baresi和Bertani,1984;Knox和Harris,1986)。原噬菌体序列的G+C含量显著高于周围反刍甲烷短杆菌基因组,表明它起源于另一有机体。观察到的同源性水平未表明其起源的明显宿主,这表明不同于迄今遇见的其它任何噬菌体。
DNA序列插入到预测的反刍甲烷短杆菌膜蛋白内,并侧接于具有与attL和attR位点相一致的二级结构的DNA序列。尽管与其它已知蛋白质缺少强烈同源性,但在内部可鉴定出噬菌体的所有功能性特征模块。该序列的一个有趣特征是3’末端存在低G+C区,这与参与DNA硫修饰系统(dnd)的蛋白质显示出同源性。这些基因位于的attR依附位点上游,因此可能在噬菌体整合过程中被带进反刍甲烷短杆菌基因组中。该区域编码多种dnd相关的ORF(dnd1、2和3),以及II型甲基酶亚基和推定的转录调节子。
dnd表型促使其DNA在电泳过程中降解。对各dnd的ORF功能进行分析表明宿主基因组中掺入了硫或含硫物质。还发现Dnd表型存在于不同来源和不同栖息地的各种细菌种类的DNA中。在代表不同属的多种细菌基因组和海洋生物的eDNA中,发现组织相似的基因簇,这表明这种修饰是一种广泛的现象。体内(35)S标记实验显示Dnd表型和DNA硫修饰同时发生于多种代表性细菌的基因组中(ZhouX,HeX,LiangJ,LiA,XuT,KieserT,HelmannJD,DengZ.新型DNA硫修饰(AnovelDNAmodificationbysulphur).MolMicrobio1.2005年9月;57(5):1428-38)。
II型R\M系统是最简单最流行的。甲基转移酶和核酸内切酶编码为两个独立蛋白质并独立作用,而非以复合物的形式工作。没有特异性蛋白质。两种蛋白识别相同的识别位点因此活性竞争。甲基转移酶以单体形式作用,一次对双连体中的一条链甲基化。核酸内切酶以同源二聚体形式作用,促进两条链的切割。切割在识别序列附近或内部的预定位点发生。在这一点上,目前尚不清楚预测的功能如何与dnd系统共同作用。但是,清楚的是噬菌体能够用作基因递送运载体。具体说,能够利用溶原性转化区作为基因置换的基因座。
dnd系统可能被噬菌体转运至反刍甲烷短杆菌中。同样,尚不了解dnd系统在保护或修饰反刍甲烷短杆菌或外来DNA中的作用。序列的另一个有趣的特性是反义链上编码的ORF数目。这些ORF对应低GC区并与来自多种有机体的蛋白质具有低BLAST吻合度。这表明在整合入反刍甲烷短杆菌后,这些基因在基因组中累积。尚不清楚这些ORF是否代表插入正在累积,并最终导致噬菌体失活和驯化,或是否完全激活。
对于减少甲烷特别重要的一个基因是位于裂解盒中的ORF2058。ORF2058被注释为肽酶,并与肽酶C39家族蛋白具有蛋白家族(Pfam)匹配性(ProteinFamily(Pfam)match)(评分:-13.7,E值:0.00054)。这些蛋白质是半胱氨酸肽酶,并且是MEROPS肽酶数据库定义的更大CA肽酶家族的一部分(Rawlings等,2006)。C39肽酶家族常常与ABC转运蛋白相关联,在细菌素输出和加工中用作成熟蛋白酶。CA肽酶家族还包括病毒半胱氨酸内肽酶,如切割古菌细胞壁的交联肽的C71古菌噬菌体内异肽酶。属于甲烷杆菌科的产甲烷古菌的细胞壁包含假胞壁质的平行链,一种被肽交联的N-乙酰基-L-塔罗糖胺糖醛酸(N-acetyl-L-talosaminurinicacid)的聚合物。C71假胞壁质内异肽酶能够切割古细菌细胞壁肽交联并能裂解细胞。
基于来自马尔堡甲烷嗜热杆菌(Methanothermobactermarburgensis)噬菌体ΨM2(图3)的假胞壁质内异肽酶的位置和同线性,ORF2058可具有产甲烷菌溶素基因的角色,其编码参与子代噬菌体释放前的细胞裂解的裂解酶。将ORF2058与来自马尔堡甲烷杆菌(M.marburgensis)的PeiP和来自沃氏甲烷杆菌(M.wolfeii)的PeiW(图5)进行比对,显示这些蛋白质间的总体同源性低。然而,参与内异肽酶催化三联体的组氨酸和天冬氨酸残基具有保守性,另外ORF2058的半胱氨酸残基位置靠近PeiP和PeiW的保守半胱氨酸,它形成了催化三联体的第三个保守位点(Makarova等,1999,Luo等,2002)。而且,在ORF2058中也找到了环绕PeiP和PeiW中催化性His残基的Gly-His-Tyr基序。这些发现表明ORF2058是溶菌素基因,功能是在噬菌体裂解循环中裂解反刍甲烷短杆菌细胞。ORF2058以及PeiP和PeiW间的差异可能反应了不同的古菌细胞壁肽交联,因此反应了不同的肽酶底物特异性。
实施例5B:噬菌体诱导
反刍甲烷短杆菌(Methanobrevibacterruminantium)菌株M1T(DSM1093)生长于BY+培养基中(基本培养基,Joblin等,1990),该培养基由[g/l]NaCl(1)、KH2PO4(0.5)、(NH4)2SO4(0.25)、CaCL2.2H2O(0.13)、MgSO4.7H2O(0.2)、K2HPO4(1)、澄清反刍液(300ml)、dH2O(360ml)、NaHCO3(5)、刃天青(0.2ml)、L-盐酸半胱氨酸(0.5)、酵母提取物(2)以及巴赫微量元素溶液(10ml)(加入微量元素;Balch等,1979)组成,由(g/l)三乙酸腈(1.5)、MgSO4.7H2O(3)、MnSO4.H2O(0.5)、NaCl(1)、FeSO4.7H2O(0.1)、CoCl2.6H2O(0.1)、CaCl2(0.1)、ZnSO4.7H2O(0.1)、CuSO4.5H2O(0.01)、AlK(SO4)2.12H2O(0.01)、H3BO3(0.01)、Na2MoO4.2H2O(0.01)、NiSO4.6H2O(0.03)、Na2SeO3(0.02)和Na2WO4.2H2O(0.02)组成。
当波长600(OD600)时测量的光密度(OD)介于0.10-0.14时,分别用1ml和2ml灭菌空气(~160至320μl氧气)(图1C)和2μg/ml丝裂霉素C(图1D)刺激反刍甲烷短杆菌。两种刺激均可观察到典型裂解曲线,空气刺激的潜伏时间为~90分钟。丝裂霉素C刺激的最初结果表明非常短的潜伏期。为了校验从宿主基因组中切除噬菌体,设计两条寡核苷酸,分别面向两个噬菌体附着位点(R1F:caaagagagattaaagaagcagacg;SEQIDNO:146以及L2Ragtagtgttggaatcagtgaaaagg;SEQIDNO:147)。如果噬菌体基因组在切除后再次环化,这对引物则能产生扩增子。
图1E描绘了当用空气刺激反刍甲烷短杆菌时,最初的切除实验。诱导后发现清楚明确的具有期望大小的扩增子,表明成功的切割和再环化。在未诱导的反刍甲烷短杆菌细胞中也发现相似但微弱的条带,表明在正常非刺激的生长中,具有自发切割的能力。
实施例5C:裂解酶生物实验
ORF2058编码的多肽可用作瘤胃产甲烷菌特异性裂解酶,并且亚克隆入大肠杆菌表达载体用于产生重组蛋白。使用引物Mbbrum11for22(1122For,caccatggttagattcagcagagac;SEQIDNO:148)和Mbbrum11rev22(1122Rev,tcatgcaggacagacaacatagtag;SEQIDNO:149)通过PCR在150μL反应体系中扩增ORF2058,该反应体系含121.5ng反刍甲烷短杆菌菌株M1基因组DNA;0.2μM1122For和1122Rev引物;15μLAccuprimePfx缓冲液(含dNTP,英骏公司(InVitrogen));2.4μLAccuprimePfx(英骏公司)。PCR条件为95℃2分钟初始变性,然后进行35个下述循环:95℃15秒、55℃30秒和68℃40秒。无需最后的延伸步骤。纯化PCR产物,并用Nanodrop(赛默飞世尔科技公司,美国佐治亚州)定量。
ORF2058克隆:根据厂商推荐,将PCR-扩增ORF2058克隆入pET100或pET151-DTopo载体(英骏公司)中,并转化到化学感受态TOP10细胞(英骏公司)中。用菌落PCR分析转化子,纯化质粒DNA并测序。选择具有匹配ORF2058的DNA序列的克隆。
ORF2058表达:利用电穿孔将来自含有经校验的ORF2058插入物的克隆的质粒DNA转化到电感受态BL21*或Rosetta2细胞中。发现表达可溶性ORF2058蛋白的最佳生长条件是LB培养基,在吸光度600为0.48-0.6时用0.5mMIPTG进行诱导,并在30℃继续培养6小时。然后离心收集细胞并冻存于-20℃。
细胞裂解:融解细胞团块,并重悬于下列缓冲液中(pH7.5):300mMNaCl、2mMDTT、10mM咪唑、20mMTris、20%甘油、1%Triton-X、5mMCaCl2和10mMMgCl2。加入溶菌酶终浓度为1mg/ml,然后在冰上轻轻搅拌30min。加入DNA酶I和RNA酶I,终浓度均为5μg/ml,然后在冰上轻轻搅拌30分钟。将细胞裂解物在12,000rpm离心15分钟,用0.8μm滤器过滤粗提裂解物。
镍亲和层析:将来自细胞裂解步骤的过滤上清液施加于80mL镍亲和柱,并用含20mM-250mM咪唑的下列缓冲液(pH7.5)梯度洗脱:300mMNaCl、2mMDTT、20mMTris和20%甘油。用装有10,000kDa分子量截止膜的密理博超滤小室浓缩从层析柱上洗脱的含有所表达0RF2058蛋白的组分。利用下列洗脱缓冲液从镍柱上洗脱大肠杆菌BL21*细胞中表达的pET100中的ORF2058构建物:pH8.2(20mMTris、250mM咪唑、300mMNaCl、10mMb-巯基乙醇、10%甘油),并且在另外加入甘油和二硫苏糖醇的缓冲液中储存酶,该缓冲液的终浓度为40%甘油,1mM二硫苏糖醇,pH8.2。
脱盐:使用含下列缓冲液(pH7.0):20mMMOPS、1mMDTT、300mMNaCl和20%甘油的250mLBioGelP6DG(伯乐公司,美国加州)(BioRad,CA,USA)柱对Rosetta2细胞中pET151构建物表达的浓缩蛋白进行脱盐。如上所述浓缩来自柱的组分,将最终样品过滤并用液氮速冻,然后储存于-20℃。
裂解静息的反刍甲烷短杆菌细胞:在含BY+培养基的亨盖特试管(Hungatetube)中将5ml反刍甲烷短杆菌M1(DSM1093)的培养物培养至对数后期,室温下5,000x离心30分钟收集亨盖特试管中的细胞。将细胞移至无氧室中(95%CO2-5%H2,科艺实验室产品公司,美国密歇根州)(CoyLaboratoryProducts,MI,USA),弃去上清,将来10ml培养物的细胞重悬于1mlMOPS缓冲液pH6.8(50mMMOPS,5mMCaCl2,1mM二硫苏糖醇)中。用另外的MOPS缓冲液稀释细胞悬液,将其OD(600nm)调整至~0.12。
将标准细胞悬液(50μl)分配至微孔板中,加入不同浓度的ORF2058裂解酶(由pET100构建物制备),用缓冲液将反应总体积补至250ml。在37℃孵育细胞和蛋白混合物,并记录OD读值。在静息反刍甲烷短杆菌细胞中加入酶(每个实验加入的酶μg数)的效果如图7所示。与未加入酶的对照细胞相比,酶的加入以剂量依赖方式降低悬浮细胞的OD600nm读数。这表明ORF2058裂解酶能够在无氧条件下攻击和裂解反刍甲烷短杆菌静息细胞。
裂解生长的反刍甲烷短杆菌细胞:反刍甲烷短杆菌生长于RM02培养基中。RM02培养基由下列组分组成(g/L):KH2PO4(1.4)、(NH4)2SO4(0.6)、KCl(1.5)、微量元素溶液SL10(1ml)、硒/钨溶液(1ml)、0.1%(w/v)刃天青溶液(4滴)。将组分混合并在无氧100%CO2的条件下煮沸,用100%CO2鼓泡并在冰浴中冷却。冷却后加入NaHCO3(4.2g)和L-盐酸半胱氨酸·H2O(0.5g),将9.5ml培养基分配至亨盖特管中,用100%CO2对试管进行通气。将试管高压灭菌,使用前避光储存24h。接种前,加入NoSubRFV(每管0.5ml,包含底物、酵母提取物、维生素)。接种后用80%CO2/20%H2通气至25lb/in2。反刍甲烷短杆菌生长至对数中期(OD600nm~0.1),这时加入不同浓度的ORF2058裂解酶(由pET151DTopo克隆制备)。继续孵育培养物并记录OD读数。加入酶对反刍甲烷短杆菌生长和甲烷形成(以括号表示生长217小时后相对未加入对照的%甲烷产生)的影响如图8所示。结果显示ORF2058裂解酶以剂量依赖方式显著影响反刍甲烷短杆菌生长,在加入2小时内降低生长培养物的OD600。两次最高水平的酶加入也减少了甲烷形成,与加入氯仿(100μl/10ml培养物)的程度相似。
实施例6:概述
反刍甲烷短杆菌基因组测序中的一个意外发现是存在原噬菌体序列。对于基因组序列的分析鉴定出异常高GC含量区,其中包含多种噬菌体相关的基因。进一步的生物信息学分析鉴定出预测的原噬菌体的整体结构,并称其为将约40%的噬菌体基因指定为不同的功能组,包括噬菌体整合、DNA复制和包装、噬菌体结构蛋白质和裂解。发现侧接噬菌体基因组的DNA序列代表潜在的噬菌体整合位点(attL和attR)。
噬菌体似乎将其本身插入到反刍甲烷短杆菌的推定膜蛋白中,该蛋白可能含有噬菌体基因组的原始产甲烷菌整合位点,attB。而且,发现于DNA复制模块内的终止子样结构被认为代表了噬菌体DNA复制起点。噬菌体基因组3′末端的低-GC区含有似乎是DNA硫修饰系统的组件,包括可能控制dnd系统表达的基因。这些基因可能在噬菌体整合的过程中被带入反刍甲烷短杆菌的基因组中,并且其在修饰噬菌体、宿主或外源DNA方面的角色还有待阐明。反刍甲烷短杆菌对于dnd系统的保留表明它使宿主受益。然而,dnd系统在反刍甲烷短杆菌或外源DNA修饰中的作用还有待研究。
序列的另一有趣特点是对应低GC区且与各种有机体蛋白质匹配性较低的反义链编码基因的数目。这表明这些基因在其整合入反刍甲烷短杆菌之后在的基因组中积累,这些基因可能代表正在进行之中的插入建立,也许最终导致噬菌体失活和噬菌体驯化。与反刍甲烷短杆菌基因组相比噬菌体序列的高GC含量表明它起源于另一有机体。然而,之前的宿主并未明确,因为与其它迄今为止已知的噬菌体相比蛋白质显示出某种独特性。
关于减少甲烷的尤其让人感兴趣的基因是位于裂解盒中的那些基因。具体说,一个基因编码与C39肽酶家族类似的蛋白质。该肽酶家族包括病毒半胱氨酸内肽酶等,如C71古菌噬菌体内异肽酶,该酶切割组成甲烷短杆菌细胞壁的假胞壁质中的交联肽。根据噬菌体基因组内的基因位置以及与来自其它非反刍产甲烷菌噬菌体基因组的假胞壁质内异肽酶的同线性,该基因可用作编码参与噬菌体后代释放前细胞裂解中的裂解酶的溶素基因。对该基因和它编码的酶尤感兴趣,因为可能在具有相似细胞壁的反刍甲烷短杆菌和其它反刍产甲烷菌中有控制机制。
反刍噬菌体及其参与裂解宿主细胞的酶有可能用来控制瘤胃中产甲烷菌群体和其它群落成员(细菌、原生动物和真菌)。此外,通过研究噬菌体的生命周期,有可能鉴定出易于受噬菌体蛋白质抑制的关键的宿主酶靶点。本发明人对牛、绵羊和鹿中反刍噬菌体的组成进行过调查研究,显示噬菌体数量和类型随时间的变化。还鉴定出受噬菌体影响的新西兰产甲烷菌分离物。利用纯产甲烷菌培养物评价噬菌体裂解酶,开发基于培养物和PCR的技术以筛选新噬菌体。纯化自瘤胃样品的噬菌体可进行随机DNA测序分析,从而发现噬菌体酶。
噬菌体或其酶在用于降低甲烷排放的缓解技术中具有多种优势。噬菌体是瘤胃微生物群落中的天然成员,因此,不会被视为抗生素治疗(并可更容易地克服任何管理限制)。噬菌体通常对窄范围的宿主具有特异性,因此可以选择性靶向产甲烷菌。现在认为噬菌体治疗是对抗生素耐受型有机体的一种治疗,一般认为是安全的。一旦产生,噬菌体通常相对稳定。将对噬菌体易感的产甲烷菌菌株引入瘤胃可能具有长期益处,尤其是在早期进行接种的情况下(如羊羔或和牛犊)。已知某些产甲烷菌包含噬菌体基因组、对裂解噬菌体易感、或发生自溶(提示有裂解酶),包括史氏甲烷短杆菌(Methanobrevibactersmithii)(菌株PS)、布氏甲烷杆菌(Methanobacteriumbryantii)和甲烷短杆菌菌株MF-1。用噬菌体抑制引起农业问题的有机体的一个著名实例是使用噬菌体靶向大肠杆菌0157:H7。
选择反刍甲烷短杆菌进行基因组测序是因为它在各种饲养条件下的反刍动物瘤胃中广泛存在(基于培养和分子检测数据),容易获得培养物,易于进行实验室常规培养以及可获得关于这种有机体的大量的前期研究数据和背景文献。本发明提供关于反刍甲烷短杆菌基因组的重要数据,并且对瘤胃内噬菌体进行详细构图。原噬菌体序列为抑制反刍甲烷短杆菌以及未来的有助于确定基因功能的遗传学操纵提供了具体试剂。可利用该噬菌体阻断产甲烷菌中的保守功能/组件以防止或减少瘤胃中的甲烷形成。
参考文献
AltermannE,KlaenhammerTR(2005)通路探险人:用京都基因和基因组(KEGG)百科全书数据库进行通路作图(PathwayVoyager:pathwaymappingusingtheKyotoEncyclopediaofGenesandGenomes(KEGG)database).BMCGenomics6:60-66。
Altermann,EKlaenhammerTR(2003)GAMOLA:序列注释以及对原核基因组草图和完成序列进行分析的新的本地解决方案(GAMOLA:anewlocalsolutionforsequenceannotationandanalyzingdraftandfinishedprokaryoticgenomes).OMICS:Ajournalofintegrativebiology7,161-169。
AltschulSF,MaddenTL,SchafferAA,ZhangJ,ZhangZ,MillerW,LipmanDJ(1997),缺口BLAST和PSI-BLAST:新一代的蛋白数据库检索程序(GappedBLASTandPSI-BLAST:anewgenerationofproteindatabasesearchprograms).NucleicAcidsResearch25,3389-3402。
BalchWE,FoxGE,MagrumLJ,WoeseCR,WolfeRS(1979)产甲烷菌:一个独特生物学群体的重新评估(Methanogens:reevaluationofauniquebiologicalgroup).MicrobiologicalReviews43,260-296。
Baresi,L.和Bertani,G.1984.分离一种产甲烷菌的细菌噬菌体(Isolationofabacteriophageforamethanogenicbacterium),刊于《美国微生物协会年会摘要》(AbstractsoftheAnnualMeetingoftheAmericanSocietyforMicrobiology),华盛顿特区,美国微生物协会(WashingtonDC:AmericanSocietyforMicrobiology),第133页。
Bickle,T.A.和D.H.Kruger.1993,DNA限制性生物学(BiologyofDNArestriction).Microbiol.Rev.57:434-450。
BultCJ等(1996)产甲烷古细菌詹氏产甲烷菌的完整基因组序列(Completegenomesequenceofthemethanogenicarchaeon,Methanococcusjannaschii).Science273,1058-1073.
CoutinhoPM,HenrissatB(1999)碳水化合物-活性酶:整合数据方案.“碳水化合物生物工程最新进展”(Carbohydrate-activeenzymes:anintegrateddatabaseapproach.‘RecentAdvancesinCarbohydrateBioengineering’)(HJGilbert,GDavies,BHenrissat和BSvensson编)3-12皇家化学会,剑桥(TheRoyalSocietyofChemistry,Cambridge)(碳水化合物活性酶数据库(CarbohydrateActiveEnzymesdatabase),http://www.cazy.org/)。
DelcherAL,HarmonD,KasifS,WhiteO,SalzbergSL(1999)用GLIMMER提高微生物基因识别(ImprovedmicrobialgeneidentificationwithGLIMMER).NucleicAcidsResearch27,4636-4641。
Fleischmann,RD等(1995)流感嗜血杆菌Rd的全基因组测序和组装(Whole-genomerandomsequencingandassemblyofHaemophilusinfluenzaeRd).Science269,496-512。
FrickeWF,SeedorfH,HenneA,KruerM,LiesegangH,HedderichR,GottschalkG,ThauerRK(2006)斯氏甲烷球形菌基因组序列揭示为什么人小肠古菌仅限于用甲醇和H2形成甲烷和合成ATP(ThegenomesequenceofMethanosphaerastadtmanaerevealswhythishumanintestinalarchaeonisrestrictedtomethanolandH2formethaneformationandATPsynthesis).JournalofBacteriology188,642-658.
GoddeJS,BickertonA(2006)称为CRISPR的重复性DNAe及其相关基因:原核动物间水平转移的证据(TherepetitiveDNAecalledCRISPRsandtheirassociatedgenes:evidenceofhorizontaltransferamongprokaryotes.)JournalofMolecularEvolution62,718-729。
HaftDH,SelengutJ,MongodinEF,NelsonKE(2005)原核基因组中45个CRISPR相关(Cas)蛋白质家族和多种CRISPR/Cas亚型的指南(aguildof45CRISPR-associated(Cas)proteinfamiliesandmultipleCRISPR/Cassubtypesexistinprokaryoticgenomes).PLoSComputationalBiology1:474-483。
JansenR,EmbdenJD,GaastraW,SchoulsLM(2002)原核细胞中DNA重复相关基因的鉴定(IdentificationofgenesthatareassociatedwithDNArepeatsinprokaryotes).MolecularMicrobiology43,1565-1575。
JansenR,vanEmbdenJD,GaastraW,SchoulsLM(2002)在原核细胞中鉴定新颖序列重复家族(Identificationofanovelfamilyofsequencerepeatsamongprokaryotes).OMICS:Ajournalofintegrativebiology6,23-33。
JensenLJ,FriisC,UsseryDW(1999)微生物基因组的三种观点(Threeviewsofmicrobialgenomes).ResearchinMicrobiology150,773-777。
JoblinKN,NaylorGE,WilliamsAG(1990)史氏甲烷短杆菌对厌氧反刍真菌木聚糖水解活性的影响(EffectofMethanobrevibactersmithiionxylanolyticactivityofanaerobicruminalfungi).AppliedandEnvironmentalMicrobiology56,2287-2295。
KanehisaM,GotoS,KawashimaS,OkunoY,HattoriM(2004)解密基因组的KEGG资源(TheKEGGresourcefordecipheringthegenome).NucleicAcidsResearch32,D277-D280。
Kiener,A.,Konig,H.,Winter,J.和Leisinger,T.1987.纯化并利用沃氏甲烷杆菌的假胞质壁内肽酶裂解热自养甲烷杆菌(PurificationanduseofMethanobacteriumwolfeiipseudomureinendopeptidaseforlysisofMethanobacteriumthermoautotrophicum.)J.Bacteriol.169,1010-1016.
Knox,M.R.和Harris,J.E.1986.分离并表征史氏甲烷短杆菌的噬菌体(IsolationandcharacterisationofabacteriophageofMethanobrevibactersmithii.)第十四届国际微生物大会摘要(AbstractsoftheXIVInternationalCongressonMicrobiology),曼彻斯特:国际微生物协会联盟(Manchester:InternationalUnionofMicrobiologicalSocieties)。
KurtzS,SchleiermacherC(1999)REPuter:完整基因组最大重复的快速计算(REPuter:fastcomputationofmaximalrepeatsincompletegenomes).Bioinformatics15,426-427。
LoweTM,EddySR(1997)tRNAscan-SE:改进对基因组序列中转移RNA基因进行检测的程序(tRNAscan-SE:aprogramforimproveddetectionoftransferRNAgenesingenomicsequence).NucleicAcidsResearch25,955-964。
Loenen,W.和N.Murray.1986.噬菌体λ的限制性缓解蛋白(Ra1)增强修饰(Modificationenhancementbyrestrictionalleviationprotein(Ral)ofbacteriophagelambda.)J.Mol.Biol.190:11-22。
Lucchini,S.,F.Desiere,和H.Brussow.1999.嗜热链球菌噬菌体种类的比较基因组学支持模块化进化理论(ComparativegenomicsofStreptococcusthermophilusphagespeciessupportsamodularevolutiontheory).J.Virol.73:8647-8656。
Luo,Y.N.,Pfister,P.,Leisinger,T.和Wasserfallen,A.2002.假胞壁质内异肽酶PeiW和PeiP,甲烷嗜热杆菌菌株产生的新颖蛋白酶家族的两个中度相关的成员(PseudomureinendoisopeptidasesPeiWandPeiP,twomoderatelyrelatedmembersofanovelfamilyofproteasesproducedinMethanothermobacterstrains),FEMSMicrobiol.Lett.208,47-51。
Makarova,K.S.,Aravind,L.和Koonin,E.V.1999.与动物转谷氨酰胺酶同源的古细菌、细菌和真核蛋白的超家族(Asuperfamilyofarchaeal,bacterial,andeukaryoticproteinshomologoustoanimaltransglutaminases).ProteinSci.8,1714-1719。
MakarovaKS,GrishinNV,Shabalina,SA,WolfYI,KooninEV(2006)原核细胞中推定的基于RNA干扰的免疫系统:用计算机分析预测酶机器、真核RNAi功能类推和假拟作用机制(AputativeRNA-interference-basedimmunesysteminprokaryotes:computationalanalysisofthepredictedenzymaticmachinery,functionalanalogieswitheukaryoticRNAi,andhypotheticalmechanismsofaction).BiologyDirect1:7-32.
新西兰统计2005(www.stats.govt.nz)。
新西兰温室气体目录(NewZealand’sGreenhouseGasInventory)1990-2004。国家目录报告和一般报告格式(TheNationalInventoryReportandCommonReportingFormat).(2006)环境部(MinistryfortheEnvironment).http://www.mfe.govt.nz/publications/climate/nir-apr06/nir-apr06.pdf。
ReeveJN,NollingJMorganRM,SmithDR(1997)甲烷生成:基因、基因组、谁是第一个?(Methanogenesis:genes,genomesandwho’sonfirst?)JournalofBacteriology179,5975-5986。
Rawlings,N.D.,Morton,F.R.和Barrett,A.J.2006.MEROPS:肽酶数据库(MEROPS:thepeptidasedatabase).NucleicAcidsRes.34,D270-D272.
SamuelBS,HansenEE,ManchesterJK,CoutinhoPM,HenrissatB,FultonR,LatreilleP,KimK,WilsonRK,GordonJI(2007)史氏甲烷短杆菌对人肠道的基因组适应(GenomicadaptationsofMethanobrevibactersmithiitothehumangut).ProceedingsoftheNationalAcademyofSciencesUSA104,10643-10648。
SmithDR等(1997)热自养甲烷杆菌H的完整基因组序列:功能分析和比较基因组学(CompletegenomesequenceofMethanobacteriumthermoautotrophicumΔH:Functionalanalysisandcomparativegenomics).JournalofBacteriology179,7135-7155。
SmithPH,HungateRE(1958)反刍甲烷短杆菌的分离和表征(IsolationandcharacterizationofMethanobacteriumruminantiumn.sp.)JournalofBacteriology75,713-718.
StadenR,BealKF,BonfieldJK(1998)司塔登软件包(TheStadenPackage).分子生物学方法:生物信息学方法和实验指南(MethodsinMolecularBiology:BioinformaticsMethodsandProtocols)132,115-130。
TatusovRL,NataleDA,GarkavtsevIV,TatusovaTA,ShankavaramUT,RaoBS,KiryutinB,GalperinMY,FedorovaND,KooninEV(2001)COG数据库:来自完整基因组的蛋白质的系统发育分类的新进展(TheCOGdatabase:newdevelopmentsinphylogeneticclassifcationofproteinsfromcompletegenomes)NucleicAcidsResearch29,22-28。
将上述说明书提及的所有公开物和专利全文纳入本文作参考。
如果参考上述说明书中提及具有已知等同形式的内容,那么将这些等同形式也纳入本文,就好像在本文中单独列出那样。虽然已结合具体的优选实施方案对本发明作了描述,但应了解,如权利要求所述,本发明不应过分地受限于这些具体实施方案。应当理解的是在不背离本发明的构思和范围的情况下,可对本发明作进一步的修改。
序列表
<110>田园温室气体研究有限公司(PASTORALGREENHOUSEGASRESEARCHLTD)
<120>噬菌体mru多核苷酸和多肽及其应用
<130>CDH229498PCTPR
<140>PCT/NZ08/000248
<141>2008-09-25
<150>60/989,841
<151>2007-11-22
<150>60/989,840
<151>2007-11-22
<150>60/975,104
<151>2007-09-25
<160>151
<170>PatentIn3.5版
<210>1
<211>258
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>1
ValArgAsnMetLysAsnLysSerLeuIleLeuIleSerLeuLeuLeu
151015
LeuIleThrIleIleSerIleGlySerValValAlaThrAspAsnGlu
202530
GluIleAsnMetAspAsnIleAsnAsnIleAspAsnAsnGluAspIle
354045
AlaAsnIleAspAsnValAspAsnValAspAsnSerAsnIleAsnAsn
505560
ProThrAspIleArgIleAspAsnSerAsnLeuAsnArgGluThrGlu
65707580
LeuAspSerAsnLeuAsnLysSerAsnGlnIleArgGluAspGluLeu
859095
GluGlnSerAsnAlaLysSerAsnLeuLysSerSerLysLeuSerSer
100105110
ThrIleThrValAspGlySerAspGluAsnGlnMetSerAsnProThr
115120125
IleGlnSerAlaIleAspSerAlaAsnAlaGlyAspThrIleIleIle
130135140
ThrGlyLysSerTyrValHisCysHisPheIleValAsnLysProLeu
145150155160
ThrIleIleSerGluIleGlyThrSerMetSerProCysProSerAsn
165170175
ThrLysGlySerGlyAlaHisGlyIlePheTyrIleSerProGluAla
180185190
SerGlyThrValLeuLysGlyPheAsnLeuThrAsnThrTyrGlyAsp
195200205
TyrAspAspTyrGlyIleLeuIleArgGlyAlaGluAsnValGluIle
210215220
IleAsnCysThrIleAsnThrValSerAspGlyAspGlyIleArgIle
225230235240
GluAsnAlaThrAsnThrLysIleAlaAspCysLeuIleLysAspSer
245250255
AsnIle
<210>2
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>2
MetLysThrPheArgGlnGlnLeuLeuGluAspProGluPheGlnAsn
151015
TyrLeuLeuGlnArgProAsnLeuThrGluSerSerLeuGlnSerTyr
202530
LeuAsnAlaAlaThrAsnPheValArgPheThrGlyGluProPheTyr
354045
LysThrValHisGluLeuArgSerGlnGlnAsnAspArgIleGluAsn
505560
AsnIleIleIleArgPheAsnProAsnGlnSerArgIleAsnIleMet
65707580
GlnPheGluPheIleGluTyrLeuLysGlyArgGlyCysThrCluVal
859095
SerIleAspSerTyrValArgTyrMetArgThrIleLeuSerThrLeu
100105110
GlyIleIleLeuProLysSerProLysLeuAspAspThrProGlnAsp
115120125
TrpTyrLeuLeuThrLysAspAspIleLysTyrValLeuAspThrAla
130135140
AsnLeuGlnTyrLysAlaValIleAsnPheAlaAlaValThrGlyLeu
145150155160
ArgValArgAspMetArgSerLeuThrIleLysAspPheMetThrAla
165170175
ThrGluGluTyrHisGlyCysThrGluValGluAspPheLeuAspSer
180185190
AlaProAspGlyMetIleGlyPheTrpGluLeuPheProGlnLysThr
195200205
ArgLysPheArgLeuProCysLysValCysAsnThrProGluSerSer
210215220
AspLeuLeuLeuPheSerLeuAsnGluArgValLysTyrPheGluTrp
225230235240
LysAsnGluLysAspGlyThrAspLeuLysIleThrLysAsnAsp
245250255
<210>3
<211>98
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>3
MetAsnThrLeuLysIleGluCysSerLysAspAspTyrIleIleLys
151015
ThrAlaLysAlaAsnSerGluAsnGluLeuLysValGluValProGlu
202530
AsnTrpAsnCysAspTyrValAsnAlaValLeuTrpGluGluAspIle
354045
CysGluValLeuGluLysGlyAspGluArgMetLeuLeuIleProMet
505560
CysGlyGluLeuLeuLeuGluGlyValGlnGluAspGluTyrIleLys
65707580
TyrIleCysLeuProValLysTyrGlnAspGlnMetValLeuIleAla
859095
LysIle
<210>4
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>4
MetGlyMetLysLysValLysIleGluSerLysAlaLysAsnAsnMet
151015
ThrArgAsnGluLysLeuPheTyrLysLeuTyrAspAspLeuTyrAsn
202530
GluAspArgLeuIleLeuPheSerThrTyrPheAsnIleTyrAspLys
354045
PheIlePheLysLysAspIleIleHisTyrValLeuMetAsnTyrSer
505560
GluAsnGluIleIleGluAlaMetLysLysIleAspGluIleGlnSer
65707580
GluGlyIleAspIleLysThrPheIleProLysLysTyrCysProLys
859095
CysLysLysValMetAspSerTyrGlyLysIleCysProAspCysGly
100105110
ThrIleLeuIleGluAspGluLysLysIleGlnGluLeuGlnAlaLys
115120125
AspLysAlaTyrGluGluTyrLeuGluLysGluTyrAsnIleTyrLeu
130135140
GlnAsnSerTyrHisAsnMetIleGlnGlySerTyrThrIleLysIle
145150155160
ArgThrArgLysProLysThrGluThrGluIleValArgIleProAla
165170175
GlnThrValThrSerArgGlyLysPheAsnSerIleSerGlnHisTyr
180185190
ProSerGluThrTyrThrArgGlnLysValThrArgAlaLysTyrLys
195200205
GluCysArgValLeuPheAspLysGluLysMetIleLeuAsnIleAsp
210215220
GlyThrAlaThrLysLeuTyrTyrAspGluValCysGluLeuGluTyr
225230235240
ProGluGlnGluValAsnGluLeuValThrLeuThrLeuHisAsn
245250255
<210>5
<211>228
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>5
MetLysThrGlnAspLeuIleAsnIleIleAsnAspGluGluSerPro
151015
ValPheLeuAsnArgGluValPheGluMetAspTyrValProAspIle
202530
TyrLysTyrArgAspGluGlnLeuAlaLysMetAlaMetTyrCysAsn
354045
SerIleProAspAsnIleAlaProLysAsnLeuGlnLeuCysGlyGly
505560
AsnAlaThrGlyLysThrThrThrLeuLysGlnPhePheLysMetLeu
65707580
AsnGluAlaPheProAsnIleValThrValTyrIleAsnCysGlnLeu
859095
PheAsnThrGluAsnThrValTyrGlyLysIleTyrAsnLysLeuTyr
100105110
GlyValLysGlySerIleAsnGlyLysSerAsnThrMetLeuPheAsp
115120125
LysIleValAlaArgLeuLysLysGluAsnLysIleLeuIleIleGly
130135140
LeuAspAspPheAspSerPheLysSerArgAspGlyLeuAsnLysMet
145150155160
LeuTyrAsnPheLeuArgIleHisGluAlaGluGluGlyIleGlnIle
165170175
CysIlePheThrValSerAsnLysGlyGluSerGluSerLeuLeuLeu
180185190
ProSerArgGlnSerSerThrGlyPheArgTyrSerLeuThrSerThr
195200205
ProTrpSerArgCysThrThrTyrTrpThrThrGlyAlaProSerVal
210215220
SerIleLeuAla
225
<210>6
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>6
MetPheLeuGluLysCysAspGlyLysAspThrIleSerMetSerLeu
151015
GlnGluLysMetAsnLeuIleLeuGluThrMetGluSerLysGlySer
202530
ProPheIleSerCysIleHisCysAsnIleProIleAsnGluAlaGlu
354045
GluTrpTyrLysAsnGlyGluIleGlyAspGlnAspPheIleAsnPhe
505560
TyrAspAspValAsnLeuIleGluGluSerPheGlyPheGluIleTyr
65707580
LysLysSerGluTyrProThrLeuHisThrGlnSerIleAsnGlnIle
9095
AlaSerThrTyrProMetAsnArgThrGlnAsnGluLysThrProLeu
100105110
PheLeuArgArgGluArgLysLeuTyrGluIleThrAsnIlePheLys
115120125
SerHisSerThrAsnGluIlePheIleSerMetAspSerLysSerLys
130135140
LeuLysHisGluIleLysTyrAspPheThrLeuLysGluLeuAsnGlu
145150155160
IlePheLysAsnTyrLeuGluGluAspCysSerIleTyrIleLeuAsn
165170175
AspAsnArgAlaPheValMetThrLeuGlyHisPheGlnPheGluPhe
180185190
AspValPheGlySerAlaLysGluSerTyrValPheAspValGluIle
195200205
AspAspGluLysTyrAspLysIlePheIleArgSerSerTyrTyrPhe
210215220
AsnIleProValAspGluLeuAspGlyLeuAlaLysIleLeuLysGln
225230235240
LysArgIleIleGluGluGlyPhePheGluGlyGlnPheLeuTyr
245250255
<210>7
<211>68
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>7
MetIleIlePheLeuLysLeuLysPheGlyArgValIleMetGluLys
151015
LeuIleGluIleAspGlyValGlnTyrThrGluAlaGlnIleArgArg
202530
AlaLeuAlaIleGluArgAspValArgSerProAsnPheValAspMet
354045
LeuLeuGlyLysIleLysProSerGluLeuAlaSerArgValSerGlu
505560
LysGlyAspAla
65
<210>8
<211>51
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>8
MetCysTyrValGlyAsnThrArgThrLeuValTyrHisThrGluAsp
151015
CysPheCysAsnHisTrpLeuLeuAsnGluAsnLysThrIleLeuGlu
202530
GluLysProValAspMetLysProCysSerPheCysLysProGlnPhe
354045
AspThrGlu
50
<210>9
<211>77
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>9
MetLeuAspMetValAlaGluMetValGluAsnIleArgLysGlyGlu
151015
GlyAspGlyTyrSerIleTyrProProPheSerCysIleValPheLeu
202530
GlnGlyLysLysTyrSerGluCysCysCysLysAlaGluAlaArgAsp
354045
GlnLysPheAlaLeuValAsnLeuValGlyPheArgArgGluAspVal
505560
LysValIleAspProArgThrAsnGluGluLeuPheVal
657075
<210>10
<211>53
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>10
MetSerMetLeuAlaAspPheGluProAlaArgLeuHisLysArgThr
151015
TrpAlaGluArgHisAspValGluIleLeuAlaValIleCysLeuAla
202530
IleSerIleAlaMetLeuLeuLeuPhePheAlaLeuAlaGluProThr
354045
ValAlaGlyValIle
50
<210>11
<211>150
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>11
MetThrLysGluPheGluAspPheMetArgArgAsnThrGlyLeuLeu
151015
ValPheLeuArgTrpAspThrValAlaTyrLeuLysTyrLeuGluSer
202530
HisTyrAspGluArgLysTyrGluCysAlaTyrArgLeuLeuGluAla
354045
IleAspAsnLeuPheAspPheTyrGlnIleThrPheSerLysLysThr
505560
GluArgGluIleProAspGlnLeuPheGluLysAspLysIleAsnLys
65707580
GlyPheLeuSerHisIleGlyLysAlaCysLysLysGlnSerAspPhe
859095
TyrGlyGlnArgTrpLysSerThrArgGlyIleArgAspAlaTyrGly
100105110
HisTyrSerAlaGlyAsnPheLeuPheAlaAspIleTyrGlyCysLeu
115120125
HisArgIleSerAspAspCysTyrArgIleLeuAsnPheSerGluTyr
130135140
GluIleGluGluLysAla
145150
<210>12
<211>251
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>12
MetAsnGluIleValThrThrThrAsnGluAsnAsnValProValAsp
151015
ValAspTyrAlaIleGluGluTrpLysAlaTyrGlnArgLeuThrArg
202530
GluLeuLeuAspGluThrAspTyrGlnThrHisArgGlyArgLysTyr
354045
LysThrLysSerAlaTrpGlnLysTyrAlaArgAlaPheAsnIleAsn
505560
ThrGlnIleIleAspLysGluIleValLysAsnAspLysGlyIleVal
65707580
IleGluAlaGluTyrThrValArgAlaThrLeuProAsnGlyArgPhe
859095
ValGluSerAspGlySerCysAspArgArgGluSerGlyLysArgGlu
100105110
MetSerAsnHisSerIleLysAlaThrAlaLysThrArgAlaThrAsn
115120125
ArgAlaIleSerGluLeuIleGlyAlaGlyAspValSerAlaAspGlu
130135140
LeuAspProAlaPheAspLysValGlnHisSerLysThrAsnHisVal
145150155160
IleGluAlaGluValAlaGluIleIleGluSerProTyrAspLysAsn
165170175
AlaGlyPheGluThrAlaAspLysIleGluProValAspGluAspPro
180185190
ValCysLysAsnTrpValLysThrIleCysLysThrIleLysAlaGlu
195200205
GlyLysProCysLeuLysGlyValLeuIleGlnLysAlaArgThrIle
210215220
GlyThrMetThrAspGluGluArgAsnArgLeuIleGluTyrIleLys
225230235240
ThrLeuProLysGlyGluValAsnLeuAspAsp
245250
<210>13
<211>76
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>13
MetIleGluCysIleGlnGluGluGlyAspPheThrAspTrpGluVal
151015
ProSerSerSerSerAspIleLysTyrIleValSerValAspAspGlu
202530
GlyAsnLeuPheCysSerCysProAspPheTyrTyrArgLysSerArg
354045
MetAsnProHisIleSerAsnProGluSerTyrCysLysHisIleArg
505560
GlnValLeuGluGluAspAsnArgLeuGlnMetLeu
657075
<210>14
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>14
MetAspAsnIleAsnLysThrLysThrSerLeuAlaLysPheGluGlu
151015
PhePheSerThrValTyrLysAspGluValMetGluValLeuGluLys
202530
TyrProGluGluArgThrLeuValValAspTyrGluAsnLeuGluMet
354045
PheAspProAspLeuAlaAspLeuLeuIleGluLysProAspGluVal
505560
IleAlaAlaSerGlnLysAlaIleLysAsnIleAspProLeuMetLys
65707580
AspProLysLeuAspIleLysPheLysAsnValSerAsnCysIleAsp
859095
PheValAsnAlaAspSerLysTyrIleGlyLysLeuIleSerPheGlu
100105110
AlaLysValMetGluAlaLysGluProLysProIleLeuAspIleAla
115120125
ValTyrGluCysArgGlyCysMetSerLeuArgGluIleProGlnThr
130135140
IleAsnSerSerLeuGluProSerLeuCysProGluCysGlyGlyArg
145150155160
SerPheArgLeuLeuGlnAspGluSerGluPheLeuGluSerGlnLeu
170175
LeuIleValSerSerAspAspThrSerLysSerLeuLysValLeuLeu
180185190
LeuArgAspGluCysSerPheAspLeuTyrSerMetGlyGlnGluVal
195200205
ArgIleThrGlyIleLeuLysSerPheSerSerAsnTyrGlyTyrGlu
210215220
TyrPheLeuGluCysAsnLeuIleGluIleLeuAsnAspSerGluAsp
225230235240
SerGluTyrAspGluTyrGlyAsnArgAsnSerProGluTyrArg
245250255
<210>15
<211>143
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>15
MetAlaAsnLysIleArgValAsnLeuThrValAspProAsnLeuTrp
151015
GlnLeuAlaLysAspLysLeuProCysSerArgSerGluPhePheGlu
202530
AsnGlnLeuLysMetPheLeuGlyIleGluAspAspGluSerGluIle
354045
IleLysAspIleGlnThrLysGluAsnGluIleAsnAlaLeuArgAsp
505560
LysLeuCysHisValArgLysSerLysGlnLeuLysLeuGluSerAsn
65707580
LysSerMetGluLysAlaMetAlaSerLeuAsnArgMetHisLysLys
859095
TyrGlyLysIleGlyGluAsnGlnIleArgAsnLeuAlaHisValHis
100105110
LysValAspPheAspAspLeuLysLysGluCysGlnAspAsnCysMet
115120125
AsnIlePheGluPheAlaGluValProLysHisAspSerValMet
130135140
<210>16
<211>134
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>16
MetThrIleGlySerLeuAspAsnPheGlyLysSerAspGlyGluAsn
151015
MetAsnProGluAspPheAspCysSerValPhePheGluMetTyrLys
202530
AlaLeuPheGluIleLeuAspValGluValGlySerPheAlaGluLeu
354045
LeuAspValTyrLysAsnValGluMetAspTyrThrLeuLysArgHis
505560
AlaLeuLysGlnLysGluIleLeuTyrTrpPheAsnThrAspTrpLys
65707580
GluGluLeuGlyLysGluLysProThrGluLysAspLysGluLysTrp
859095
IleArgGlnLysIleGlyTyrAspSerPheValValGluGlnLeuGlu
100105110
ValLysLeuLysHisIleArgArgMetTyrGluThrAlaLeuLysHis
115120125
SerPheGluAlaIleLys
130
<210>17
<211>91
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>17
MetAsnValLysThrValMetAsnAspLeuIleGlyLeuSerLysGlu
151015
PheGluGlyValGluTyrGluIleGluSerLysAsnSerIleTyrPhe
202530
TyrSerPheProLysTyrMetLysGluGlyIleValIleLeuLysTyr
354045
SerAlaIleTyrAspLeuHisThrIleLeuLysGlyMetAspGlyIle
505560
IleValAspIleLeuGluValGluAspAsnProGlyAspGluLysLys
65707580
AspLeuLeuTyrValGlnIleGluValLysGlu
8590
<210>18
<211>77
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>18
MetIleSerAspGluTrpGluGluGluTyrTyrValLysValAsnGlu
151015
GluLeuGluGlnValGluValArgPhePheSerLysValAspArgLeu
202530
ValPheAlaGlnSerTyrSerSerSerSerSerPheSerPheGluGlu
354045
AlaGluIleLeuCysAspArgIleCysAspIleLeuThrAsnAspLeu
505560
GlyAsnAlaLysTyrTyrLeuGlyGlyLysAspGluLeu
657075
<210>19
<211>49
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>19
MetAsnTyrArgGluTrpValAlaSerGlnPheGluLeuArgMetThr
151015
GluAspGlyArgValCysPheLysThrProCysSerTyrTyrThrPhe
202530
SerLysGluAspPheGluIleIleArgGluMetPheLeuAsnPheGlu
354045
Ser
<210>20
<211>57
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>20
MetAspArgIleLysGluLeuAsnValCysGlyThrCysLysHisSer
151015
HisLeuIleProAspIleAsnGlyGluIleAlaValAsnIleCysArg
202530
IleGlySerGluAlaValAsnLysAspGlyGlyLeuThrTyrCysVal
354045
AspTrpThrProArgArgLysLeuSer
5055
<210>21
<211>111
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>21
MetLeuSerLysLysGluAlaIleGlnMetThrLeuAspAsnGluLys
151015
HisTyrProValLysCysLysTyrCysGlyLysProPheThrLysSer
202530
HisAsnArgGlnMetTyrCysSerAspSerCysArgArgAsnAlaLeu
354045
ArgGluGlnLysAlaArgTyrGlnAlaLysArgArgLeuLysIleLys
505560
GlnLysValLeuIleValAspGluTyrLysLysTyrGlyLeuGlySer
65707580
TyrGlyThrSerAlaAsnGlyHisArgLysAsnAsnPheSerHisGlu
859095
TyrMetAlaIleGlnLysGluMetLysArgIleGlyLeuLysArg
100105110
<210>22
<211>183
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>22
MetTyrLeuAlaLysPheCysProAsnCysGlyAsnLysValGluGlu
151015
AsnAspLysPheCysIleTyrCysGlyAsnLysLeuArgValIleIle
202530
ProGluLysLysValLysArgSerSerAsnSerIleAsnAspGluLys
354045
ThrSerLysTyrValGluValIleAspGlyLeuMetArgTyrLysVal
505560
PheProSerSerLeuProValLysTyrIleIleTyrLysValAsnTyr
65707580
GlyThrThrSerAspGluIleLysAsnIleLeuGluAsnGlyAsnTyr
859095
AsnTyrLysIleAsnIleHisTyrPheLeuGlnAsnLysLysLeuTyr
100105110
PheArgSerProLysAsnProAsnMetPhePheLysPheHisAsnAsp
115120125
ArgPheAsnGluGluMetArgLysAspAsnLysGluIleIleHisIle
130135140
SerSerTyrAlaArgValHisArgProSerLeuThrLysIlePheAsn
145150155160
PheAsnGlnGluLysThrPheIleLeuAlaAsnLysHisPheGluGlu
165170175
AsnIleArgLysThrArgLeu
180
<210>23
<211>77
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>23
MetIleTyrAspLysAlaThrValThrSerLeuIleValAlaIleLeu
151015
LeuProLeuMetSerMetLeuGlyIleGlyGluLeuThrGlnAsnTyr
202530
IleLeuAlaIleValSerGlyMetIleAlaLeuValValTrpTyrTyr
354045
AsnGluLysHisAsnSerAspLeuValSerGlyThrThrLysCysAsp
505560
CysGluLeuCysTyrGlyGlyAspAspGluAlaLeuIle
657075
<210>24
<211>112
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>24
MetLysHisLeuTyrGluIleIleProTyrArgArgThrValTrpIle
151015
ThrGlyPheLeuLysThrThrValSerSerAlaMetIleThrThrGly
202530
ValValIleLeuPheAsnSerIleThrGluHisProTyrPheMetGlu
354045
TrpAspGluIleGlyIleValLeuGlyIleValSerIleThrIleAla
505560
CysIleTyrIleAlaMetIleAspArgTrpLysGluArgArgLysLys
65707580
GluGluLeuAspThrIleGluAspTyrIleAsnArgLysAlaGluGlu
859095
IleAlaAsnMetLysValLeuArgLysLeuGluGluLeuGluGluGlu
100105110
<210>25
<211>204
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>25
MetIleGluIleSerThrIleLysIleThrAspIleLysProAlaGlu
151015
TyrAsnProArgIleMetSerGlnLeuGluHisThrLysLeuArgAsn
202530
SerMetGluThrPheGlyValValAspProIleIleIleAsnLeuLys
354045
AsnAsnHisIleIleGlyGlyHisGlnArgTyrGluValLeuLeuAsp
505560
LysSerMetGluAspAsnGluPheIleLysGluLeuHisLeuIleArg
65707580
LeuGlyAspValGlyTrpAlaPheProGluSerAspLeuGluValGlu
859095
AspAspAspHisGluLysAlaLeuAsnLeuAlaLeuAsnAsnIleGlu
100105110
GlyGluTrpAspLeuProLysLeuGluProIleLeuThrAspLeuLys
115120125
AspValGlyPheAspIleGluLeuThrGlyPheSerAspIleGluLeu
130135140
ThrGluLeuAsnLeuGluAsnAsnLeuValPheAlaGluGluPheGlu
145150155160
ProAspGluSerGluGluAspValAspLeuGluAspIleTyrAspGlu
165170175
ProValLysGluMetLeuGlnCysProAlaCysAspHisValAspVal
180185190
ValLysArgPheLysArgValAspSerGlnGlyAsp
195200
<210>26
<211>152
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>26
MetAspValAspAsnLeuLeuGlyTyrAspLysValLeuGluLeuArg
151015
SerLeuLeuGluGluValThrAspLysValIleProValTrpHisLys
202530
AsnArgGlyIleLysAspPheLysGlnMetCysGlnAspTyrAsnPhe
354045
ValSerIleSerGlyTrpArgAsnGluAspValLysAspAspGlnPhe
505560
IleHisPheValArgHisAlaHisArgAsnGlyCysArgIleHisGly
65707580
LeuGlyLeuThrArgArgLysValLeuAspArgValProPheAspSer
859095
ValAspSerSerSerTrpLeuGlnThrIleLeuTyrAlaArgLeuGly
100105110
GlnLysGlnLeuAspSerLysPheAlaThrGluArgArgGlyAspLeu
115120125
AlaValLeuSerTyrIleLysTrpMetLysThrGlnGluGluTyrTyr
130135140
LysLysTrpArgHisTyrHisAsp
145150
<210>27
<211>218
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>27
MetIleAsnGluArgIleArgProTyrLeuAsnPheSerPheAsnAsp
151015
LysLysValIlePheValThrLeuPheValValSerAsnLeuIleSer
202530
AsnLeuLeuAlaIleLysValPheAsnLeuGlyPheTrpGlyLeuThr
354045
ThrAspCysGlyAsnLeuLeuPheProLeuGlyTyrLeuMetAlaAsp
505560
ValIleThrGluValTyrGlyGluArgThrAlaArgArgValIleLeu
65707580
LeuGlyLeuPheAlaAsnIleLeuLeuIleValAlaThrThrLeuThr
859095
ValTyrMetProTyrProSerTyrTrpThrGlyGlnGlyAlaTyrAla
100105110
TyrMetPheGlyPheThrProArgIleValLeuAlaGlyPheIleAla
115120125
TyrLeuValGlyGlnPheValAsnAlaArgLeuMetValLeuIleLys
130135140
LysTrpThrAsnSerLysTyrLeuPheMetArgThrIleGlySerThr
145150155160
LeuGlyGlyGluLeuCysAspSerCysIleCysSerSerIleAlaTyr
165170175
TyrGlyIleValProAsnSerGlyIleLeuLeuPheIleLeuMetGln
180185190
TyrValValLysValThrTrpGluValValMetGlnProLeuThrTyr
195200205
LysSerIleAlaTrpAlaArgLysAspGly
210215
<210>28
<211>194
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>28
MetProGluProTrpGluArgGlnArgAspGluAsnGlyLysLeuGlu
151015
ProIleLysAlaPheGluTyrPheThrGluTyrLeuThrMetAspLys
202530
ProArgSerMetArgValLeuCysGluArgLeuGlyLysLysAspGly
354045
TyrIleArgGlnLeuHisAlaTyrSerSerThrTrpAsnTrpValGlu
505560
ArgAlaGluAlaTyrAspGluHisIleIleLeuLysLysArgLeuArg
65707580
LysGluLysPheTyrAspGluLeuValGluSerGluLeuProAsnLeu
859095
ArgLysArgLeuGluTyrTyrAsnLysAsnMetAsnAspIleGluThr
100105110
AspMetThrThrLysProThrSerLysAlaHisAlaTyrAspLysAsn
115120125
SerLysAlaHisSerThrThrLeuAsnGluIleLeuLeuMetIleGly
130135140
LysProThrGluIleLysGluThrSerLeuGluAlaAspIleGluSer
145150155160
AspAsnLysIleAspLeuGluAsnArgValGluValAspIleThrSer
165170175
AspGluPheMetGluSerGluLeuGluTyrMetArgLysMetIleGlu
180185190
GluLys
<210>29
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>29
MetLysAspIleValAsnHisTyrGlyTyrLeuSerProTyrLysPro
151015
ThrIleArgSerAspSerLysAlaLysAsnLysPheLysLeuAsnGlu
202530
ProTyrArgGlyGlnMetLeuSerAlaGlyAlaGlyGlySerIleMet
354045
GlyTyrGlyAlaGlyLeuLeuIleValAspAspProIleLysAsnVal
505560
AlaGluAlaGluSerLysValArgGlnAlaLysLeuLysAspTrpTrp
65707580
GlyGlyThrIleLysSerArgValGlnArgArgSerAsnGlyLeuPro
859095
ProIleLysIleValIleAlaGlnArgLeuHisLeuLysAspLeuHis
100105110
GlyIleIleLysGluThrGluProThrIleProAlaAsnAspAlaPhe
115120125
ArgIleLeuArgAsnGlyGlySerIleAspProAsnThrTrpValAsp
130135140
PheAsnLeuProAlaIleCysAspSerGluAspAspIleLeuGlyArg
145150155160
LysIleGlyGluValLeuTrpGluGluGlnArgAspTyrGluTrpLeu
165170175
MetAlaGluLysArgSerMetGlySerTyrLeuPheAsnSerIleTyr
180185190
GlnGlyGlnProValGluArgAspGlyGluIlePheLysArgGluTrp
195200205
PheGlnAspGluValAsnHisLysLeuThrCysLeuIleAspProLys
210215220
AspIleProLysAspLeuProGlnLeuArgTyrTrpAspPheGlyAla
225230235240
SerGlyAspAlaGlyAspGlyThrSerAlaIleLeuThrSerTyr
245250255
<210>30
<211>261
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>30
MetSerLysLysGlnGluMetMetArgIleGluArgLeuLysHisTyr
151015
AlaTyrGlnThrGlyLeuIleIleProIlePheLysAsnHisAspLeu
202530
IleLysLysIleGluAsnGlyLysIleThrAsnThrAspGluIleLys
354045
IleTyrIleGluGluAsnGluLysGlnIleLysArgArgArgGluPhe
505560
IleSerIleIleTyrAspAsnCysLysTyrPheLysTyrAspSerIle
65707580
CysTyrLysLeuIleSerLysValAsnAsnPheGluIleLysSerLeu
859095
GluGluLeuMetAsnGluIleGluSerGluLysLysLysAsnGlyPhe
100105110
ArgLysAsnIleGluGluLysGluLeuIleLysGluAsnGluAsnLys
115120125
GlyArgLeuLysGluTyrValArgIleValArgArgGluTyrGlyLeu
130135140
AspPheThrSerValLysLysLeuLysLeuLysIleAspAsnAsnLys
145150155160
IleArgSerLysGluGluLeuAsnGluGluIleIleGluGluLysLys
165170175
LysThrGluLeuArgArgIleValTyrAspSerAspLeuAsnTrpAsp
180185190
LeuLysTrpGluLeuGluSerLysIleArgHisAsnGluIleThrThr
195200205
LysGluGluLeuIleLysGluIleArgArgIleGluPheIleAsnIle
210215220
IleTyrAspAsnAsnArgAspPheLysLeuAspTyrValThrIleGln
225230235240
LysLeuValSerLysIleGlySerAsnGluIleThrThrLysGluGlu
245250255
LeuIleLysGluMet
260
<210>31
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>31
MetSerLysAsnAlaLysAlaAspAlaPheValValThrThrGluAsp
151015
GlySerTyrAspIleValAspAlaAspValLeuGluArgTyrAlaIle
202530
LysSerGluSerAspGluThrGlySerLysGlnLeuLysThrAspGly
354045
TrpGluTyrAspAspThrLeuLeuGluProLeuTyrAspProLeuGln
505560
LeuCysGluLeuLeuGluIleAsnThrTyrHisGluAsnCysValAsp
65707580
ValValAlaArgAspSerAlaGlyIleGlyTyrAspIleValProVal
859095
ThrGlyGluLysGluLysGluLeuAsnLysProLysLeuThrAsnPhe
100105110
LeuGluAsnIleGluProAsnIleAsnGluLeuLeuTyrGlnMetAsn
115120125
TyrAspArgArgAlaThrGlyTyrGlyAlaLeuGluLeuIleArgLys
130135140
AspLysSerLysSerGluProValAsnLeuSerHisIleSerSerTyr
145150155160
ThrLeuArgArgThrSerAspGlyLysArgValLysGlnArgValGly
165170175
ThrLysThrValTrpPheValIleTyrGlyLysAsnTyrAspLysGlu
180185190
GlyAsnLeuCysAspValHisSerGluThrGlyGluPheHisProTyr
195200205
AsnSerLeuSerLysGluGluArgAlaAsnGluLeuLeuTrpThrMet
210215220
GluTyrThrThrLysSerLysTyrTyrGlyLeuProLysIleValGly
225230235240
AlaIleProAlaIleTyrSerAspIleSerArgSerLysTyrAsn
245250255
<210>32
<211>254
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>32
MetMetAlaLeuLysValArgHisSerLysArgGlnIleGlnAsnIle
151015
LysArgGluTyrArgArgArgLeuIleLeuGluGluGlnCysSerArg
202530
GluIleAlaAspPhePheArgArgLeuGluArgLysIleHisLysVal
354045
MetAspGluHisTrpGluSerGluLeuGlyLeuPheHisLeuAsnLys
505560
ValSerAspIleIleGlnAspSerArgGlnGluTyrTyrAspIleLeu
65707580
PheLysTyrCysLysAspSerTyrMetLysGlyArgGluAlaThrGlu
859095
ArgArgPheAsnArgLysLeuGluAsnIleSerMetLysAlaAspVal
100105110
AsnIleThrArgLeuGluAspLeuPheLysProAspProThrIleArg
115120125
TyrAsnLeuAsnAsnLysValPheGlnAlaSerAlaHisThrMetAsp
130135140
ArgValAspAsnArgIleMetGluAsnIleThrGlnSerTyrAspAsp
145150155160
GlyLeuGlyIleAspGluAlaLysAspArgLeuThrValGluTyrAsn
165170175
GlyLeuLysSerTrpGluAlaGlnArgIleAlaArgThrGluIleAsn
180185190
SerAlaGlnAsnAspGlyAlaPheAspValTyrGlyGluLeuGlyVal
195200205
GluTyrHisGlnTrpTrpThrAlaGlnAspGluArgValArgGluThr
210215220
ProGlnAlaAspHisArgGluLeuHisGlyLysIleValLysValGly
225230235240
AsnSerPheSerAsnGlyLeuGlnTyrProGlyAspArgThr
245250
<210>33
<211>87
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>33
MetIleIleGluIleProGlyAsnAspArgThrGluGluIleAsnLeu
151015
ProAsnGlyGlnPheValLeuIleThrTyrLeuGlnGluAsnAspMet
202530
MetSerLeuProAspGlyLysTyrValCysProPheArgMetIleGln
354045
LeuPheThrGluGluGlyGlyGluLeuIleGlyGluCysIleGluGlu
505560
AsnProHisTyrAsnThrArgPheTyrAsnThrValPheGluHisLeu
65707580
AspGluGlyIleGluTyrArg
85
<210>34
<211>179
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>34
MetLeuArgValValGluArgThrTyrTyrGlnGlnGluGluIleLys
151015
ThrLeuAspCysArgIleArgGluAlaGlyValAsnThrTyrSerLeu
202530
AlaArgGlnGlyAlaValAspTyrProThrTyrGluSerTyrAsnGlu
354045
ValArgGluGluArgIleLysGluAlaLysGluLysTyrGlyGluSer
505560
TyrTyrTyrHisTrpArgAspValGluThrTyrPheTyrTyrLeuGly
65707580
ArgPhePheSerAspLeuGluGluIleGluLysTyrLeuGluArgThr
859095
ValThrTyrLysProHisArgGluGluLeuLysGluAlaMetGluArg
100105110
LeuAspLysArgPheGluGluValIleAsnGluPheTrpTyrSerLeu
115120125
GluGluTyrGluAspIleThrGluAspValLeuGluGlnLeuLysGlu
130135140
GlyAspCysThrValHisCysGluPheLeuIleLysGluPheLysLys
145150155160
PheValAsnValIleCysArgIleIleLysGlnAsnGluIleAsnHis
165170175
LysGluPhe
<210>35
<211>96
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>35
MetAspAlaIleAsnValIleAsnGlnAsnLysIleLeuValAspVal
151015
LeuTyrArgGlyThrValAsnLeuIleAspIleValIleGlyAspAla
202530
LeuValTyrAspAsnProThrValValValLysCysTyrThrThrAsp
354045
LeuAlaPheAlaThrThrGluIleAspGluIleValLeuGluAsnGlu
505560
GluPheGluLeuLeuIleThrTyrGluAspGlyGluPheSerIleLeu
65707580
LeuLysSerHisAsnLeuGlyGluLeuGlyTyrIleGluTrpValIle
859095
<210>36
<211>101
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>36
MetValPheValAspLeuCysGluAsnGluIleAlaAspMetValGlu
151015
SerPheTyrArgAsnGlyAspGlySerSerArgIleLeuThrAsnArg
202530
AlaValGlyGluIleValGluHisTyrCysSerPheGluValAspGly
354045
ArgIleThrThrAsnLeuArgAspPheLeuLeuTyrSerValValLeu
505560
TyrAspThrIleGlyGluAlaValAspAspGlyValAsnLeuGluGlu
65707580
ValPheIleIleGluAspArgAsnCysTyrThrGlyLysSerGlnVal
859095
IleLeuIleGlyGly
100
<210>37
<211>185
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>37
MetValAsnTrpLeuLysAlaIleGlyAspAsnPheSerValAspTyr
151015
LeuLeuLeuAlaLeuPheSerSerGlyAspLeuIleLeuValAlaIle
202530
ValLeuAsnSerTyrGlyValIleSerProGluAsnValArgGluLeu
354045
ValIleAspTyrIleSerTyrArgLysValAspIlePheTrpArgHis
505560
LeuArgArgProArgMetSerPheGluAspTyrValLeuAspAsnPhe
65707580
GluGluMetGluThrGlyGluLeuThrArgGluGlnValValGluPhe
859095
ValSerArgGlnGluArgLysGlyLeuThrPheCysAsnGluIlePhe
100105110
IleAlaValProLeuLysLysGlySerLysAspAspIleValGluIle
115120125
LeuTrpAsnGluTyrPheValGluAspTyrLysGluAsnTrpLeuGlu
130135140
GlnHisGluAsnLeuGlyTrpAsnAspTrpLysLysLeuLeuLysLys
145150155160
GluIleValGluAsnGlyGlyAspAspPheGlnIlePheArgAsnHis
165170175
LeuIleAspCysValLeuMetGluTyr
180185
<210>38
<211>63
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>38
MetThrMetLysValThrPheGluAspGluAsnGlyGluArgThrVal
151015
GluPheGlyAspAspValAspPheValLeuIleGluSerAspAspAsp
202530
GlyAsnIleGluIleArgGluGlyAspTrpGluLeuAspGlyAspSer
354045
AspAspAspTrpGluGluTyrAspAspTrpAspGluGluGluPhe
505560
<210>39
<211>93
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>39
MetAspGluPheValGluThrLeuPheAspThrTyrTrpLysValAsn
151015
GluAsnGlyGluTyrMetSerLeuThrAspCysGlyAspPheTyrIle
202530
AlaLysValAlaProCysValArgAsnTrpSerIleValIleGluCys
354045
AsnCysPheCysPheHisCysLysGluPheValTyrHisGluAsnGly
505560
AlaIleLeuGluIleGlyMetGluIleSerSerLeuTyrLeuSerGln
65707580
MetGluIleLysAspLeuLysIleTyrMetIleAspCys
8590
<210>40
<211>119
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>40
MetPheLeuGluGlyIlePheGluGlnAspGlyGluAsnValArgGlu
151015
GlnValIleTyrTrpArgLysSerAsnGlnValHisAsnTrpPheVal
202530
ValAsnAlaGlnAspGlyGluAspAsnCysGlnProHisSerValSer
354045
ArgGluGlnLeuGluGluLeuArgAspLeuCysArgAlaValLeuAla
505560
AspAsnAspLysAlaGluGluLeuLeuProThrArgProGlyPhePhe
65707580
PheGlyAlaIleAspTyrAspGluTrpTyrTyrTyrAspLeuGlnTyr
859095
ThrValGluLysIleAspGluValLeuLysAspAspArgTyrLeuTyr
100105110
PheGluTyrCysSerTrpTrp
115
<210>41
<211>57
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<220>
<221>MOD_RES
<222>(42)..(42)
<223>任何氨基酸
<400>41
MetGlnLeuValValGluGlyGluAsnMetGluCysProCysAspAsn
151015
CysGluMetLeuArgGluAsnGluProIleLysValIleAspTrpLys
202530
SerAsnSerProPheGlyAsnGlyIleXaaIleHisPheTrpArgGlu
354045
ArgLeuGlnAspValGlyTyrAsnGly
5055
<210>42
<211>116
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>42
MetGluLeuMetThrArgGluMetGluGlyLysLeuLysSerPhePro
151015
PheTyrSerGlnAspGlyLysGlyAspAspAlaIleValValMetLys
202530
PhePheAsnProTyrGlyLeuGlyThrTrpTyrValLeuGluAlaGlu
354045
LysGlnGluAsnGlyAspTyrLeuPhePheGlyTyrValGluSerPro
505560
IleThrProGluPheAsnGluTyrGlyTyrPheSerLeuSerGluLeu
65707580
GluAsnLeuLysIleProIleLysIleAsnGlyIleThrValSerTyr
859095
GlyArgIleGluArgAspLeuTyrPheGluArgValArgIleGlyAsp
100105110
IleIleGlyAsn
115
<210>43
<211>74
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>43
MetPheGlyGlnLysLysGluPheValLysLysMetTyrHisValGly
151015
AspValValGluLeuValHisMetAspAspAlaGlnAlaProProSer
202530
GlyThrArgGlyGluIleLeuPheValAspAspIleGlyGlnIleHis
354045
ValArgTrpGluAsnGlySerGlyLeuAlaLeuIleTyrGlyGluAsp
505560
ArgPheLysValValGluArgLysGlyGlu
6570
<210>44
<211>50
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>44
MetAspLeuLeuTyrLeuTyrAspAspLeuThrAlaArgArgGluVal
151015
TyrAspSerValGlyLeuSerPheValValLysTyrLysPheSerSer
202530
ArgLysGluAlaGlnAspPheAlaLeuLysTyrGlyAlaGluLeuIle
354045
GluGlu
50
<210>45
<211>62
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>45
MetIleGluArgArgArgLeuGlyMetLysTyrAspIlePheThrIle
151015
LeuAspGluIleSerArgLysLeuAspAspGlyGluLeuSerAspGlu
202530
GlnValAspPheLeuLeuGlnMetGluIleLeuValGluGluGlyThr
354045
IleThrAspGluGlnAlaGlnAspValMetAsnGlyAspTyr
505560
<210>46
<211>55
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>46
MetMetLysLeuSerLeuLysGluLeuGlyGluGluIleGluMetIle
151015
LeuAlaGluGlyGlyLeuThrPheAspGlnValAspTyrLeuLeuTyr
202530
LeuGluThrCysIleAlaAspGlySerIleThrGluGluGlnLysArg
354045
GluIleIleCysArgAspPhe
5055
<210>47
<211>77
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>47
MetValArgGluGlnGluArgLeuIleMetTyrLeuGluIleAspGlu
151015
ValLysCysGluAsnIleAspArgIleGluPheAspAspValAlaMet
202530
GluIleValLeuThrAspGluLysValTyrGluArgIleLysArgTrp
354045
LeuLysSerAsnGluIleAspTyrAspCysArgGluAspArgTyrPhe
505560
AlaAsnLeuIleGluTyrValIleArgIleThrTrpTrp
657075
<210>48
<211>71
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>48
MetValThrValArgAspValGlyPheThrIleGluGluArgPhePhe
151015
LeuThrAlaGlnGluLeuGluTyrSerGluValGlyGluGluHisGlu
202530
SerValIleAspArgAlaIleAlaLeuLeuTyrThrLysLeuArgThr
354045
ArgAspPheGluPheThrAspGluGluArgGluLeuLeuGluAspAla
505560
PheValIleValSerAspGln
6570
<210>49
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>49
MetAlaLysGluAsnValIleAspTyrLysIleGluArgGlnAsnAsp
151015
AsnThrTrpSerTyrLeuTyrValThrGluArgGlyArgGlyAsnIle
202530
IleAlaSerSerPheGlyGluLeuArgGlnLysValLeuLysArgGly
354045
LeuProTrpAsnAspIleSerAsnLeuPheThrLysLysSerSerAsp
505560
SerAsnValArgArgGluSerValLysAsnIleAspAspGluSerVal
65707580
LeuAlaAspValAlaLysLysSerSerAspSerAsnValArgLeuGlu
859095
AlaValArgLysIleSerAspAsnTyrValLeuIleAspIleValLys
100105110
AsnAlaSerAspTyrAspValArgArgGluAlaValArgLysIleAsn
115120125
AspSerSerValLeuGluAspIleAlaLysAsnAsnAsnAspGluAsn
130135140
ValArgLeuGluAlaValArgAsnIleAsnAspGluSerValLeuGlu
145150155160
AsnIleSerLysAsnAlaSerAspSerLysValArgIleGluAlaIle
165170175
LysLysIleAsnAspGluThrIleIleIleLysLeuAlaLysAsnAsn
180185190
AsnAspGluAspValArgIleGluAlaValArgLysIleAsnAspLys
195200205
ThrValIleIleAspPheAlaLysAsnAlaSerAspSerLysValArg
210215220
ArgGluAlaValArgLysIleAsnAspSerSerValLeuAlaTyrVal
225230235240
LeuLysAsnAspProSerTrpIleValArgIleGluAlaValArg
245250255
<210>50
<211>231
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>50
MetValValLysCysProAsnCysPheSerProArgValSerLysCys
151015
GluAspThrAsnIleLysTrpGlnCysAspLysCysLysCysLysPhe
202530
AsnHisGlyAlaPheAspIleAsnAlaGluMetGluLysValGluGln
354045
LeuThrIleGluLysIleGluArgGluArgGluArgThrGluGlnPhe
505560
GluArgAlaIleLysGluAlaLysGluGlnPheGluArgGluArgThr
65707580
GluGlnPheGluArgGluArgLysGluArgLeuGluArgGluLysArg
859095
GluLysGluArgGluLysIleGluLysGluArgGluArgLysGluArg
100105110
LeuGluArgAsnArgIleLysIleGluGluArgGluArgGluArgIle
115120125
LysArgAsnGluArgIleArgArgGluAsnGluArgAsnArgIleLys
130135140
SerAspLysArgGluArgGluLysSerGluGluLysArgIleLysArg
145150155160
AsnGluArgIleArgLysAlaAsnGluArgAsnSerIleLysArgGlu
165170175
LysArgGluArgGluArgGluArgAsnValMetThrIleAspGluTyr
180185190
TyrArgSerIleGlyTyrGlySerThrGlyLysSerLysValTrpSer
195200205
AlaIleIleIleProIleLeuLeuValIleCysIleIleLeuIleLeu
210215220
MetPheTyrGlyGlyGlyMet
225230
<210>51
<211>248
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>51
MetThrGluGlyGlnIleArgGlnIleAlaHisGluTyrLeuAlaAsn
151015
TyrSerLeuValAspLysAsnHisGluPhePheGluThrArgGluVal
202530
IleGlyValProValGluSerTyrIleThrAsnGluProIleSerLeu
354045
LysGlyLeuAspGlyThrValAsnGluTyrProLysGlyThrTrpIle
505560
AlaThrThrArgIleThrAspGluGluGluMetGluLysAlaLeuAsn
65707580
GlyGluTyrThrGlyTyrSerIleThrThrValSerLysLysPheAla
859095
AspLysGlnIleGlnLeuProArgArgValLeuMetLysAspIleLys
100105110
AspProValGlyPheThrIleSerLeuValArgLysProCysValArg
115120125
GlyAlaLysPheCysSerMetLysGluAspIleGluAsnGlyAspVal
130135140
ValSerGluAsnIleAspAspLysLeuGluGluGluThrLysGlyPhe
145150155160
ValGlnSerIleLysGlyIlePheAsnLysGluAspLysAspGluAsp
165170175
LysAsnProGluAspGluAspIleGluLeuAspIleLysAlaIleVal
180185190
AspGluValThrLysAspPheValAsnThrAspAspPheGluThrPhe
195200205
LysAsnGluLeuGluLysAlaLeuSerAspLysPheGluThrLeuGly
210215220
AlaGluLeuPheLysSerLeuLysLysSerLeuGluLysAspLysAla
225230235240
GluGluAlaLysLysSerGlyArg
245
<210>52
<211>280
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>52
MetGlyAsnGluAlaThrLeuAsnGlnLeuValAsnGluGlnGluLys
151015
AlaValPheLysSerMetArgThrAspMetGluThrGlyLysAlaVal
202530
LeuAsnValGluGlnLeuGlyTyrPheLeuArgGluAlaThrLeuAsp
354045
AsnThrIleLeuArgAspAlaAspPheLysLeuMetLysSerPheLys
505560
LysHisLeuAsnArgValGlyIleAsnGlyArgValLeuThrAsnGly
65707580
TyrAspValAsnGlyGluThrAspProGluIleProAlaAlaAspVal
859095
AspPheGlyAlaAsnGluLeuAspValLysLysLeuLysAlaMetCys
100105110
GluIleGluAspAspGluLysGluAspAsnMetThrGlnAlaGlnPhe
115120125
GluGlnThrLeuLeuGlnMetMetGlyGluArgIleGlyGluAspLeu
130135140
GluTyrTrpAlaLeuPheAlaAspSerGluValAlaArgSerAspAsp
145150155160
ProLeuLeuAsnThrAsnAspGlyTrpLeuLysLysCysAlaAsnHis
165170175
IleSerSerArgSerIleAlaProSerAsnGlyMetPheAspIleGlu
180185190
AspGlyProGluAlaMetPheAspAlaMetIleLysAlaLeuProPro
195200205
ArgPheArgLysAsnArgArgMetLeuLysPheTyrValProPheGlu
210215220
ValGluAspAlaTyrArgAsnIleLeuIleAsnArgGlyThrGlyLeu
225230235240
GlyAspSerAlaGlnIleGlyPheAsnAlaLeuSerTyrLysGlyIle
245250255
ProIleGluHisCysSerThrLeuAspAspGluAspGlyArgGlyMet
260265270
LeuGlyAsnArgValCysSerMet
275280
<210>53
<211>147
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>53
MetArgArgArgCysLeuAsnSerProGluHisAsnGlyMetIleSer
151015
HisIleIleValLeuLeuIleCysPheIleGlyLeuValGluAlaIle
202530
LeuMetAlaLeuValAspTrpGluAspLeuAlaIleSerValArgLys
354045
SerProArgLysLeuTyrAsnValLeuLysAspGluLeuGlyLeuPro
505560
GluTrpAsnGluLeuSerValIleGluArgArgSerMetLysLysArg
65707580
TyrAlaValIleArgAspSerPheProGluLeuProProTrpGluGlu
859095
LeuSerValIleAspArgArgSerHisLysArgLeuTyrLysLeuIle
100105110
LysSerValTyrAspGlyAspTyrAspAspSerProSerLeuGluGly
115120125
ProProAlaAlaValGlyProGlnLysGluIleProLeuGluGluAla
130135140
GluTyrPro
145
<210>54
<211>137
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>54
MetThrTrpIleGlyThrGluAspValIleGluPheThrGlyValLys
151015
ProGlnThrPheArgPheGluLysGlyAspThrSerSerLeuGluThr
202530
LeuLeuGluLysTrpIleLeuGlnAlaGluGlyLeuIleIleSerTyr
354045
CysAsnTyrAspPheAsnAspLeuGluGluIleProProAlaValVal
505560
AsnValCysLeuArgLeuThrAlaAsnMetValAlaLeuAlaGlnAla
65707580
ArgLysAspThrProValIleGlnValLysGluTrpAsnValGlnThr
859095
ValSerSerAsnIlePheSerAsnAspLeuLysArgAspLeuThrPro
100105110
PheValHisGluArgLysSerTyrLysGlyAspGluIleAspPhePhe
115120125
ValIleThrGlyAspAspAspSerTrp
130135
<210>55
<211>148
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>55
MetValLysLeuGlnIleAspValGluGluLeuLysProLeuGluPro
151015
ArgPheLysLysValAlaLysArgThrValValLeuThrAlaAsnGlu
202530
LeuGlnArgAsnLeuLysLysLeuSerProValAspHisGlyArgLeu
354045
GlnGlySerTrpValIlePheGlnThrGlyGluLeuGluArgThrVal
505560
LysSerSerAlaLysTyrAlaIlePheValAsnAspGlyThrGlyLeu
65707580
TyrGlyProLeuGlyHisLysIleArgProLysAsnGlyLysPheLeu
859095
AlaPheThrProAsnLysGlyLysPheLysGlyLysLeuValValVal
100105110
ProTrpThrArgGlyGlnLysProGlnArgPheValGluArgSerMet
115120125
GluMetThrGluArgArgValGlnGluPheMetIleArgAlaMetMet
130135140
GluMetAspSer
145
<210>56
<211>169
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>56
MetArgPheValAsnThrAlaSerLeuValProGlnThrValLysAla
151015
TyrLeuGluArgGluIleCysGluGlyGlyLeuLeuGluAspValGlu
202530
ThrLeuIleProSerValAsnSerAspValProValAspProProAla
354045
IleTrpIleValGlnHisProThrThrArgTrpSerGlySerGlnPro
505560
AsnLeuSerAsnLysIleAlaMetSerValProPheGluPheValCys
65707580
ValGluTyrSerAspAspLeuGluGluAlaGluIleLeuGlyIleSer
859095
LeuAlaSerArgValGlySerSerLeuMetLysAsnPheAsnLysVal
100105110
LysValAspAspSerMetProAsnArgPhePheHisLysLeuGluPhe
115120125
GluThrLeuTyrProValGlyGluValThrValValGlyLysSerGlu
130135140
ArgIleProAlaThrSerIleIlePheAsnPheValTyrValValAsp
145150155160
TrpLeuLysCysAsnArgArgTyrAsp
165
<210>57
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>57
MetGlyIleArgValValGlyMetLysGluGluAlaArgTyrGlyVal
151015
AlaGluSerAlaProAspPheHisGlnGluValSerLysAlaLysAla
202530
SerLeuAsnSerThrProAsnThrLysSerSerGlySerArgMetLys
354045
LysLysAlaArgAlaGlyValTyrLysProThrAlaAsnIleGluGly
505560
GluValAspLeuLysArgIleGlyHisTyrLeuLysAlaPheLeuAsp
65707580
AsnTyrHisPheThrAspGlyGlySerAsnProAsnValHisGluPhe
859095
TrpGlyGlyGluAsnAsnLysLeuSerSerPheThrLeuTrpValThr
100105110
PheAspIlePheGluLysThrIleValGlySerLeuLeuAspAsnPhe
115120125
LysMetGluValSerAspGluTyrMetLysPheThrAlaAspPheVal
130135140
TyrLysThrGluGluSerAspGluIleGluAsnIleGluLeuTyrLys
145150155160
ValLysLeuLeuAspGlyAspTrpAlaLeuMetPheTyrAspValSer
165170175
ValGluIleAspGluAsnAlaProProGlyIleValSerSerPheSer
180185190
PheAspGlyLysAsnAsnIleAsnValAspLysThrIleGlyLeuGly
195200205
SerArgGlyProGlnArgLysAlaAlaAlaGlnGlyArgAspIleSer
210215220
IleSerPheValSerThrLeuGluArgGluThrLeuGluLeuIleGln
225230235240
LysAlaGluTyrGlyGluValGlyThrGluProSerGluCysLys
245250255
<210>58
<211>146
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>58
MetValValValLysLysSerAspIleLeuLysGlyValLysLysIle
151015
GluLysValLysIleGluAlaLeuAspGlyAspGluMetTyrLeuArg
202530
ProLeuSerGlnAlaGluIleAsnGluValAspGluIleGluAlaLys
354045
AlaMetGlyIlePheGluThrAsnGluThrAlaHisArgGlyArgArg
505560
GlnLysProLysSerValValGluSerLysGlyLysIleAsnLeuGlu
65707580
LeuGlnGlnLysAlaGlnHisGlnAlaLysThrLysAlaIlePheLeu
859095
SerLeuAspAsnGluLysAsnValGlyGluGluAlaTrpSerGluThr
100105110
GluIleGluGlnMetProHisLysLeuPheGluGluLeuPheAsnHis
115120125
ValLysArgLeuSerGlyIleGluLeuAspGluAspAspValAspThr
130135140
PheHis
145
<210>59
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>59
MetProSerSerAsnValMetAsnIleIleValLysAlaGluAspMet
151015
AlaSerSerValAlaGlnLysValGluAsnSerPheArgLysLeuGly
202530
AsnThrIleAspSerThrPheThrThrSerLeuSerAsnThrLysPhe
354045
AsnGlnGluLeuThrSerPheGlyThrAspLeuAspLysValThrGln
505560
ArgLeuLysGlnValGlyValAsnGlyGlnSerSerPheAsnGlnLeu
65707580
ThrAsnAlaGluArgArgThrLeuGluLysLeuSerGluPheAspPro
859095
ValSerAlaGlnValLeuGlnHisLeuSerArgIleGlyIleThrGly
100105110
GlnGlnThrPheAsnGlnLeuSerValSerGluGlnLysSerLeuMet
115120125
AsnMetLysSerThrAlaGlnGlnLeuGluGluValAsnSerLysLeu
130135140
ArgValValGlyIleGlyAlaAlaGlnAlaAlaAsnMetLeuAsnGln
145150155160
MetLysLeuAspProSerValGlySerAsnLeuAspArgAlaLysLeu
165170175
LysValSerGluMetGlyTyrSerLeuAspSerThrLysGlyLysIle
180185190
LeuValLeuGlyThrAlaIleGlnThrSerLeuGlyAsnLysTrpAsp
195200205
SerIleLysThrLysValGlnThrThrAlaThrAsnIleArgThrAla
210215220
LeuGlyAsnAlaLeuThrSerValLysSerLysValGlnAsnLeuGly
225230235240
AsnAlaPheSerGlyLeuGlyGlyIleIleSerSerAlaIleGly
245250255
<210>60
<211>274
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>60
MetAlaSerValThrLysTyrProSerAsnValSerGlnThrThrGly
151015
GlyLysPheValSerPheSerAsnLeuAlaAsnIleLysAsnAsnAla
202530
AspGlyAlaHisAlaValSerSerValLeuIleLysSerLysLysGln
354045
SerProAsnArgProSerThrValSerCysLysGlyPheGlyPheSer
505560
LeuProGluGlyAlaGluProThrLysIleThrValThrTyrArgHis
65707580
ArgLysAsnAlaGlySerAspTyrSerSerLysAsnLysThrHisIle
859095
CysAsnIleGlyGlyProThrIleSerLeuLeuGlyValSerGlyPhe
100105110
SerSerLysGlySerGlyCysThrThrThrMetThrThrHisThrLys
115120125
AlaPheSerValHisGlyLysLeuSerArgAlaGlnValAsnSerAla
130135140
AsnPheGlyValLysLeuAspTyrProThrAsnSerAsnThrTyrAsn
145150155160
GlyTyrMetArgIleSerTyrValArgValThrValGluTyrIleThr
165170175
SerGlnTyrSerValSerValLysHisValSerGlyThrTyrGluAsp
180185190
GluAspTyrValValSerLeuGlyIleSerAsnLysAsnLeuThrSer
195200205
TyrAsnProThrCysThrLeuThrValProAlaGlyPheThrTyrLys
210215220
GlyValThrGlyAlaAlaThrGlyThrValThrLysValAsnAsnArg
225230235240
ThrPheSerTrpAsnProGlnLeuGlnGlyArgAlaGlySerArgGln
245250255
IleSerLeuAlaPheGluProAsnValThrPheProGluGlyThrAsp
260265270
SerTyr
<210>61
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>61
MetGlyIleAlaIleValValMetAspAsnGluGluAsnPheLeuGln
151015
PheLeuAspProAspLeuCysThrIleAsnGluThrIleGluGluLeu
202530
GlyLeuArgThrLeuGluPheAsnTyrLysPheGlnAspTyrValGlu
354045
AspArgAspLeuPheArgIleGlyAsnLysIleTrpIleSerAsnSer
505560
GlnSerLeuGluAspCysLeuTyrValIleAsnThrProValGluAsn
65707580
SerValTyrGlnGluAsnTyrPheAlaCysGluIleGluGluValLeu
859095
AlaGluLeuTyrTyrAlaProLeuPheSerGlnThrGluLeuThrSer
100105110
AlaAsnGlyPheThrLeuArgThrThrAsnGlyGluGlnThrValAsp
115120125
ValAspTrpAsnAlaLeuAsnTyrTrpPheGlyLeuTyrPheAsnIle
130135140
GlyValValGlnGluCysLeuGlyThrTyrAlaAsnArgIleThrVal
145150155160
AsnGlyThrMetAsnArgLeuAsnLeuLeuArgSerIleGluGluGln
165170175
ThrGlyAsnArgPheValThrArgTyrGluLysAspLeuLeuAspAsn
180185190
ThrIleHisArgTyrLeuAspPheLeuAsnProValAsnValSerLys
195200205
AsnTrpLysLeuAsnIleGluTyrAspPheIleTyrGluAspAspGly
210215220
GluTyrCysGluAlaTyrThrSerAspGlyAsnProIleSerGluIle
225230235240
TyrAspAspIleGluGluGluAspAspIleValAspPheProPro
245250255
<210>62
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>62
MetValGluLysIleThrValSerProGlnGluValArgGlyTyrGly
151015
AsnValValAspGluLysGluLeuGluAspTyrGlySerTyrArgCys
202530
AspValSerGluSerSerGluValIleLysGlyValGluGluArgIle
354045
PheSerValSerGlyValProAlaProAlaLeuSerIleAlaAsnVal
505560
ThrGluAspThrArgArgGlyArgCysAlaHisIleSerAlaSerPhe
65707580
GluAspGlyGluGlyAspGlyLeuAspAspLysAlaIleSerLeuLys
859095
SerGlyAspAspValLeuAlaThrIleThrThrGlySerGlyGluAsn
100105110
ValPheAspValValLeuTyrAspSerAlaGlnLeuTyrAlaValPhe
115120125
AspGlyAspAspTyrTyrProProAlaValSerGluAlaIleThrVal
130135140
AsnProAlaLysSerLeuTrpAspValGluPheIleLeuAspGluGlu
145150155160
GluTyrGluValGlyAspThrAlaIleLeuSerGlyThrValGlyThr
165170175
IleValAspGluIleValAspGlyGluIleValThrArgArgGlnMet
180185190
GluAlaAsnValThrLeuThrLeuValThrAspLeuGlyIleArgArg
195200205
CysSerThrAsnAlaAsnGlyGluPheValLeuGlnValProAsnIle
210215220
GlnGlnAsnGlnTrpArgValValIleAlaAlaThrSerThrHisLeu
225230235240
ValPheAsnGlyLeuIleAspValProValHisAspTyrSerLeu
245250255
<210>63
<211>228
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>63
MetValArgPheSerArgAspMetLeuGlnAspGlyAlaLysArgMet
151015
PheLysTrpLeuArgLysGlyGluGlyLeuProAsnTyrLeuIleMet
202530
TyrAspMetAspArgAsnLysGluTyrLysLeuValProLysGluTyr
354045
AlaGlyLeuTyrGluSerArgAsnIlePheTrpIleLysAsnGlyArg
505560
GluProAsnTyrValThrLeuThrSerValAlaArgAsnProLeuVal
65707580
MetAspTyrGlnAsnThrAsnTyrThrCysCysProThrSerLeuSer
859095
LeuAlaSerGlnMetLeuTyrHisTyrLysSerGluSerGluCysAla
100105110
LysAlaLeuGlyThrSerLysGlySerGlyThrSerProAlaGlnLeu
115120125
IleAlaAsnAlaProLysLeuGlyPheLysIleIleProIleLysArg
130135140
AspSerLysGluValLysLysTyrLeuLysLysGlyPheProValIle
145150155160
CysHisTrpGlnValAsnGlnSerArgAsnCysLysGlyAspTyrThr
165170175
GlyAsnPheGlyHisTyrGlyLeuIleTrpAspMetThrSerThrHis
180185190
TyrValValAlaAspProAlaLysGlyValAsnArgLysTyrLysPhe
195200205
SerCysLeuAspAsnAlaAsnLysGlyTyrArgGlnAsnTyrTyrVal
210215220
ValCysProAla
225
<210>64
<211>749
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>64
MetLysLysHisCysPheTyrPheLeuGlyAspSerPheAlaAspIle
151015
CysAsnGluAlaMetPheCysGluLysHisLeuValGluGlyAsnTyr
202530
LeuAspSerIleIleArgAlaGlyLysAlaSerGluIleIleThrVal
354045
AsnIleCysGluLeuGluGlyGlnAspGlyLeuIleSerSerGlyGln
505560
LysLysArgLeuGluMetLeuGlyTyrLysGlyIleIleSerTyrAsp
65707580
IleTyrLysArgLeuAsnHisIleArgLysIleArgAsnLysAlaVal
859095
HisGlyHisLeuSerAspIleGluAspAsnAlaAsnIleLeuHisAla
100105110
TyrLeuTyrLeuIleCysAlaTyrPheTyrLysGluTyrArgAspThr
115120125
AsnPheSerAlaGluAspTyrThrGlyProIleMetAspIleAlaSer
130135140
LysProLysGluThrAlaSerGluThrSerGluAspAsnGluAsnIle
145150155160
GlyGluPheIleSerSerProLeuAspAspTyrLeuPheGluLysTyr
165170175
AspAspSerTyrLeuLeuAsnGluLeuSerLysLeuLysAspSerSer
180185190
LysGluAlaValGluAspAspAsnLeuSerGluPheLysGluTyrLeu
195200205
HisIleAspArgSerIleGlnGluAspPheLeuLysAlaLeuAsnArg
210215220
AlaThrSerPheAsnSerSerHisLeuIleMetLeuCysGlySerVal
225230235240
GlyAspGlyLysSerHisLeuIleAlaAsnLeuLysLysLysAsnPro
245250255
GluLeuPheAsnGlnPheAlaIleHisTyrAspAlaThrGluSerPhe
260265270
AspProGluLysAsnAlaIleAspThrLeuAlaSerValLeuGluPro
275280285
PheAsnAspAsnAsnLeuAsnAsnSerThrGluLysLeuIleLeuAla
290295300
IleAsnLeuGlyValLeuAsnAsnPheLeuGluSerSerTyrAlaAsn
305310315320
GluAspTyrThrLysLeuLysLeuIleIleGluGluAlaAsnIlePhe
325330335
GluSerAsnGluValSerAspAsnIleTyrGlyAspLysValSerPhe
340345350
ValThrPheSerAspTyrAsnMetPheGluLeuAsnAspAspGluAsn
355360365
SerAsnTyrThrSerSerLysTyrIleSerSerLeuPheAsnLysIle
370375380
ThrGlnLysGluAspThrAsnProPheTyrValAlaTyrLeuLysAsp
385390395400
LysAspSerHisPheIleAsnProIleIleTyrAsnTyrGluMetLeu
405410415
MetAspGluGluValGlnLysThrIleIleAspTyrLeuIleLysIle
420425430
PheIleLysTyrArgLysIleIleSerThrArgAspLeuLeuAsnPhe
435440445
IleTyrGluIleIleValProProGluPheLeuLysSerGluAspLeu
450455460
AspAsnIleAsnAspPheMetAspTyrSerLeuProAsnLeuLeuPhe
465470475480
GlyTyrProGluArgSerAspLeuLeuLysLeuCysAsnGluLeuAsp
485490495
ProThrLeuHisArgAsnGluSerLeuAspLysPheIleIleAspLeu
500505510
AsnIleAsnAspAspThrGluLysIleLeuAsnArgTyrPheAspPhe
515520525
ThrArgPheAsnPheLeuGluGluTyrGlyGluTyrLeuValAspPhe
530535540
ArgGluPheAsnAsnSerGluLysGluLysValThrAsnIleLeuIle
545550555560
ArgPheAlaValPheTyrGlyLysSerIleIleLysAsnAsnPheLys
565570575
AspLysValTyrLeuAsnTyrLeuLysTyrLeuTyrAlaTyrAsnThr
580585590
GlnSerHisLysAspTyrLysTyrLeuPheThrGluValLysAspAla
595600605
IlePheAsnTrpLysGlySerTyrLysLysAsnThrIleCysIleAsp
610615620
ThrLeuAspSerPheLysValTyrLysAsnLeuLysLeuLysProSer
625630635640
ValAspLysPheGluLysSerLeuLeuAspGlyLeuPheLeuGlyAsn
645650655
ArgPheLysThrAspIleLysIleTyrPheSerValGluSerAsnLys
660665670
LysLysIleProLeuAsnValAspPheSerLeuTyrGlnTyrIleMet
675680685
LysLeuTyrAsnGlyPheLysProAsnGlnSerAspLysAspAspLeu
690695700
IleIleLeuAspGluPheIleAsnAsnLeuLeuAspGluAspThrAsp
705710715720
AspAspLeuTyrValIleSerLeuGluThrTyrGluGluPheLeuPhe
725730735
GluSerAsnAspPheGlyThrPheGluPheLysArgGly
740745
<210>65
<211>456
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>65
MetAspPheSerGluAsnTyrAsnIleLeuLeuLysGlnMetThrCys
151015
AspValAsnLysArgLysLeuIleHisGlnIleAsnGlnAsnSerPro
202530
LeuLeuProPheLysThrAsnThrProLysLysAlaAsnPheGluAsn
354045
GlyPheAspIleIleLeuGlyGluLeuSerArgIleLeuLeuAsnLys
505560
ThrIleGluLysAsnPheLysLeuAspAsnIleValSerAsnLeuIle
65707580
AspAsnAsnIleGluIleGluAspGlyThrLysGluTyrIleThrLys
859095
LeuLeuAsnGluTyrLeuPheAspGluLysAsnAspLeuLysIleSer
100105110
HisProAsnLeuTyrLeuTyrIleProLeuSerAsnAsnLysSerSer
115120125
AsnGlyGluGlnGluValAlaLeuPheLeuArgAspIlePheCysLys
130135140
AsnAsnGlnAsnLeuIleAsnPhePheGluSerTyrAspSerAsnHis
145150155160
IleIleLeuAsnLeuIleLeuLysAsnThrProAsnLeuHisHisLys
165170175
IleThrGluThrLysTyrValIleHisPheGluGluIleAlaAsnLeu
180185190
PheAsnGluAspIleAsnTyrAlaIleLeuTyrLysLysPhePheMet
195200205
GluAsnIleGlyAsnIlePheAlaTyrTyrTyrPhePheTyrIleSer
210215220
GlnLeuIleLeuLysIleSerLysGlyPheAsnAspAsnAsnGluPhe
225230235240
GluLysLeuTyrTyrLeuLeuAspTrpGluSerAlaSerLysAsnArg
245250255
LysSerLeuAsnSerTyrSerLeuLeuLysHisHisSerLysProLeu
260265270
TyrAlaLysMetAlaValIleAspGlnIleAsnThrLeuLeuGlyThr
275280285
AsnAsnLeuLeuGluLysAspIleSerGluTyrPheAsnAsnLeuAsp
290295300
IleAsnSerLysAsnAsnPheLeuHisPheLeuLysLysTrpValSer
305310315320
AspTyrArgTyrValArgAsnPheAspAspLysGluLeuProAspAsn
325330335
LeuLeuGluLeuThrGluIleLeuPheGluSerLeuLysAsnGluLys
340345350
LeuGlyValAspGlyAlaValGlnSerArgTyrAlaLeuAsnLeuGlu
355360365
AspIleAlaLysLysTyrLeuLeuLysArgArgGlySerTyrGlyTyr
370375380
ValLeuAsnIleAsnArgAspMetLeuLeuValLeuThrAlaLeuCys
385390395400
ValLysAspLysLysIleLysLeuAsnGlnLeuPheIleGluPheGlu
405410415
LysArgGlyValTyrPheAspLysTyrSerLysGluGluValValAsn
420425430
PheLeuThrLysLeuAsnLeuIleAspLysLysSerAspSerGlyAsp
435440445
AlaGlnTyrValLysProValLeu
450455
<210>66
<211>1740
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>66
MetLeuAsnGlnPheTyrAspTyrLeuSerAsnLysLeuLeuAsnTyr
151015
PheAspAspThrLysIleLeuSerGlyGluLysPhePheIleSerPhe
202530
AspGluAspAspGlnIleMetSerPheTyrAsnSerLeuArgSerIle
354045
AlaGluThrAsnPheSerCysSerGluPheIleTyrValHisThrIle
505560
SerGlyLysGluTyrAsnThrTyrSerIleAsnIleAsnGlyValLys
65707580
PheValIleSerGluSerLeuThrIleAsnValAspPheLeuValThr
859095
LeuArgAsnGlnValThrSerGlnGluGlyValTrpLysAspThrAla
100105110
LeuLeuValIleCysAsnGluAlaIleAspSerIleGlyLysGlyMet
115120125
ArgAsnLeuGlnLysGluGlyMetProLeuAsnValLysSerIleSer
130135140
LysAsnLeuGluAspGluIleAsnAspSerGlnIleLeuAsnTyrSer
145150155160
AspLysGlnIleAlaLysPheSerLeuAsnIleGlnGluGluGluLeu
165170175
PheGlnThrThrLeuTrpAspTyrGluThrIleLeuSerIleIleAsn
180185190
LysGlyPheValSerAspGluAspLeuArgGluLeuAsnLeuPheLys
195200205
AspAspGlnLeuAsnGlnAsnSerProGlnLysMetLeuLysArgLeu
210215220
LysGluAsnTyrAspThrPheAsnGluValAsnLysPheSerGlnTyr
225230235240
GlyAspLysLysGluGlnLeuLysAsnMetPheThrAspSerGlyVal
245250255
SerIleLeuSerLysAspAspTrpTyrLysAlaGluTrpLysMetVal
260265270
LysLysSerLysAspAspPheIleAsnGlnGlnAsnProLeuAsnTyr
275280285
AsnGluAsnLeuGluLysIleThrGluAsnGlyLeuAsnTyrTrpGlu
290295300
IleProAsnSerPheThrLysThrGlyLysArgLysArgAsnIleIle
305310315320
ValPheAsnProAsnHisSerHisGluValSerLeuLysPheSerPhe
325330335
AspGlnIleLeuSerAsnSerPheLeuAsnThrAsnSerLysLysPhe
340345350
ThrIleAlaArgGlyLysSerLeuIleValAsnPheThrLeuAspSer
355360365
SerGluProIlePheLysThrIleLysTyrLysHisLysAsnGluAsn
370375380
IleSerGluPheThrPheAsnIleValValLeuAsnPheGluProGlu
385390395400
IlePheAsnSerIleLysSerArgPheSerValAsnValLysSerLys
405410415
GlnIleIleValThrAsnAspGluAspSerPheAspIleValPheGly
420425430
ThrGlySerLysGluIleGluLysLeuIleLysGluAsnGlyGluLys
435440445
LeuTyrLeuTyrAspAspGluSerLeuIleIleSerGluGlnSerPro
450455460
AlaTrpAsnAspGlyLysLeuSerPheLysLeuTyrLysAspAsnAsn
465470475480
TyrAlaProPheLeuIleLysGluLysSerLysLysThrLeuProVal
485490495
AsnSerTyrValIleTrpAsnLeuLysArgArgAsnMetGluAsnPhe
500505510
IlePheAsnGlyValLysAlaValGlnAspValAsnSerPheTyrLeu
515520525
ValGluGluPheLysGluPheLeuLysMetGluArgGluIleIleLys
530535540
GlnAspIlePheTyrAlaLysArgAsnIleAspGlySerLeuGluLys
545550555560
IleGluValSerPheSerAsnGluLeuGluThrAlaTyrMetAspIle
565570575
PheAsnTyrTyrLysThrPheAspAspSerProGluAspAsnLeuPro
580585590
SerLeuValTyrLeuAsnAspAspLeuLysGluLeuTyrLysLysPhe
595600605
IleThrIlePheAsnLysGluIleSerGluIleGluGluAsnSerIle
610615620
LeuSerAspPheLysTyrLysLysAsnLeuLeuLysLeuGlyArgIle
625630635640
GluThrAspAsnLysIleMetTyrSerProLeuSerProLeuAsnIle
645650655
AlaTyrGlnLeuGluValSerLysGlnCysGlyAsnGluAspLeuSer
660665670
ValAsnIleLeuGluArgLeuValProAsnAsnLeuIleProTyrIle
675680685
CysSerAspAspGlyLysGluLeuPheArgProIleTyrGlnGluGlu
690695700
AlaHisGluTrpLeuIleTyrGluLysSerGluGluValSerIleGly
705710715720
ThrThrAsnValPheIleSerAsnValValThrGluLysLeuAsnGln
725730735
PheValLysHisPheAsnTyrLeuPheSerPheAsnAsnSerSerPro
740745750
IleLysIleAsnLeuIleAsnIleLysAspAspLysGluValValLys
755760765
GlyValPheAsnPheIleArgSerArgLeuProAspLysThrLysThr
770775780
LysLysValIleProValGluIleAsnIleTyrAsnAspAlaGluLys
785790795800
SerSerPheAspAsnLeuPheAspCysGlnSerGluIleGlnLeuLeu
805810815
GluGluPheGlyIleLysLysLeuLysSerAspIlePheAspProIle
820825830
AspIleIleHisMetIleGlnAsnAsnIleSerTyrTyrLysHisPro
835840845
PheLysLysGluGluTyrGluTyrAlaHisLeuSerPheTyrLysVal
850855860
LysSerHisAsnAsnIleAlaAsnAspAsnMetAspLysIleGluThr
865870875880
GlyLeuSerLeuAsnGlyLeuLeuSerSerValThrSerThrThrLys
885890895
HisSerGluTyrArgThrGlyPheGlyThrAsnAsnIleLeuAsnMet
900905910
SerAsnProLeuIleLysThrValIleAsnLeuAsnGluLeuValGlu
915920925
AsnSerLysAsnPheGlyLysAsnThrTyrSerLysAsnLysSerVal
930935940
IleThrThrValGluLeuGluGluAspAsnIleGluGluLeuTyrAsp
945950955960
LysSerHisTrpValThrPheIleGluProThrPheGlyIleGluTyr
965970975
PheAspSerSerAspSerAsnLeuIleIleIleHisTyrSerAspGln
980985990
TyrSerSerSerSerLysTyrAspThrIleThrValThrAsnLysSer
99510001005
ThrGlnTyrGluGluIleIleArgAspPheLeuGlnSerLysTyr
101010151020
ValLysValThrAspGluGluLeuTyrAspValIleLysMetPhe
102510301035
AsnSerIleAsnGlyGluTrpLeuLeuArgValIleSerAsnSer
104010451050
GlyHisTyrAspArgGluLysLeuSerIleIleSerAlaIleLys
105510601065
TyrCysLeuSerIleLeuAspHisLysAspIleValTrpIlePro
107010751080
ValSerMetGluGluIleLeuArgIleAlaGlyAsnValLysLeu
108510901095
AspLysAsnLysGlyIlePheAspSerLysLeuIleLysGlyAsn
110011051110
HisSerAspAspLeuLeuPheIleGlyValLysPheAsnGluAsp
111511201125
AsnArgIleGluValIlePheTyrProIleGluValLysIleGly
113011351140
LeuAsnAsnAlaSerThrIleLysLysGlyLysSerGlnLeuAsp
114511501155
AsnThrTyrLysLeuLeuLysThrGlnLeuGlnAsnIleAsnVal
116011651170
GluAsnSerGluPheArgAsnLysPhePheArgAsnPhePheIle
117511801185
GlnIleLeuLeuSerAsnGluGlnLysLeuValThrAsnHisIle
119011951200
TrpAspGluLysGlyLeuAspArgIleGluGluPheLysAlaGlu
120512101215
LeuLeuAsnAspGluTyrAspIleLeuTyrGlyLeuGluGluTyr
122012251230
IleGlyLysGlySerLeuValSerPheLysLysGluSerHisHis
123512401245
IleSerIleTyrMetAspValAspLysGlnValIleGluLeuPro
125012551260
GluAspPheAlaTyrTyrGlyLeuAlaThrProIleArgGluIle
126512701275
HisAspGluIleGlnSerAspAsnThrAspIleLeuAlaGluThr
128012851290
LeuLeuSerHisValAspIleSerGluIleArgAlaLysAsnAsn
129513001305
AspIleCysAspSerAsnGluAspMetSerIleAspAspAspPhe
131013151320
AspAsnLeuSerGluPheGluAspSerPheIleGluGluGluSer
132513301335
GluIleSerGluGluProAspGluGluLeuThrAspAlaThrSer
134013451350
SerSerAspAsnGluSerIleGluAsnIleGlyGluSerProSer
135513601365
LysIleSerAsnValArgAlaLeuIleGlyThrGlnLysGlyTyr
137013751380
AsnHisLysValTyrTrpGluPheGlyHisProSerLeuAlaAsn
138513901395
ArgHisMetLeuIleGlnGlyLysSerGlyGlnGlyLysThrTyr
140014051410
PheIleGlnArgMetLeuLysGluLeuSerIleGlnGlyIlePro
141514201425
SerIleIleIleAspTyrThrAspGlyPheLysProSerGlnLeu
143014351440
GluProAsnPheLysAspSerLeuGlyAspLysIleSerGlnTyr
144514501455
PheValValLysGluAsnPheProIleAsnProPheLysArgAsn
146014651470
ThrIleMetIleAspLysAspIlePheIleGluGluAspAsnSer
147514801485
ThrIleAlaSerArgPheLysSerIleIleAsnSerValTyrGly
149014951500
LeuGlyIleGlnGlnSerAsnThrLeuTyrGlnThrValLeuAsp
150515101515
CysLeuAspLysTyrAspAspAsnPheAspLeuAsnIleLeuLys
152015251530
GluGluIleLeuLysAspGluSerAsnSerAlaGlnThrValLeu
153515401545
AsnLysLeuAsnGluLeuLeuAspLysAsnProPheAlaSerThr
155015551560
AspPheAspTrpSerValLeuAspAsnLysAspGlyLysValTyr
156515701575
IleIleGlnLeuThrAlaLeuSerLysAspIleGlnThrIleIle
158015851590
ThrGluPheIleLeuTrpAspLeuTrpAsnTyrLysLeuThrAsn
159516001605
GlySerGluAspAsnProPheIleValValLeuAspGluAlaHis
161016151620
AsnLeuAspPheSerAsnAspSerProCysSerLysIleLeuLys
162516301635
GluGlyArgLysPheGlyTrpSerGlyTrpPheAlaThrGlnSer
164016451650
ValLysGlySerMetLysIleAspGluIleAlaLysLeuGluAsn
165516601665
AlaAspGluLysIleTyrPheHisProThrAspValSerThrIle
167016751680
AlaLysAspLeuSerLysAspAsnGluAspLysLysIleTyrGlu
168516901695
LysGluLeuSerGlnLeuThrLysGlyTyrCysIleValGlnGly
170017051710
SerAlaIleAspSerSerGlyAsnLeuTyrGlnProAsnProVal
171517201725
ThrValLysIleGluGluIleSerPheAspGluAsn
173017351740
<210>67
<211>1054
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>67
MetGluSerLysAspArgIleGluAsnThrIlePheAsnAspLysArg
151015
MetAspAlaTyrIleAspLysTyrPheGluGluPheThrLeuSerSer
202530
GluGlnGluGluAlaLeuAsnIleTrpIleAspLysLeuAsnAsnAsp
354045
GlnLeuThrSerGluLysGlyAsnTyrHisAsnPhePheGluIleIle
505560
LeuGluAspLeuLeuGlyTyrLysArgSerAspValLysHisGluGlu
65707580
AsnIleGlyAspGluGlyHisProValGluPheValLeuGluLysAsp
859095
GlyLysAspTyrValIleIleGluLeuLysGlyThrThrTyrLysAsp
100105110
LeuThrLysArgArgProGlyGlnGlnSerProValGluGlnAlaThr
115120125
AsnTyrAlaSerAlaLysLysGluThrGluTrpAlaThrValSerAsn
130135140
TyrAspGluPheArgPhePheAsnProThrAlaArgAspAsnTyrIle
145150155160
SerPheLysPheArgGlnLeuLysAspLeuGluIlePheLysLysPhe
165170175
LeuLeuValPheSerLysPheSerLeuIleAspGluAspIleProLys
180185190
LysLeuLeuAsnGluThrLysValIleGluArgGluLeuGluAsnGlu
195200205
PheTyrGlnLeuTyrSerAspThrArgLeuMetIleIleLysGluLeu
210215220
GluTyrSerSerGluAspIleAsnArgIleGluAlaIleLysLeuSer
225230235240
GlnIleIleLeuAsnArgPheIlePheLeuCysPheAlaGluAspLeu
245250255
AlaLeuMetGluGluGluThrThrAlaAspValLeuLeuThrProLeu
260265270
LysHisArgAsnLeuIleGlyAsnThrMetTrpAsnArgLeuAsnGlu
275280285
LeuPheIlePheAlaAsnGlnGlyAsnLysHisArgArgIleProAla
290295300
PheAsnGlyGlyLeuPheGluAspAspLeuSerAsnLeuLysIleArg
305310315320
AspGluIleGluAspArgSerPhePheGluAsnTrpAsnLeuLysGlu
325330335
AspPheGluAspLysTyrGluAspIleAlaLysLeuIleGlyValTyr
340345350
LysAspThrLeuAsnProIlePheIleAsnLeuLeuIleIleSerThr
355360365
TyrAspPheAspSerGluLeuAspValAsnIleLeuGlyHisIlePhe
370375380
GluAsnSerIleSerAspIleGluGluLeuLysAsnAspAsnGlnGlu
385390395400
GlnArgLysLysAspGlyValTyrTyrThrProGluTyrIleThrAsp
405410415
TyrIleCysArgAsnThrIleIleProTyrLeuSerIleSerGlyLys
420425430
AlaSerThrValHisGluLeuLeuTyrGluTyrGluSerSerAsnSer
435440445
LeuAspValLeuAspSerLysLeuThrAsnIleLysValLeuAspPro
450455460
AlaCysGlySerGlySerMetLeuAsnLysSerValAspIleLeuPhe
465470475480
GluIleHisGluAlaLeuHisAlaSerLysTyrAlaGlyAspSerSer
485490495
LeuAspArgPhePheAspSerLeuGluLysArgLysGluIleIleSer
500505510
AsnAsnIleTyrGlyValAspLeuAsnGluGluSerValGluIleThr
515520525
LysLeuSerLeuPheLeuLysLeuAlaThrThrValGlyLeuLysGlu
530535540
GlyPheGlnLeuProSerLeuAspLysHisIleLysCysGlyAspSer
545550555560
LeuValAspAspGluSerIleAlaGlyAsnLysAlaPheAsnTrpTyr
565570575
GluSerPheSerGluValPheGluSerGlyGlyPheAspIleIleVal
580585590
GlyAsnProProTyrValAspIleLysGluMetAspGluLysThrAla
595600605
LysTyrIlePheAspAsnTyrGluThrSerPheAsnArgIleAsnLeu
610615620
TyrSerThrPheValGluLysSerTyrTyrLeuLeuLysAsnGluGly
625630635640
IlePheSerPheIleMetProAsnSerIleLeuPheAsnSerThrTyr
645650655
SerLysIleArgGluLeuIleLeuAsnAsnThrSerIleLeuAsnIle
660665670
ValArgThrSerAspAspValPheLysAspAlaLysValGluProIle
675680685
IleLeuIlePheLysLysGlyTyrAspGluGlyAsnLysThrLysIle
690695700
LeuIleLysLysAspAspMetAspGluIleProIleAsnAsnTyrSer
705710715720
GluHisPhePheThrGlnGluArgTrpPheGluAsnAsnSerIleIle
725730735
AsnIlePheSerAspAspPheThrPheAspLeuLeuLysLysIleAsp
740745750
GlyAsnAsnGluArgLeuIleAspTyrCysAspPheSerLeuGlyLeu
755760765
ThrProTyrAspLysTyrLysGlyMetSerGluAspIleIleLysAsn
770775780
ArgLysPheHisSerLysIleLysLeuAspAspThrPheLysGluLeu
785790795800
LeuAspGlySerAspIleThrArgTyrAsnValLysTrpGlyGluLys
805810815
GluTyrIleLysTyrGlyAspTrpLeuGlyAlaProArgGluGluLys
820825830
PhePheLysAsnProArgIleLeuIleArgGlnIleLeuSerIleAla
835840845
ProLysGluSerArgLysArgIlePheAlaAlaTyrThrGluGluGlu
850855860
LeuTyrAsnAlaGlnIleAlaPheAsnLeuValLeuLysGluGlyPhe
865870875880
AspAspLysAsnLeuLeuLysTyrPheLeuGlyIleIleAsnSerLys
885890895
MetMetThrTrpTyrTyrGluGluArgPheMetAspLysAsnLysLys
900905910
AsnPheAlaLysIleLeuIleGluAsnAlaLysAsnLeuProValIle
915920925
IleAsnSerAsnPheLeuAspGluIleValSerAsnValAspSerIle
930935940
IleGluLeuAsnLysGluPheTyrSerValArgAsnAlaPheGlnThr
945950955960
TrpLeuLysIleGluPheGluIleGluLysLeuSerLysLysLeuGlu
965970975
AsnTyrTyrAspLeuAsnPheGluGluPheLeuLysGluIleLysLys
980985990
LysLysValValIleArgProAsnGlnIleGlnAspLeuSerGluLeu
99510001005
PheAsnGluSerLeuGlyLysIleGluTyrLeuGlnArgGluIle
101010151020
LysGluAlaAspGluLysIleAsnLeuLeuValTyrGluLeuTyr
102510301035
GlyLeuAsnHisGluGluIleGluIleIleGluAsnSerPheAsn
104010451050
Asp
<210>68
<211>86
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>68
MetAspAspGluThrLeuIleLeuIleGluTyrIleArgAsnAlaPro
151015
ThrArgGluMetValLeuLysSerPheGluGlyValAspPheIleArg
202530
ProIleGlnIleSerArgLysThrGlyIleHisProAsnAsnValSer
354045
LysLysLeuLysAspLeuArgGluHisGluLeuValTyrValIleAsn
505560
ProGluTyrHisValProLysLeuTyrArgLeuThrGluLysGlyLys
65707580
AsnMetLeuGlnPheLeu
85
<210>69
<211>255
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>69
MetAsnLysLysIleIleLeuSerLeuLeuLeuValLeuLeuValAla
151015
IleSerValSerAlaValAlaAlaAlaAspAlaAspValThrTyrIle
202530
AsnAspAlaAlaAspValAspAspValAlaAspGluLysValAlaPro
354045
LeuThrAlaSerAlaAspAlaGlnAspIleGlnThrLysLeuAspAsn
505560
AlaLysProGlyAspThrIleGluLeuGluAsnLysThrTyrAspVal
65707580
AspThrThrPheAsnValThrLysGlnValThrIleLysGlyGlnAsp
859095
ThrValIleLysAlaSerGlyAlaSerGlnGlyGlySerGlyAlaLeu
100105110
PheIleAlaAsnGluAlaGlyThrAlaPheGluGlyIleThrPheIle
115120125
AsnThrAspGlyHisLysAsnTyrGlyGluGlnValSerGlyTyrAla
130135140
IleGlnLeuAlaIleGluAsnGlyThrValAspAsnCysLysPheIle
145150155160
AspTrpSerSerGlyValTyrGlyLysGlyAlaSerPheCysSerIle
165170175
ThrAsnSerTyrPheAsnGlySerSerGluGlnValThrAsnGlyGly
180185190
LysLysGluTyrGlyThrLysAlaIleAsnLeuMetGlySerHisAsp
195200205
IleThrValThrGlyCysThrPheGluGlyGlnValLeuAspAlaIle
210215220
SerIleAlaSerAsnSerGlyAsnAsnIleMetThrAspAsnThrPhe
225230235240
IleAspAsnCysTyrAlaIleTyrPheGlyGlyAlaSerThrGln
245250255
<210>70
<211>208
<212>PRT
<213>马尔堡甲烷短杆菌(Methanobrevibactermarburgensis)
<400>70
SerArgTyrAsnArgPheLysGluValAsnGlyArgGluProArgVal
151015
ValPheIleTyrSerGlyGlyGlyProSerValSerLeuGluThrPhe
202530
LysAspMetCysLysArgTyrAsnGlnPheLeuGluGluAsnArgArg
354045
GluProArgIleValTyrValThrProProGluProProValProGlu
505560
GluValArgGluMetArgArgValLeuGlyGluPheLysThrAlaThr
65707580
GlnLeuTyrThrLeuValSerArgArgCysLysTyrLysPheTyrTyr
859095
AsnAspGlnThrProAsnArgGluAlaLeuLysLysMetValThrAsp
100105110
GlyIleAsnCysThrAspAlaCysGlnLeuPheLysProValIleGlu
115120125
GlyLeuGlyTyrSerValArgIleGluHisValLysValArgCysAsn
130135140
AspAsnLysTrpTyrGlyHisTyrPheLeuArgValAlaGlyLysGlu
145150155160
LeuAlaSerValSerLeuProSerGluArgTrpThrValTrpAspTyr
165170175
ValSerAlaThrLysThrGlyArgProLeuGlyAlaProCysCysSer
180185190
ArgGlyIleGlnHisLeuGlyTrpGlyIleValSerProLysHisAsp
195200205
<210>71
<211>202
<212>PRT
<213>沃氏甲烷短杆菌(Methanobrevibacterwolfeii)
<400>71
ArgArgTyrGluAspPheValArgIleAsnGlyArgGluProAsnIle
151015
IleTyrLeuGluGlnGlyLysSerAspHisValSerLeuGlyThrPhe
202530
LysAspMetLeuArgArgTyrLysAspPheValArgIleAsnGlyArg
354045
GluProAsnTyrIleSerIleGlnProGlnProSerLeuLysGlyHis
505560
TrpThrThrLysValIleGluLysIleGlyThrPheHisAspAlaThr
65707580
SerLeuTyrGluArgValLysLysThrCysLysTyrLysTyrTyrTyr
859095
AsnAspGlnValProAsnHisValAlaValMetArgMetThrThrSer
100105110
GlyIleAsnCysThrAspAlaCysGlnLeuPheSerLysValLeuGlu
115120125
GluMetGlyTyrGluValLysIleGluHisValArgValLysCysAsn
130135140
AspGlyLysTrpTyrGlyHisTyrLeuLeuArgValGlyGlyPheGlu
145150155160
LeuLysAspGlyThrIleTrpAspTyrValSerAlaThrLysThrGly
165170175
ArgProLeuGlyValProCysCysThrAlaGlyPheGlnHisLeuGly
180185190
TrpGlyIleValGlyProValTyrAspLys
195200
<210>72
<211>155
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>72
ValAlaArgAsnProLeuValMetAspTyrGlnAsnThrAsnTyrThr
151015
CysCysProThrSerLeuSerLeuAlaSerGlnMetLeuTyrHisTyr
202530
LysSerGluSerGluCysAlaLysAlaLeuGlyThrSerLysGlySer
354045
GlyThrSerProAlaGlnLeuIleAlaAsnAlaProLysLeuGlyPhe
505560
LysIleIleProIleLysArgAspSerLysGluValLysLysTyrLeu
65707580
LysLysGlyPheProValIleCysHisTrpGlnValAsnGlnSerArg
859095
AsnCysLysGlyAspTyrThrGlyAsnPheGlyHisTyrGlyLeuIle
100105110
TrpAspMetThrSerThrHisTyrValValAlaAspProAlaLysGly
115120125
ValAsnArgLysTyrLysPheSerCysLeuAspAsnAlaAsnLysGly
130135140
TyrArgGlnAsnTyrTyrValValCysProAla
145150155
<210>73
<211>212
<212>PRT
<213>人工序列
<220>
<223>人工序列描述:合成的共有序列
<220>
<221>MOD_RES
<222>(1)..(1)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(4)..(5)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(7)..(8)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(15)..(15)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(20)..(20)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(23)..(28)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(32)..(32)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(43)..(43)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(46)..(47)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(49)..(49)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(53)..(54)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(56)..(56)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(58)..(58)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(60)..(69)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(72)..(72)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(74)..(74)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(80)..(80)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(87)..(87)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(92)..(92)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(103)..(103)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(106)..(107)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(115)..(115)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(127)..(128)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(132)..(132)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(149)..(149)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(156)..(156)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(162)..(162)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(165)..(166)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(168)..(174)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(191)..(191)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(196)..(196)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(198)..(198)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(207)..(207)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(209)..(209)
<223>任何氨基酸
<220>
<221>MOD_RES
<222>(212)..(212)
<223>任何氨基酸
<400>73
XaaArgTyrXaaXaaPheXaaXaaIleAsnGlyArgGluProXaaVal
151015
IlePheIleXaaAsnGlyXaaXaaXaaXaaXaaXaaValSerLeuXaa
202530
ThrPheLysAspMetLeuLysArgTyrLysXaaPheLeuXaaXaaAsn
354045
XaaArgGluProXaaXaaIleXaaIleXaaProXaaXaaXaaXaaXaa
505560
XaaXaaXaaXaaXaaGluMetXaaLysXaaLeuGlyThrPheLysXaa
65707580
SerAlaThrSerLeuTyrXaaLeuValAlaLysXaaCysLysTyrLys
859095
PheTyrTyrAsnAspGlnXaaProAsnXaaXaaAlaValLysLysMet
100105110
LeuThrXaaGlyIleAsnCysThrAspAlaCysGlnLeuPheXaaXaa
115120125
ValIleGluXaaLeuGlyTyrSerValLysIleGluHisValLysVal
130135140
LysCysAsnAspXaaLysTrpTyrGlyHisTyrXaaLeuArgValAla
145150155160
GlyXaaGluLeuXaaXaaValXaaXaaXaaXaaXaaXaaXaaThrVal
165170175
TrpAspTyrValSerAlaThrLysThrGlyArgProLeuGlyXaaPro
180185190
CysCysSerXaaGlyXaaGlnHisLeuGlyTrpGlyIleValXaaPro
195200205
XaaHisAspXaa
210
<210>74
<211>264
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>74
gtgagaaatatgaagaataagagtttaatattaatttctttattattactgattacaata60
ataagcataggatctgttgttgcaacggataatgaagaaattaatatggataatataaat120
aatattgataataatgaggatatcgctaatattgataatgtcgataatgtcgataactcc180
aatataaacaatccaactgacataagaatagacaattcaaacctaaatagagaaacagaa240
ctagattcaaatttaaataaatct264
<210>75
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>75
atgaagacttttagacaacagctattggaagaccctgaattccagaactacctgttgcag60
agaccgaacctgacggagagcagcctgcagtcatacctcaatgccgccaccaacttcgtg120
aggttcacaggggagccgttctacaagaccgtgcatgagctcagaagccagcagaacgat180
aggattgagaacaacatcatcataaggttcaacccgaaccagtcaaggataaacatcatg240
cagtttgagttcata255
<210>76
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>76
atgaatacattaaaaatagaatgttcaaaagatgattatatcataaagactgcaaaggca60
aattctgaaaatgagttgaaagttgaagttcctgagaactggaactgcgactatgtgaat120
gctgtcctgtgggaagaggacatctgcgaagtgcttgaaaagggtgatgaaagaatgctt180
ttgattcctatgtgcggtgaactgcttcttgaaggagtgcaggaagatgaatacataaag240
tacatttgccttcct255
<210>77
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>77
atgggaatgaaaaaagttaagatcgaaagtaaagcaaaaaataatatgacaagaaacgaa60
aaactcttctataaattatatgacgatttatataatgaagatagattaattttattctcc120
acatattttaacatatatgataaatttatttttaaaaaagatataatccattatgtttta180
atgaactactctgaaaatgaaattattgaagcaatgaaaaaaattgatgaaattcagtca240
gaaggcattgatatt255
<210>78
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>78
atgaaaacacaagatctaattaatataataaatgatgaggaatctcctgtattcctcaac60
agggaagtctttgagatggactatgtgccggacatctacaaatacagggacgagcagctg120
gcgaaaatggcgatgtactgcaattcaatacctgacaacatagctcccaagaacctgcaa180
ttgtgcggaggcaatgcgacaggaaagaccacaacattaaagcagttcttcaagatgttg240
aacgaggcttttcca255
<210>79
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>79
atgtttttggaaaaatgcgatggaaaagatacaatcagcatgtctcttcaagaaaagatg60
aatcttatattggaaactatggaaagcaaaggaagccccttcatatcctgtattcattgt120
aacatacctataaatgaagcagaagaatggtacaaaaatggagaaataggagatcaggac180
tttataaatttctatgatgatgtaaacttgattgaagaaagttttgggtttgaaatttat240
aaaaaatcagaatat255
<210>80
<211>207
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>80
ttgataattttccttaaactaaaatttggacgtgtaatcatggaaaaattaatcgaaatt60
gacggagttcaatacacagaagcccaaatcagaagggctttagccattgaacgagacgtg120
cgctctcctaatttcgttgatatgttattgggaaagatcaaacctagcgaacttgcaagc180
agagtttctgaaaaaggtgatgcctaa207
<210>81
<211>156
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>81
atgtgctatgtgggaaacaccaggacattggtctatcacacagaggactgcttctgcaac60
cactggctgttgaacgagaacaagaccattctagaggaaaagcctgtagacatgaaacct120
tgcagcttctgcaaaccacagtttgacactgaatag156
<210>82
<211>234
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>82
gtgttggatatggttgcagagatggttgaaaacatcaggaaaggagaaggagatggatat60
tccatctaccctcctttttcctgcattgttttcctacaaggcaaaaagtattccgaatgc120
tgctgcaaggctgaggcaagggatcagaagtttgcacttgtgaaccttgtaggcttcaga180
agagaggatgtcaaggtcatagacccaaggaccaacgaggagctgttcgtatga234
<210>83
<211>162
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>83
atgagcatgcttgcagacttcgagcctgcaaggctccacaagaggacatgggctgaaagg60
catgatgtcgaaatccttgctgtcatatgccttgccataagcattgcaatgctacttctt120
ttctttgcgcttgcagagccgactgttgcaggagtgatttag162
<210>84
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>84
atgactaaggaatttgaggacttcatgagaaggaacacaggactgcttgttttcttgaga60
tgggacacagtggcatatctgaaataccttgagtcccattatgacgaaaggaagtacgaa120
tgcgcttacagattgttggaggcaatcgacaatctctttgacttctaccagataaccttc180
agcaaaaagactgaaagggaaattcctgaccagctttttgaaaaggacaagataaacaaa240
ggcttcctttcacac255
<210>85
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>85
atgaatgagatagttactacaactaacgagaataatgtacctgtcgacgttgactatgcc60
atcgaggaatggaaggcataccagcgattgaccagagagctattggacgaaacagattat120
cagacacacagaggcaggaagtacaagaccaagagcgcttggcagaagtacgcacgtgcc180
ttcaacataaacacacagataatcgacaaggaaatcgtcaagaatgacaagggaatcgtc240
attgaggctgagtat255
<210>86
<211>231
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>86
atgattgagtgcatacaggaagagggagacttcacggattgggaggttccttcctcctct60
tccgacatcaagtacatagtttcagtggatgatgagggaaacctgttctgcagctgtcct120
gacttctattacaggaagtccaggatgaaccctcacatctcaaaccctgaatcctattgc180
aaacacatcagacaagtcttggaggaggacaatagattgcaaatgctctag231
<210>87
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>87
atggataatataaataagacaaaaacaagtttagctaagtttgaagagtttttcagcact60
gtatacaaggacgaagtcatggaagttttggaaaagtatcctgaggaaaggacattggtt120
gtggactatgagaatttggaaatgtttgatcctgatttggcagacttgttgattgaaaag180
cctgacgaagtaatcgcagcttcacagaaagcaatcaagaacattgacccattgatgaaa240
gatccaaagttggac255
<210>88
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>88
atggctaacaagattagagttaatctcacggttgaccctaatttgtggcaattagcaaaa60
gacaagttaccttgcagcagaagcgaattctttgagaatcagttgaagatgttcttaggg120
attgaagatgacgagtcggaaatcattaaggacatccaaaccaaagaaaatgagattaac180
gcactaagagacaagttatgtcatgttcgcaaatcaaagcagttgaaattggaatcaaac240
aaatctatggagaag255
<210>89
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>89
atgacaattggaagtttggacaattttggaaagtcagatggagaaaacatgaaccctgaa60
gatttcgactgttctgttttctttgaaatgtacaaggcactttttgagatattggatgtt120
gaagttggcagcttcgctgaactcttggatgtgtacaagaatgtcgagatggattacacc180
ttgaagagacatgccctcaagcagaaggaaatcctttactggttcaataccgactggaag240
gaggaacttggaaag255
<210>90
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>90
atgaatgtgaaaacagtcatgaatgaccttataggattgtcaaaggagttcgagggagtg60
gaatatgagattgaatccaaaaattcaatctacttctattcctttccaaagtacatgaag120
gaaggcattgtgattctgaaatattccgcaatctatgacctgcacaccatattgaaaggc180
atggatggaatcatagtggacattctggaggttgaggacaatcctggtgatgagaagaag240
gatttgctatatgtg255
<210>91
<211>234
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>91
atgattagcgacgaatgggaagaggaatactatgtcaaggtcaacgaggaactggagcag60
gtggaagtcaggtttttcagcaaggtcgacaggctcgtctttgctcaatcctactcttct120
tcatcttccttttcctttgaggaggctgaaatcctgtgcgacaggatatgcgacatactg180
acaaacgatttgggaaatgccaagtattatctaggaggaaaagatgaattatag234
<210>92
<211>150
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>92
atgaattatagggaatgggttgcaagccagttcgagctgaggatgactgaggacggaagg60
gtttgcttcaagacaccatgcagctactacacattttcaaaggaggactttgagataata120
agggagatgttccttaatttcgagtcctga150
<210>93
<211>174
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>93
atggatagaataaaggaattgaatgtatgcggaacctgcaagcacagccatttgattcca60
gacatcaacggagagatagcagtgaacatttgcaggataggttcagaggctgtcaacaag120
gacggaggacttacatattgcgtagactggacaccaaggaggaagctgtcatga174
<210>94
<211>336
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>94
atgttaagtaaaaaagaagccatacagatgacgctggacaatgagaagcactatcctgtt60
aagtgcaagtactgcggaaagccgttcaccaagtctcacaacaggcagatgtactgttca120
gacagttgcagacggaatgccttgagggaacagaaggcaagataccaggctaaaaggagg180
ctaaaaataaagcagaaagtgctgattgtagatgaatacaagaaatacggtttgggtagc240
tatggaacaagtgcgaacggacacagaaagaacaatttttcacatgagtacatggctatt300
caaaaggagatgaaaagaataggattgaagagataa336
<210>95
<211>261
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>95
atgtatttggctaaattttgtcctaactgtggaaataaagtagaagaaaatgataaattc60
tgcatttattgtggaaataaactaagagttataattcctgaaaaaaaagtgaaaagaagc120
tcaaatagtattaatgatgaaaaaactagcaaatatgttgaagtcattgatgggctaatg180
agatataaagtttttccatcaagtttacctgtgaaatatattatttataaagtgaattat240
ggaacaacatctgatgaaata261
<210>96
<211>234
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>96
atgatttatgataaagcgacagttacaagcctcatagtggctatcctattgccattgatg60
agcatgttaggaatcggagaattgactcagaactacatattggcaatagtgagcggtatg120
atagcccttgtggtttggtactacaacgagaagcacaacagcgatttggtgagcggaacc180
accaagtgcgactgcgagctttgctatgggggagacgatgaagcacttatatga234
<210>97
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>97
atgaagcacttatatgagataatcccttacaggaggactgtttggattacagggttcctg60
aagacaacagtctcctcggcaatgataaccactggcgtagtgatattgttcaacagcata120
accgagcacccttacttcatggagtgggacgagataggaatcgttcttggaatcgtttcc180
atcaccatcgcctgcatttacatagcgatgatagacagatggaaggaacgcaggaagaag240
gaggagcttgacacg255
<210>98
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>98
atgatagaaatcagcaccataaagatcaccgacataaagcctgccgaatacaatccgagg60
ataatgagccagcttgaacacacaaagctcaggaactccatggagacattcggagtggtt120
gacccaataataatcaacctgaagaacaaccacatcataggagggcaccaaaggtacgag180
gtccttctggacaagtccatggaggacaacgagttcataaaggagctccacctcatcagg240
cttggagatgtaggc255
<210>99
<211>330
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>99
atggacgtcgacaacctgctgggatatgacaaggtactggaattgaggtctttattggag60
gaggtcacggacaaggtgatacccgtatggcacaagaaccgcggaatcaaggacttcaag120
cagatgtgccaggactacaatttcgtcagcataagcggctggagaaacgaggacgtcaag180
gatgaccagttcatccatttcgtcaggcatgcacacaggaacggctgcaggattcacgga240
ttgggattgacacggagaaaggttctcgacagggttcccttcgacagcgtcgacagcagc300
agctggctccagaccatattgtatgcaagg330
<210>100
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>100
atgattaatgaaaggataagaccttatttgaattttagcttcaatgacaagaaagtcatt60
ttcgtcacattgttcgttgtgagcaatctgataagcaacctgttagccatcaaggttttc120
aacttgggattttggggattgacaaccgattgcggaaatctcctgttcccgttaggatac180
cttatggcagacgtgattacagaagtctatggagagaggacagctcgaagggtcatattg240
cttgggctctttgca255
<210>101
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>101
atgcccgaaccttgggaaaggcaaagggacgagaacggaaagcttgagccaataaaggca60
ttcgagtacttcaccgagtacctgacaatggacaagccacgaagcatgagggttctgtgc120
gagaggctcggcaagaaagatgggtatattaggcaacttcatgcctactcatccacatgg180
aactgggtcgaaagggcagaggcatacgatgaacacataatattgaagaaacggttaagg240
aaagagaagttttac255
<210>102
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>102
gtgaaggacattgtcaatcattacggctacctttcaccgtacaagccgaccatcaggtct60
gatagtaaggctaaaaacaagttcaagctcaatgagccttatcgtggacagatgttgagt120
gcaggtgctggcggttcaatcatgggatacggtgcaggtctccttattgtcgatgaccct180
atcaagaacgtcgctgaagccgaatccaaggtacgtcaggcaaagctcaaggactggtgg240
ggaggaaccatcaag255
<210>103
<211>273
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>103
atgagtaagaaacaagaaatgatgagaattgaaaggttaaaacactatgcatatcaaaca60
ggactaataatccctatttttaaaaatcatgatttaattaaaaaaatagaaaatggaaaa120
ataactaatactgacgaaataaagatatatattgaggaaaatgaaaagcagataaaaaga180
agaagagaatttataagtattatttatgataattgcaaatattttaaatacgacagcata240
tgttataaattaatatccaaagtaaataatttt273
<210>104
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>104
ttgagtaagaatgctaaagcagacgcctttgttgtgaccactgaagacggatcctatgac60
attgtcgatgcagatgtcttggagaggtatgcaataaagagcgaatctgacgagacagga120
agcaagcagttgaagactgatggttgggaatatgatgatacattgcttgagccgttgtat180
gacccattgcagttgtgtgagctattggagataaacacatatcatgagaactgtgtcgat240
gttgttgcaagggac255
<210>105
<211>252
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>105
atgatggcgctcaaggtgcgtcattcaaagaggcagattcagaatatcaagagagaatac60
agaaggcgtttgatactcgaagagcagtgcagtagggagattgcggacttcttcagaagg120
cttgagaggaaaatccacaaggtcatggatgagcactgggaaagcgaattgggtcttttc180
catctgaacaaggtttcagacatcatacaggacagcaggcaggagtactatgacatcctg240
ttcaagtactgc252
<210>106
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>106
atgataattgaaattcctggaaatgacaggacagaagaaataaatttgccgaacggacag60
tttgtactgataacctacttgcaggaaaatgacatgatgtcattgcctgacgggaagtat120
gtctgcccattcagaatgattcagcttttcactgaagagggcggtgaactgattggagag180
tgcattgaggaaaatcctcactacaacactcgcttctacaatactgtctttgagcatttg240
gatgaaggaattgag255
<210>107
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>107
atgttaagagtcgtagagagaacctattatcaacaagaagaaatcaagacactagactgt60
cgaattagagaggcaggagtcaacacttactcccttgctcgtcaaggagcagttgactat120
cctacctacgaatcctacaacgaggtgagagaggaaaggataaaagaggctaaggaaaaa180
tacggtgaatcctactactatcactggagagacgttgagacctacttctattacttagga240
agattctttagtgat255
<210>108
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>108
atggacgcgataaacgttatcaaccaaaacaagatattagtagatgttttgtaccgtggg60
actgtaaacctgattgacatcgtcatcggtgatgcattggtctatgacaatccgacagtt120
gtagtcaagtgctacaccacagatttggcttttgcaaccacagagattgatgagattgta180
ttagagaacgaagaatttgagttattaataacttacgaggacggagagttctcaattttg240
ttgaagtcccacaat255
<210>109
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>109
atggtttttgtcgatttgtgcgagaacgaaatagcagacatggtcgagagcttctatcgc60
aatggagacggtagcagcaggatattgaccaacagagcagttggagagatagtggagcac120
tactgttcctttgaagtagacggtagaatcaccactaatctccgagatttcctattatat180
agtgttgtcttatatgacaccattggagaggctgtcgatgacggagtcaaccttgaggaa240
gtgttcatcatagaa255
<210>110
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>110
gtggtgaattggttgaaggctattggagataacttctcagtggattatctccttttagca60
ttattctctagtggagatttgatattggttgccatcgttctcaattcttatggtgtcatc120
tcacctgagaatgtaagggaactggtgattgactatataagttacaggaaagttgatatt180
ttttggagacatctaaggagacctagaatgagttttgaagattatgtcttagacaatttt240
gaagagatggaaact255
<210>111
<211>192
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>111
atgacaatgaaagttacttttgaagatgagaacggtgagagaacagtcgagttcggcgat60
gacgtcgatttcgttttaatcgaaagcgatgatgacggaaacattgagattcgcgaagga120
gactgggaattggacggagattccgacgatgattgggaagagtacgatgactgggacgag180
gaggagttctga192
<210>112
<211>279
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>112
gtggacgaattcgttgagaccctgttcgacacctactggaaggtgaatgagaacggagag60
tacatgagccttaccgattgcggtgatttctacatcgcaaaggttgctccctgtgttcgc120
aactggagcatagtgatagaatgcaattgcttctgttttcattgcaaggaatttgtctac180
catgagaacggagcaatacttgagataggtatggagattagctctctttacctaagccaa240
atggagataaaagatttgaagatatacatgatagattgt279
<210>113
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>113
atgtttttggaaggaatatttgaacaagacggagagaatgtaagagaacaggtgatttac60
tggagaaagtccaatcaggtacacaactggttcgtagtcaacgctcaggacggagaggac120
aactgccaaccacactcagtaagcagagaacagttagaggaactaagagacctatgcaga180
gcagtgctcgcagacaatgacaaggcagaggaacttctcccaacaagacctggtttcttc240
tttggtgcgatagac255
<210>114
<211>174
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>114
ttgcagttggtggtagaaggtgagaatatggaatgcccttgcgataattgtgagatgtta60
agagagaacgaaccaatcaaggtgattgactggaagtccaattctccatttggaaatggg120
atttktattcacttttggagggaacggcttcaggatgttggctataatgggtga174
<210>115
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>115
atggaactgatgactagggaaatggaagggaaactcaaatccttccctttctattcccaa60
gacggaaaaggagatgacgcgatagtggtgatgaagttcttcaacccttacggattggga120
acttggtatgtattggaggcagagaaacaggagaatggtgattaccttttcttcggatat180
gttgaatcaccgataacacctgaattcaacgagtacggttacttctcattgtctgagttg240
gagaaccttaagata255
<210>116
<211>225
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>116
atgttcggacagaagaaagaatttgtcaaaaagatgtatcatgtcggagacgttgtcgaa60
ctggttcatatggacgatgcacaggctccacctagtggaaccagaggagaaatactcttc120
gtagacgatattggtcaaatccatgtgagatgggagaacggctcaggtctggcactaata180
tatggtgaggacaggttcaaagttgtagagaggaaaggagaatag225
<210>117
<211>153
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>117
atggatttgttgtatctttatgatgacctgactgcaaggagagaagtctacgattcagtc60
ggattgagttttgtggtcaagtataaattctcatctcgtaaggaagcacaggatttcgca120
ttgaagtacggtgcagaactgattgaggaatga153
<210>118
<211>189
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>118
atgattgaacggaggagattaggaatgaagtacgatatttttactatcttggatgaaatt60
tcaaggaagttagatgacggtgaattatccgatgagcaggttgatttcctgttgcagatg120
gagattctagtagaggaaggcactatcacagacgagcaggcacaagatgtcatgaatgga180
gattattaa189
<210>119
<211>168
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>119
atgatgaaattaagtttgaaggaactcggtgaggaaattgagatgatacttgcagaaggt60
ggattaacctttgatcaagtcgattatctgttgtacttggagacctgcattgcagacgga120
agcataacagaggagcagaagagagaaattatctgtagggacttctaa168
<210>120
<211>234
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>120
ttggtgagagaacaggagagattgattatgtatttggaaattgacgaggtcaagtgcgaa60
aacattgacagaattgagtttgacgatgtcgcaatggaaatcgtcctgacagacgaaaag120
gtgtacgagagaataaagagatggctcaagtccaatgagattgactacgattgcagggaa180
gaccggtatttcgccaatctcatagaatatgtcattaggataacttggtggtaa234
<210>121
<211>216
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>121
gtggtaaccgtgagagatgtcggattcaccattgaggaacggttcttccttactgctcag60
gaattggagtattccgaagtgggagaggaacacgagagcgtcattgacagagccatcgca120
ttgctgtacacgaagctcagaaccagagacttcgagttcaccgacgaagaacgggaactc180
ttggaggatgcttttgtcattgtcagcgaccaatag216
<210>122
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>122
atggctaaagaaaatgttatagattataagattgagcgacaaaatgataacacttggagt60
tatttatatgtaactgaaagagggagaggaaatatcattgcttcatcttttggagaattg120
aggcagaaagttttaaaaagaggtttgccttggaatgatatatctaacctattcactaaa180
aagagttctgattctaatgttcgtcgcgaatctgtaaagaatattgatgatgaatctgtt240
ttggctgatgtcgct255
<210>123
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>123
atggtagtcaaatgtcctaattgttttagtccacgtgtttcaaaatgtgaagatactaat60
attaaatggcaatgtgataaatgcaaatgcaaatttaaccatggtgctttcgatattaat120
gctgaaatggagaaagtagaacaattaacaatagaaaaaattgaaagagaacgagaaaga180
actgaacaatttgaaagagctattaaagaagcaaaggaacaatttgaaagagaaagaact240
gaacaatttgaaaga255
<210>124
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>124
ttgaccgagggtcagataaggcagattgcacatgagtatctggcaaattacagccttgtc60
gacaagaaccatgagttcttcgagaccagagaagttataggagttcctgtggagtcatat120
ataacaaacgagcctataagcctcaagggcttggacggaacagtcaatgagtatccaaaa180
ggaacctggatagccaccacaaggataactgatgaagaggagatggaaaaggcactcaat240
ggagagtacactgga255
<210>125
<211>330
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>125
atgggaaacgaagctactttaaaccaattggtaaacgagcaggaaaaggcagtcttcaag60
tccatgaggactgacatggagacaggaaaggctgtattgaacgtcgagcagctaggttac120
ttccttagagaagcaacattagacaatacaattttaagagatgcggacttcaagctgatg180
aaatcattcaagaagcatctcaacagggtaggaataaacggaagggtcctcacaaacgga240
tatgacgtgaacggcgagaccgaccctgagattcctgcggctgacgtcgacttcggagca300
aacgagttggacgtcaagaagctcaaggca330
<210>126
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>126
atgcggaggcgttgcctgaactctccagagcataatggtatgatttcgcatatcattgtg60
cttctcatttgctttataggattggttgaggcgatactgatggcattggttgattgggag120
gacttggcaatatccgttcgcaagtctcctagaaagctttataatgttttgaaggatgag180
ttaggtcttcctgaatggaacgaactgtctgtgattgaaaggagaagcatgaagaaaagg240
tatgctgtcataaga255
<210>127
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>127
atgacttggattggtacggaagatgtcatcgagttcacaggagtcaagcctcagacattc60
aggttcgagaagggagacacctccagcctggaaacattgcttgagaagtggattctgcag120
gcagaaggacttataatatcctactgcaactacgatttcaatgacttggaggagatacct180
ccagcagttgttaatgtctgccttaggctcactgcaaacatggtcgcattggcacaggca240
aggaaggacactcct255
<210>128
<211>258
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>128
ttggtgaaattgcagattgacgttgaggaactcaagccattggagccaaggttcaaaaag60
gttgccaaaaggacagttgtgttgactgcaaatgaattgcagagaaacctcaagaagttg120
agtcctgtggatcatggaaggcttcagggctcttgggtaatcttccagacaggagaattg180
gaaaggactgtgaaaagcagtgcaaagtatgccattttcgtgaatgacggaacaggactg240
tacggtcctttgggtcat258
<210>129
<211>333
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>129
atgagattcgtaaatactgcttcgcttgttcctcagactgtcaaggcatatcttgaaagg60
gaaatctgcgaaggagggttgcttgaggatgtagagacactcattccgtccgtgaacagc120
gacgttcctgttgacccacctgcgatatggatagtccagcaccccactaccagatggtct180
ggcagtcagccaaatctctcaaacaagatagctatgtcagtccctttcgagttcgtatgc240
gtggaatacagcgatgacttggaagaggctgagatattgggaataagcctagccagcagg300
gttggctcaagcctgatgaagaacttcaacaag333
<210>130
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>130
atgggaattcgtgttgtaggaatgaaggaagaggcaaggtatggagttgcggagtcagcg60
ccggacttccatcaggaagttagcaaggcaaaggcttccttgaactccactccgaacaca120
aagtcaagcggctcaaggatgaagaagaaggcacgtgcaggcgtgtacaagcctactgcc180
aacatcgaaggtgaagttgacttgaagaggataggacattatctcaaggctttcctggac240
aattaccattttact255
<210>131
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>131
atggttgtagttaagaaatccgatattttaaagggcgtaaaaaagattgaaaaggtgaag60
attgaggctttggacggagacgagatgtacttgagaccgttgtcccaagccgagatcaac120
gaggtcgacgagattgaggcaaaggctatgggaatcttcgagaccaacgagaccgcacac180
aggggaagaaggcagaagcctaagagtgtggttgagagcaaaggaaagataaatctcgaa240
ttgcagcagaaggca255
<210>132
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>132
ttgccgtcaagcaatgtaatgaacataatagtcaaggcagaggacatggcatcatctgtc60
gcccaaaaggttgaaaacagcttcaggaaattgggaaacacaatagacagcaccttcacc120
acatctctttcaaacaccaagttcaatcaggaactcacttcttttggaacagacttggac180
aaggtaacccaaaggctgaagcaggtaggcgtgaacggtcagtccagcttcaaccagctt240
acaaatgctgaaagg255
<210>133
<211>312
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>133
atggcaagtgttacaaaatatccgagcaacgtttcacagaccactggaggaaagttcgtg60
tccttcagcaatctggcaaacataaagaacaatgctgacggagcgcatgccgtgagcagt120
gttcttatcaaaagcaagaagcagtctccaaacagaccgtccacagtctcatgcaaaggc180
ttcggattcagccttcctgaaggtgctgaacctactaaaatcacagtaacttataggcat240
aggaagaatgctggaagcgactacagctcaaagaacaagactcacatatgcaacatcgga300
ggacctacaatc312
<210>134
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>134
atgggcatagctattgttgttatggacaatgaggagaacttcctgcaattccttgaccct60
gatttatgcaccatcaatgagaccatagaggaattgggcttgaggactttggagttcaac120
tacaagtttcaggactatgttgaggacagggatcttttcaggataggtaacaagatctgg180
attagcaattcccagagcttggaggactgcctttatgtgataaacactcctgtggagaac240
agcgtctatcaggag255
<210>135
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>135
atggtcgagaagattacagtgagtcctcaggaagtcagaggatacggaaatgttgttgat60
gagaaggaattggaagattacggaagctacaggtgtgatgtgagcgagagctcggaggtg120
atcaagggagttgaggaaaggatattcagcgtttctggtgttcctgctcctgctctgagc180
attgccaatgttactgaggacactcgcaggggcaggtgcgcccacatctccgcctcattt240
gaggatggggaaggc255
<210>136
<211>381
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>136
atggttagattcagcagagacatgctccaggacggagcgaagagaatgttcaagtggcta60
agaaagggcgaagggttgcctaactacttgataatgtatgacatggacaggaataaggag120
tataagttggttccaaaggaatatgcaggactgtatgagtccagaaacatattctggatt180
aagaacggaagggagcctaactatgttacactgacttccgttgcaaggaatcctcttgtg240
atggactaccagaacaccaattacacctgttgcccaaccagtttgtcccttgcctcacaa300
atgctatatcactataagtcagaaagtgaatgcgctaaggctttgggaactagcaagggc360
agtggaacaagccctgcacag381
<210>137
<211>2250
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>137
atgaaaaaacattgcttttattttttaggggacagttttgccgatatatgcaatgaagcc60
atgttttgtgaaaaacatttagtagaaggaaactatttggattcaattatccgtgcagga120
aaggcttcagagataataactgtaaacatttgtgaacttgaaggtcaagatggcttaata180
agctctggtcagaagaaaagattggaaatgcttggatataagggtatcatttcttatgat240
atttataaaagattaaaccatattcgtaaaattagaaataaggctgtccatgggcattta300
agtgatattgaagacaatgcaaatattctgcatgcctatctgtatctaatttgcgcatat360
ttctataaggaatatagagacactaatttttcagcggaagattatacgggccctattatg420
gacattgcctctaagcctaaagagactgcttcagagacttcagaggataatgaaaatatt480
ggagagtttatttcaagtccattggatgattatctttttgaaaagtatgatgacagttac540
ctgttaaatgaactgtctaaacttaaggactcttcaaaggaagctgttgaagacgataac600
ttaagcgaatttaaggaatatcttcatattgacagatctattcaagaagattttttaaag660
gcattgaacagagccactagttttaattcatctcatctgattatgctttgcggtagtgtt720
ggagatgggaaatcacacttgattgcaaatttaaaaaagaaaaaccctgaactctttaat780
caatttgctatccattatgatgctacagagagttttgatcctgaaaagaatgcaatagac840
actttagcctcagtattggaacctttcaatgacaataatcttaacaattcgacagaaaaa900
cttattttagccattaacttgggtgtattgaacaatttcctggaatcatcttatgctaat960
gaagattacactaaactcaagttaattatagaagaagcgaacatatttgaatctaatgag1020
gtttcagataacatttatggagataaggttagttttgtcactttcagtgattacaacatg1080
tttgaattgaatgatgatgaaaattcaaactacacatcatcaaagtacatctcttcccta1140
tttaataagataacccaaaaggaggatacaaaccctttttatgttgcatatctcaaggat1200
aaggactctcactttatcaatcctataatctataattatgagatgctgatggatgaggag1260
gtccagaagacaatcattgattatttaatcaagattttcataaaatacagaaaaatcatt1320
tcaactagagacttattgaacttcatttatgagataatagttcctccggaattcctgaaa1380
agtgaggatttggacaatatcaatgatttcatggactattcattgcctaatttactcttc1440
ggatatccagaaaggtcagatttattgaagctatgcaatgaattggatccgacattgcat1500
cgtaatgaatctttagataagttcataatagacttgaacattaatgacgatactgaaaag1560
atattaaatcgttattttgatttcactcgttttaatttccttgaagagtatggagagtat1620
ctggttgattttagggagtttaacaattctgaaaaagagaaggtcaccaatattctaatt1680
aggtttgcagtattctatggaaagagcattatcaagaataatttcaaggataaggtttat1740
ttaaattatttaaaatatctgtatgcctataatacacagtctcataaggattacaaatat1800
ctgttcactgaagttaaggacgctatttttaattggaaaggttcctataagaagaatact1860
atatgtattgacactttggattcatttaaagtgtataaaaatttaaaattaaaaccatct1920
gttgataaatttgaaaaaagtttattagatggtctctttttaggaaatagatttaaaaca1980
gatataaaaatttatttttcagttgaatctaacaaaaagaaaatacctttaaatgttgat2040
ttttcattatatcaatacataatgaaattatataatggttttaagcctaatcaatcagat2100
aaagacgatttaataattttagatgaatttattaataatttattagatgaagatacagat2160
gatgatttatatgtaattagtttagaaacttatgaagaatttttatttgagtcaaatgat2220
tttggcacttttgaatttaagaggggttaa2250
<210>138
<211>1372
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>138
atggatttttcagaaaattataatatattattaaaacaaatgacttgtgatgtaaataaa60
aggaaattaatacatcagattaatcaaaattctccattgttaccttttaaaactaatact120
cctaaaaaagctaattttgaaaatggttttgatataatattgggtgaattatccagaatc180
ttattaaataaaactattgaaaaaaattttaaattagataatattgtttcaaatttaatt240
gataataatattgaaattgaagatggaactaaggagtatataacaaaattgctaaatgaa300
tatttattcgatgaaaaaaatgatttaaaaatatctcatccgaatttgtatttatatatt360
cctctttcaaataataaaagttctaatggagaacaggaagtagcattgtttttaagagat420
attttttgtaagaataatcaaaatcttattaacttttttgaatcatatgattcaaatcac480
attatcttaaatttaattttaaaaaatactcctaatttacatcataaaataactgaaact540
aagtatgtaattcattttgaggaaattgcaaatttatttaatgaagatatcaattatgca600
atactttataagaaattttttatggaaaacattggtaatatttttgcttattactatttc660
ttttatatctctcaattaattctaaaaatttctaaaggctttaatgataataatgaattt720
gaaaaattgtactatttattggactgggaatctgcaagtaaaaatcgtaaatcattaaat780
agttatagtttactaaaacatcattctaaaccattatatgcaaaaatggcagtcatagat840
caaataaatacactattaggtacaaataatttattggaaaaagatatttcagaatatttt900
aataatttggacatcaattctaaaaataattttttacattttcttaaaaaatgggtttca960
gattataggtatgtaaggaattttgatgataaagaattaccagataatttattagaatta1020
actgaaattctttttgaaagtttaaaaaatgaaaaactgggtgtggatggagctgtacaa1080
tctaggtacgctttaaatcttgaagatatagctaaaaaatatttgttaaagcgtagaggt1140
tcgtatggttatgtattaaatattaatagagatatgttgcttgttttaactgcattatgt1200
gttaaagataagaaaattaagttaaatcaactatttattgaatttgagaaaagaggagtt1260
tattttgacaaatattcaaaagaagaagtagtaaattttttaactaaattaaatttaatt1320
gacaagaaaagtgatagtggagatgctcaatatgttaaaccagttttatgat1372
<210>139
<211>5223
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>139
atgttaaaccagttttatgattatctatctaataaattactaaattattttgatgatact60
aagattttaagtggtgaaaaatttttcattagttttgatgaagatgaccaaataatgtct120
ttttataatagtttaagaagtattgcagaaactaatttttcttgttctgaattcatatat180
gtccatactatttcaggaaaggaatataatacttattccataaacattaatggagtcaaa240
tttgtcatttctgaaagtttaacaattaacgtagatttcttagttactttaagaaatcaa300
gttacttctcaagagggtgtttggaaggatactgcattattagttatctgtaatgaagca360
atagatagtattggaaaaggtatgagaaatttacagaaagaaggaatgccattaaatgta420
aaatctatttcaaaaaatttagaggatgaaattaacgattctcaaattcttaactattcc480
gataagcaaatcgctaagttttctttgaatattcaagaagaagaattgtttcaaacaaca540
ttatgggattatgaaactatcttatcaataatcaacaagggttttgttagtgatgaagat600
ttaagagagttgaatctttttaaagatgaccaactaaatcaaaattctcctcaaaagatg660
ttaaaaagattaaaagaaaattatgacacatttaatgaagtaaataaattttcacaatat720
ggagataaaaaagaacagcttaaaaatatgtttactgattctggagtttctattttaagt780
aaagatgactggtataaagcagaatggaaaatggttaaaaaatcaaaggatgactttatt840
aatcaacaaaatcctttaaattacaatgaaaatcttgaaaaaatcacagaaaatggctta900
aattattgggaaattcctaactcatttactaaaactggaaaaagaaaacgaaatatcatt960
gtttttaatccaaatcattctcatgaagttagtttaaagttcagttttgatcagattctt1020
agtaattcattccttaatacaaattcaaaaaaattcactattgcaagaggcaaatcatta1080
atagtcaattttactctggattctagtgaaccaattttcaaaactataaaatataaacat1140
aaaaatgaaaatatctctgaatttacttttaatattgttgttttgaattttgagcctgaa1200
atttttaattctattaaatctcgttttagtgtcaatgtcaaatctaaacagattattgta1260
acaaatgatgaggatagttttgatattgtttttggtactggttcaaaagaaatagagaaa1320
ttaattaaagaaaatggtgaaaagttatatctttatgatgatgaatctttaataatttct1380
gaacaatctcctgcttggaatgatggaaaattaagttttaaattatataaagacaataat1440
tatgccccatttttgattaaagaaaaatctaagaaaacactgccagtaaattcctatgta1500
atttggaatttgaaaagaagaaatatggaaaactttatttttaatggagtaaaagctgtt1560
caagatgtaaacagtttctatctcgtagaagaatttaaagaatttctaaaaatggaacga1620
gaaatcattaaacaggacatattttatgctaaaaggaatattgatggttctttagaaaaa1680
attgaagtttcattcagtaacgagttagaaactgcttacatggacatatttaattattat1740
aagacttttgatgattctccagaagacaatcttccaagtttagtttatttaaatgatgat1800
ttaaaagagttatataagaaatttataactatcttcaataaggaaatatcagaaattgaa1860
gagaattctattttgtctgattttaaatataaaaagaatttgcttaagttaggtcgtatt1920
gaaactgataacaaaataatgtattctccattatctccactaaatatcgcttatcaatta1980
gaagtttctaaacaatgcggaaatgaggatttatccgtaaatatattagaacggttagtt2040
ccaaataacttaattccttatatttgttcagatgatggaaaagaattgtttagacctatt2100
tatcaagaagaagctcatgaatggttgatttatgagaaaagtgaagaagtatcaattgga2160
acaacaaatgtatttatttctaatgttgttactgaaaaacttaatcaatttgtcaaacat2220
tttaattacttatttagttttaacaactcctcaccaattaaaattaacttaatcaatata2280
aaagatgataaagaagttgtgaaaggagtatttaattttattagatctagattgcctgat2340
aaaactaaaacaaaaaaagttattcctgttgaaatcaatatttacaacgacgctgaaaag2400
agttcttttgacaatttatttgattgtcagtctgaaattcagttactggaagaatttgga2460
attaaaaaattaaaatcagatatttttgatcctatagatattatccatatgattcaaaat2520
aatatttcatattataaacatccatttaaaaaagaagaatatgaatatgctcatctttct2580
ttctataaagtcaaatcacataacaatattgcaaatgacaatatggataaaattgaaact2640
ggattatctttaaacggtttattatcttcagttacatcaactactaaacattcagaatat2700
agaacgggtttcggtacaaacaatattttaaatatgagtaatcctcttattaaaacagtg2760
attaacttgaacgaacttgttgagaatagcaagaactttggaaaaaatacttattcaaaa2820
aataaatcagttatcactactgttgaattagaagaagacaatattgaagaattgtacgac2880
aaatctcattgggtaacatttattgaacctacatttggtatcgaatactttgacagttct2940
gatagtaatttgatcattattcattacagcgatcaatatagttcctctagcaagtatgat3000
actattactgtaactaataaatcaacacaatatgaggaaattataagagatttcctccaa3060
tctaaatatgtaaaagttacagatgaagaattgtatgatgtaataaagatgtttaattca3120
attaatggtgaatggttacttagagtaatttctaattccggccattatgatagggaaaaa3180
ttaagtattatttctgctattaaatattgcttatccattttggaccataaagatattgtt3240
tggattccagtttctatggaagaaatcttaagaattgcaggaaatgttaaattagataaa3300
aataaaggaatttttgactctaagttaataaaaggaaatcatagtgatgatctgctattc3360
attggtgtaaaattcaatgaagataatagaatcgaagttatattctacccaatcgaagtt3420
aaaataggtttgaataatgcttcaactattaaaaaaggtaaaagtcaattagataatact3480
tataaacttcttaaaactcaactacaaaatattaatgtagagaattctgaatttagaaat3540
aaattctttagaaatttcttcatccaaatattattgtccaatgagcaaaaattagtaact3600
aatcatatttgggatgaaaaaggattggatagaattgaagaattcaaagcagaactatta3660
aatgatgaatatgatattttatatggtttagaagagtacattggtaaaggttctttggtt3720
tcatttaaaaaagaatctcatcacatctctatctatatggatgttgataagcaagtaatt3780
gagttaccagaagattttgcttattacggtttagccactcctataagagaaatccatgat3840
gagattcagtcagacaatacagatattcttgcagaaacattgttatcacatgtagatata3900
agtgaaattagagcaaagaataatgatatatgcgattcaaatgaggatatgtcaatagat3960
gatgattttgataatttaagtgaatttgaggatagttttattgaagaagaatcagaaatt4020
tctgaagagcctgatgaagaattaactgatgcaacttcaagcagtgataatgaatcaatt4080
gagaatattggagaatctccttctaaaatttctaatgtcagagcattaattggaactcag4140
aagggttataatcataaagtttattgggaatttggacatccttctttagcaaataggcat4200
atgttaattcaaggaaaatctggacaaggtaaaacatatttcattcaacgaatgttaaaa4260
gagttgtctattcaaggcattcctagcataattattgattatactgatggattcaagcct4320
tctcaattagaacctaattttaaagactctttaggagataaaataagccaatattttgtt4380
gtaaaagaaaatttcccaataaatccatttaaacgaaacactatcatgattgataaggac4440
atatttattgaagaagacaacagcactattgcgagccgatttaaatctatcattaattct4500
gtttatgggctaggtattcaacagtccaatactttatatcaaacagttttagattgcttg4560
gataagtatgatgataattttgatttgaatatcctaaaagaagaaattctaaaagacgaa4620
tcaaatagtgcacaaacagtcttgaataaattaaatgagttattggataaaaatccgttc4680
gcatccactgatttcgactggtctgtcttagataataaagacggtaaagtttacattatc4740
caattaactgcactttctaaggatatacagacaattataactgaattcatcctttgggat4800
ttatggaattacaaattaacaaatggtagtgaagataatcctttcattgttgttttagat4860
gaagctcataatcttgatttttccaatgactctccatgtagtaaaattcttaaagaaggc4920
aggaaatttggatggtctgggtggtttgcaacacaatctgttaaaggatctatgaaaatt4980
gatgaaatagctaaattagagaatgcagatgagaagatatatttccatccaacggatgtt5040
tcaacaatagctaaagatttgtcaaaagacaatgaagataaaaaaatatatgaaaaagag5100
ttatctcaattgacaaaaggatattgtattgttcaagggtctgcaatagattcaagtggc5160
aatttgtatcagccaaatcctgtaactgtaaaaattgaggagataagttttgatgaaaat5220
taa5223
<210>140
<211>3165
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>140
atggaaagtaaagacagaatagagaatactattttcaatgataaaagaatggatgcttat60
atagacaaatattttgaagagtttactctgagttctgaacaagaagaggcactgaatatt120
tggatagataaattaaataacgatcaattaacaagtgaaaaagggaattatcataatttt180
tttgaaattattcttgaagatttacttggttataaacgttctgatgttaaacatgaagag240
aatattggtgatgaaggccatcctgtagagtttgtattagaaaaagatggaaaagattat300
gtgattatagaactaaaaggaacaacttataaagacctcactaaaagaagacctggacag360
caatcaccagtagagcaagctacaaattatgctagtgctaaaaaagaaactgaatgggct420
acagtttcaaattatgatgaatttagattttttaatccaacagcaagagataattatatt480
tcattcaagtttaggcaattgaaagatttggaaatctttaaaaaatttttattagtattc540
agtaaattttcacttatcgatgaagacatacctaaaaaattacttaatgaaacaaaagtc600
attgaaagagaattagaaaatgaattttatcaattgtatagtgacactagattaatgatt660
attaaggaattggaatattcttcagaagatattaataggattgaagcaataaaattatct720
caaataatattaaatagatttattttcctttgttttgcagaagatttagcgcttatggag780
gaagagacaactgctgatgtattattaacacctttaaagcatagaaatttaatcggaaat840
acaatgtggaataggttaaatgaattatttatttttgcaaatcaaggaaataaacatagg900
agaatacctgcatttaatggaggattatttgaggatgatttatctaatttgaaaataagg960
gatgaaattgaagataggtctttctttgaaaattggaatttaaaagaagattttgaagac1020
aaatatgaggatattgctaaactaattggagtttataaagatactcttaatccaattttc1080
attaatttattaataatttctacatatgactttgattcagaacttgatgtaaatatctta1140
ggacatatttttgaaaacagtattagcgatattgaagagttaaaaaatgataatcaagag1200
caaagaaaaaaagatggagtgtattacactccagaatatattacagattatatttgtaga1260
aatacaattattccatatttaagtatttctggtaaagccagcacagttcatgaattatta1320
tacgaatatgaatcatctaattcattggatgttttagattcaaaattaactaacatcaaa1380
gttctagatcctgcctgtggtagtgggagcatgttaaataaatcagtagatatattattt1440
gaaattcatgaagcattacatgcaagtaaatatgctggagattcatctttagatagattt1500
tttgatagtttagaaaaacgaaaggaaattataagtaataatatttatggggttgatttg1560
aacgaggagtccgttgaaattactaaattatccttattcctaaaattagcaactactgtt1620
ggacttaaagaagggtttcaacttcctagtttagataaacatattaaatgtggggattca1680
ttagtggatgatgagtcaattgccggaaataaagcatttaactggtatgaatcattttca1740
gaagtttttgaaagtggcggatttgatattattgtaggaaatcctccgtatgtggatatt1800
aaagaaatggatgaaaaaacagcaaaatacatatttgataattatgaaacttcttttaac1860
aggataaatttatattctacatttgtggaaaaaagttattatttgctaaaaaatgaaggg1920
attttttcatttatcatgcctaattccattttatttaattctacttactctaaaatcaga1980
gaactaattcttaataatacatccatattaaatattgtaagaacttctgatgatgttttt2040
aaagatgctaaagtggaacctattattttaatcttcaaaaaaggatatgatgaaggaaat2100
aagactaagatacttataaaaaaagatgatatggatgaaattccaataaataattattca2160
gaacatttctttacacaagaaagatggtttgaaaataattcaataattaatattttttca2220
gatgattttacttttgatttattaaagaaaattgatggaaataatgaaagattaattgat2280
tattgtgattttagtttaggtttaactccttatgataaatataaaggtatgagtgaggat2340
attattaaaaatagaaaattccattcaaaaataaaacttgacgatacttttaaagaatta2400
ttggatgggtccgatattacaagatataatgtaaaatggggcgaaaaagaatatattaaa2460
tatggggactggttaggagcacctcgggaagaaaaattctttaaaaatcctagaatttta2520
ataagacagattttatctatagctcctaaggaatctcgaaaaaggatttttgccgcttac2580
acagaagaagaattatataacgctcaaattgcttttaatttagtattgaaagaaggcttt2640
gatgataaaaatttattgaaatattttttaggaataattaattctaaaatgatgacttgg2700
tattatgaagaaagatttatggataaaaataaaaagaattttgcaaaaattttgattgaa2760
aatgctaaaaatcttccagtcattattaattcaaattttttagatgagatagtatctaat2820
gtggattcaataatagagttaaataaagagttttatagtgtaagaaatgcatttcaaaca2880
tggcttaaaatagaatttgaaattgaaaaactctctaagaaactagaaaactattatgat2940
ttaaactttgaagaattcttaaaagagataaaaaagaaaaaagtagtcattagaccaaat3000
caaatacaggacttgtccgaattatttaatgaaagtttaggaaaaatagaatatctgcaa3060
agagagattaaagaagcagacgaaaaaattaacctactggtctatgaattatatggttta3120
aatcatgaagaaatagaaattatagaaaatagctttaatgattaa3165
<210>141
<211>261
<212>PRT
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>141
AlaThrGlyGlyAlaCysGlyAlaThrGlyAlaAlaAlaCysAlaThr
151015
ThrAlaAlaThrCysCysThrAlaAlaThrThrGlyAlaAlaThrAla
202530
CysAlaThrCysAlaGlyAlaAlaAlaCysGlyCysGlyCysCysAla
354045
AlaCysAlaAlaGlyAlaGlyAlaAlaAlaThrGlyGlyThrGlyCys
505560
ThrThrAlaAlaGlyThrCysAlaThrThrThrGlyAlaAlaGlyGly
65707580
AlaGlyThrGlyGlyAlaCysThrThrThrAlaThrAlaAlaGlyAla
859095
CysCysAlaAlaThrCysCysAlaAlaAlaThrThrThrCysThrAla
100105110
GlyGlyAlaAlaAlaAlaCysAlaGlyGlyCysAlaThrThrCysAla
115120125
CysCysCysAlaAlaAlaCysAlaAlaThrGlyThrCysAlaGlyCys
130135140
AlaAlaGlyAlaAlaAlaThrThrAlaAlaAlaGlyGlyAlaThrCys
145150155160
ThrThrCysGlyCysGlyAlaAlaCysAlaThrGlyAlaAlaCysThr
165170175
GlyGlyThrCysThrAlaThrGlyThrCysAlaThrAlaAlaAlaThr
180185190
CysCysThrGlyAlaGlyThrAlaCysCysAlaThrGlyThrThrCys
195200205
CysThrAlaAlaAlaCysThrThrThrAlaCysAlaGlyGlyCysThr
210215220
ThrAlaCysThrGlyAlaAlaAlaAlaGlyGlyGlyThrAlaAlaAla
225230235240
AlaAlaThrAlaThrGlyCysThrThrCysAlaAlaThrThrCysThr
245250255
ThrGlyThrAlaGly
260
<210>142
<211>255
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>142
atgaataaaaaaattatcttatccctccttttagtattattagtagctatttctgtctct60
gcagttgcagcagcagatgctgatgtcacatatataaacgatgctgcagatgtagacgat120
gttgcagacgaaaaagttgctcctcttacagctagtgctgatgcacaagacatccaaact180
aagcttgataatgctaaacctggagacacaattgaattagaaaacaagacatatgacgtt240
gatacaacatttaat255
<210>143
<211>40
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>143
tttttaattgattgtaataattaattattctgggtctgac40
<210>144
<211>80
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>144
aaacctttatggaagtcgagtaagtattggtacgtattataagtataaatacgtatccta60
tacttactttattaaaattt80
<210>145
<211>42
<212>DNA
<213>反刍甲烷短杆菌(Methanobrevibacterruminantium)
<400>145
cagaataaggataataattaattatattgtttttattttttt42
<210>146
<211>25
<212>DNA
<213>人工序列
<220>
<223>人工序列描述:合成引物
<400>146
caaagagagattaaagaagcagacg25
<210>147
<211>25
<212>DNA
<213>人工序列
<220>
<223>人工序列描述:合成引物
<400>147
agtagtgttggaatcagtgaaaagg25
<210>148
<211>25
<212>DNA
<213>人工序列
<220>
<223>人工序列描述:合成引物
<400>148
caccatggttagattcagcagagac25
<210>149
<211>25
<212>DNA
<213>人工序列
<220>
<223>人工序列描述:合成引物
<400>149
tcatgcaggacagacaacatagtag25
<210>150
<211>6
<212>PRT
<213>人工序列
<220>
<223>人工序列描述:合成的6xHis标签
<400>150
HisHisHisHisHisHis
15
<210>151
<211>39
<212>PRT
<213>人工序列
<220>
<223>人工序列描述:合成的共有序列
<220>
<221>MOD_RES
<222>(1)..(1)
<223>Met或Leu
<220>
<221>MOD_RES
<222>(6)..(6)
<223>可能或可能不存在
<220>
<221>MOD_RES
<222>(7)..(15)
<223>任何氨基酸;该区域可包括0-9个残基
<220>
<221>MOD_RES
<222>(16)..(16)
<223>Ile或Leu
<220>
<221>MOD_RES
<222>(17)..(17)
<223>Ile、Phe或Leu
<220>
<221>MOD_RES
<222>(18)..(19)
<223>Ile或Leu
<220>
<221>MOD_RES
<222>(20)..(20)
<223>Ile或Ser
<220>
<221>MOD_RES
<222>(21)..(21)
<223>Leu、Ile或Ala
<220>
<221>MOD_RES
<222>(22)..(25)
<223>任何氨基酸;该区域可包括0-4个残基
<220>
<221>MOD_RES
<222>(26)..(26)
<223>Leu、Ile、Val或Phe
<220>
<221>MOD_RES
<222>(27)..(27)
<223>Leu、Ile、Ala或Val
<220>
<221>MOD_RES
<222>(28)..(28)
<223>Leu或Ile
<220>
<221>MOD_RES
<222>(29)..(29)
<223>Ile、Leu或Val
<220>
<221>MOD_RES
<222>(30)..(30)
<223>Leu、Ala、Ile或Val
<220>
<221>MOD_RES
<222>(31)..(32)
<223>Ile、Leu、Phe或Val
<220>
<221>MOD_RES
<222>(33)..(33)
<223>Ser、Ala或Leu
<220>
<221>MOD_RES
<222>(34)..(34)
<223>Ile、Leu或Val
<220>
<221>MOD_RES
<222>(35)..(35)
<223>Gly、Ser或Ala
<220>
<221>MOD_RES
<222>(36)..(36)
<223>Ala或Ser
<220>
<221>MOD_RES
<222>(37)..(37)
<223>Val、Ala或Ile
<220>
<221>MOD_RES
<222>(38)..(38)
<223>Ser或Ala
<400>151
XaaLysLysLysLysLysXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa
151015
XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa
202530
XaaXaaXaaXaaXaaXaaAla
35
Claims (36)
1.一种分离的多肽,其氨基酸序列组成为SEQIDNO:63,所述多肽是产甲烷菌细胞的抑制剂和/或检测噬菌体的生物标记物。
2.一种分离的多核苷酸,其编码权利要求1的多肽。
3.一种分离的多核苷酸,其核苷酸序列组成为SEQIDNO:136,其编码产甲烷菌细胞的抑制剂和/或检测噬菌体的生物标记物。
4.一种载体,其包含编码权利要求1所述多肽的多核苷酸。
5.一种包含权利要求2或3所述多核苷酸的载体。
6.一种包含权利要求4或5所述载体的宿主细胞。
7.一种经遗传修饰来编码权利要求1所述多肽的宿主细胞。
8.一种经遗传修饰包含权利要求2或3所述多核苷酸的宿主细胞。
9.如权利要求6-8中任一项所述的宿主细胞,其特征在于,所述细胞是原核细胞。
10.如权利要求9所述的宿主细胞,其特征在于,所述细胞是大肠杆菌。
11.如权利要求6-8中任一项所述的宿主细胞,其特征在于,所述细胞是产甲烷菌。
12.如权利要求11所述的宿主细胞,其特征在于,所述细胞是反刍甲烷短杆菌。
13.一种偶联物分子,其包含权利要求1所述多肽。
14.如权利要求13所述的偶联物分子,其特征在于,所述分子还包含抗甲烷生成化合物、信号序列、抗体或抗体片段、肽核酸、抗微生物肽或抗生素。
15.一种包含权利要求1所述多肽的融合分子。
16.如权利要求15所述的融合分子,其特征在于,所述分子还包含信号序列、抗体或抗体片段、肽核酸或抗微生物肽。
17.一种与权利要求1所述多肽结合的抗体或抗体片段,其为检测噬菌体的生物标记物。
18.如权利要求17所述的抗体或抗体片段,其特征在于,所述抗体是多克隆的或所述抗体片段来自多克隆抗体。
19.如权利要求17所述的抗体或抗体片段,其特征在于,所述抗体是单克隆的或所述抗体片段来自单克隆抗体。
20.一种分离的噬菌体,其包含权利要求1所述的多肽。
21.一种分离的噬菌体,其包含权利要求2或3所述的多核苷酸。
22.一种包含权利要求1所述多肽的药物组合物。
23.一种包含权利要求2或3所述多核苷酸的药物组合物。
24.一种包含权利要求20或21所述噬菌体的药物组合物。
25.一种抑制产甲烷菌细胞的方法,所述方法包括:产生或分离权利要求1所述的多肽;和b)将所述细胞与权利要求1所述的多肽相接触。
26.如权利要求25所述的方法,其特征在于,所述细胞是反刍甲烷短杆菌。
27.如权利要求26所述的方法,其特征在于,所述细胞是反刍甲烷短杆菌菌株M1T即DSM1093。
28.一种抑制产甲烷菌细胞的方法,所述方法包括:a)产生或分离权利要求13或14所述的偶联物分子;和b)将所述细胞与权利要求13或14所述的偶联物分子相接触。
29.如权利要求28所述的方法,其特征在于,所述细胞是反刍甲烷短杆菌。
30.如权利要求29所述的方法,其特征在于,所述细胞是反刍甲烷短杆菌菌株M1T即DSM1093。
31.一种抑制产甲烷菌细胞的方法,所述方法包括:a)产生或分离权利要求15或16所述的融合分子;和b)将所述细胞与权利要求15或16所述的融合分子相接触。
32.如权利要求31所述的方法,其特征在于,所述细胞是反刍甲烷短杆菌。
33.如权利要求32所述的方法,其特征在于,所述细胞是反刍甲烷短杆菌菌株M1T即DSM1093。
34.一种抑制产甲烷菌细胞的方法,所述方法包括:a)产生或分离权利要求20或21所述的噬菌体;和b)将所述细胞与权利要求20或21所述的噬菌体相接触。
35.如权利要求34所述的方法,其特征在于,所述细胞是反刍甲烷短杆菌。
36.如权利要求35所述的方法,其特征在于,所述细胞是反刍甲烷短杆菌菌株M1T即DSM1093。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97510407P | 2007-09-25 | 2007-09-25 | |
US60/975,104 | 2007-09-25 | ||
US98984007P | 2007-11-22 | 2007-11-22 | |
US98984107P | 2007-11-22 | 2007-11-22 | |
US60/989,841 | 2007-11-22 | ||
US60/989,840 | 2007-11-22 | ||
PCT/NZ2008/000248 WO2009041831A1 (en) | 2007-09-25 | 2008-09-25 | PHAGE ϕ-MRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101932595A CN101932595A (zh) | 2010-12-29 |
CN101932595B true CN101932595B (zh) | 2016-02-10 |
Family
ID=40511642
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880109156.6A Active CN101932595B (zh) | 2007-09-25 | 2008-09-25 | 噬菌体φmru多核苷酸和多肽及其应用 |
CN200880109364.6A Active CN101918431B (zh) | 2007-09-25 | 2008-09-25 | 用于微生物细胞的细胞通透肽和多肽 |
CN2008801094507A Pending CN102015755A (zh) | 2007-09-25 | 2008-09-25 | 用于抑制微生物细胞的疫苗和疫苗组分 |
CN201611216760.1A Active CN107129524B (zh) | 2007-09-25 | 2008-09-25 | 用于抑制微生物细胞的疫苗和疫苗组分 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880109364.6A Active CN101918431B (zh) | 2007-09-25 | 2008-09-25 | 用于微生物细胞的细胞通透肽和多肽 |
CN2008801094507A Pending CN102015755A (zh) | 2007-09-25 | 2008-09-25 | 用于抑制微生物细胞的疫苗和疫苗组分 |
CN201611216760.1A Active CN107129524B (zh) | 2007-09-25 | 2008-09-25 | 用于抑制微生物细胞的疫苗和疫苗组分 |
Country Status (17)
Country | Link |
---|---|
US (7) | US8586709B2 (zh) |
EP (5) | EP3936516A1 (zh) |
JP (5) | JP6067209B2 (zh) |
CN (4) | CN101932595B (zh) |
AR (3) | AR068551A1 (zh) |
AU (4) | AU2008304019A1 (zh) |
BR (5) | BR122020023381B1 (zh) |
CA (3) | CA2700162C (zh) |
CL (3) | CL2008002861A1 (zh) |
DK (3) | DK2203466T3 (zh) |
ES (3) | ES2625144T3 (zh) |
MX (3) | MX340736B (zh) |
NZ (2) | NZ780936A (zh) |
RU (1) | RU2528854C2 (zh) |
UY (3) | UY31361A1 (zh) |
WO (3) | WO2009041830A2 (zh) |
ZA (1) | ZA201001933B (zh) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR068551A1 (es) * | 2007-09-25 | 2009-11-18 | Pastoral Greenhouse Gas Res Lt | Peptidos y polipeptidos permeabilizantes celulares para celulas microbianas |
GB0815484D0 (en) | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
KR20170024129A (ko) * | 2009-06-26 | 2017-03-06 | 카톨리에케 유니버시테이트 루벤 | 항균제 |
CA2765810C (en) * | 2009-06-26 | 2018-10-16 | Lysando Holding Aktiengesellschaft | Antimicrobial endolysin fusion proteins |
NZ795881A (en) | 2009-08-27 | 2024-07-05 | Pastoral Greenhouse Gas Res Ltd | Complete genome sequence of the methanogen methanobrevibacter ruminantium |
US9534223B2 (en) * | 2010-04-27 | 2017-01-03 | Lysando Ag | Method of reducing biofilms |
EP4230644A3 (en) * | 2012-09-19 | 2024-04-24 | Gemvax & Kael Co., Ltd. | Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate |
KR102210322B1 (ko) | 2013-03-15 | 2021-02-01 | 더 제너럴 하스피탈 코포레이션 | Rna-안내 게놈 편집의 특이성을 증가시키기 위한 rna-안내 foki 뉴클레아제(rfn)의 용도 |
US10760064B2 (en) | 2013-03-15 | 2020-09-01 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
US10011850B2 (en) | 2013-06-21 | 2018-07-03 | The General Hospital Corporation | Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing |
JP2016536021A (ja) | 2013-11-07 | 2016-11-24 | エディタス・メディシン,インコーポレイテッド | CRISPR関連方法および支配gRNAのある組成物 |
EP3597740B1 (en) * | 2014-11-06 | 2022-03-23 | DuPont US Holding, LLC | Peptide-mediated delivery of rna-guided endonuclease into cells |
CN104789675A (zh) * | 2015-04-15 | 2015-07-22 | 江苏师范大学 | 一种检测荷斯坦奶牛瘤胃微生物的方法 |
US11845928B2 (en) * | 2015-05-04 | 2023-12-19 | Tsinghua University | Methods and kits for fragmenting DNA |
US9512446B1 (en) | 2015-08-28 | 2016-12-06 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
US9926546B2 (en) | 2015-08-28 | 2018-03-27 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
US20190292514A1 (en) * | 2016-07-14 | 2019-09-26 | Basf Se | Fermentation medium comprising chelating agent |
KR102551666B1 (ko) * | 2016-12-29 | 2023-07-04 | 일루미나, 인코포레이티드 | 세포 구획 내의 생체분자에 대한 직교 접근 및 그의 태그부착을 위한 분석 시스템 |
CN112986589B (zh) * | 2017-01-05 | 2023-01-24 | 深圳迈瑞生物医疗电子股份有限公司 | 网织红细胞模拟粒子、血小板模拟粒子制备方法及质控物 |
US10745439B2 (en) * | 2017-03-20 | 2020-08-18 | Regents Of The University Of Minnesota | Kinase substrates and methods of use thereof |
US20190233816A1 (en) | 2018-01-26 | 2019-08-01 | Massachusetts Institute Of Technology | Structure-guided chemical modification of guide rna and its applications |
CN111885915B (zh) * | 2018-03-19 | 2023-04-28 | 瑞泽恩制药公司 | 使用crispr/cas系统对动物进行转录调制 |
WO2020102591A1 (en) * | 2018-11-14 | 2020-05-22 | Rubryc Therapeutics, Inc. | Cd25 antibodies |
CN109627301B (zh) * | 2019-02-18 | 2022-08-05 | 浙江新银象生物工程有限公司 | Nisin固体稳定剂开发及应用 |
US20230140823A1 (en) * | 2020-03-19 | 2023-05-04 | Micreos Human Health B.V. | A stabilized protein of interest. |
CN112143747B (zh) * | 2020-09-09 | 2022-09-13 | 昆明理工大学 | 一种噬菌体裂解酶及其基因、基因重组表达载体与应用 |
AU2021396978A1 (en) | 2020-12-08 | 2023-02-23 | Ruminant Biotech Corp Limited | Improvements to devices and methods for delivery of substances to animals |
CN112961217B (zh) * | 2021-03-19 | 2022-11-08 | 江苏元本生物科技有限公司 | 一种靶向Siglec-15的噬菌体多肽 |
CN113121705B (zh) * | 2021-04-19 | 2023-03-24 | 成都英普博集生物科技有限公司 | 用于制备短肽混合物的融合蛋白、目的多肽、短肽混合物的制备方法及应用 |
WO2024015366A1 (en) * | 2022-07-11 | 2024-01-18 | Arkea Bio Corp. | Compositions and methods for reducing methane emissions in ruminant populations |
WO2024097397A1 (en) * | 2022-11-03 | 2024-05-10 | Helix Nanotechnologies, Inc. | Ruminal and methanogen vaccines and uses thereof |
CN115938486B (zh) * | 2022-12-06 | 2023-11-10 | 内蒙古农业大学 | 基于图神经网络的抗菌性乳酸菌株筛选方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US159861A (en) * | 1875-02-16 | Improvement in brooms | ||
NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
CA1221635A (fr) * | 1983-05-03 | 1987-05-12 | Andre Speecke | Composition a activite pharmaceutique amelioree et utilisation de celle-ci pour des usages veterinaires |
GB8815968D0 (en) * | 1988-07-05 | 1988-08-10 | Pfizer Ltd | Veterinary devices |
JPH05219927A (ja) * | 1992-02-14 | 1993-08-31 | Gumma Pref Gov | 飼料の混合装置及び混合飼料の製造方法 |
JP3651915B2 (ja) * | 1993-06-30 | 2005-05-25 | 財団法人神奈川科学技術アカデミー | シグナル配列ペプチドをコードするdna断片の探索法及びそのためのベクター |
DK0724454T3 (da) * | 1993-10-19 | 2004-07-12 | Commw Scient Ind Res Org | Fremgangsmåde til forbedring af drövtyggerdyrs eller drövtyggerlignende dyrs udnyttelse af næringsstoffer |
JPH09507121A (ja) | 1993-10-26 | 1997-07-22 | アフィマックス テクノロジーズ ナームロゼ ベノートスハップ | 生物学的チップ上の核酸プローブアレー |
NZ278977A (en) | 1994-01-20 | 1997-03-24 | Pastoral Agric Res Inst Nz Ltd | Sustained release bolus for ruminants |
DE69531773T2 (de) | 1994-01-20 | 2004-07-15 | Agresearch Ltd. | Vorrichtung zur verabreichung von nützlichen stoffen an wiederkäuer |
US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
AUPN353695A0 (en) | 1995-06-14 | 1995-07-06 | Commonwealth Scientific And Industrial Research Organisation | Immunogenic preparation and method for improving the productivity of ruminant animals |
WO1998007830A2 (en) * | 1996-08-22 | 1998-02-26 | The Institute For Genomic Research | COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII) |
US5985907A (en) * | 1998-08-12 | 1999-11-16 | Health Research, Inc. | Method for inhibiting growth of methanogens |
AU2002306849A1 (en) * | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
US20030219467A1 (en) * | 2001-09-18 | 2003-11-27 | The Board Of Regents Of The University Of Nebraska | Method for the inhibition of methanogensis |
US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
AU2003222249A1 (en) * | 2002-03-04 | 2003-09-22 | Fidelity Systems, Inc., Et Al. | The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
SE523209C2 (sv) * | 2002-05-14 | 2004-04-06 | Akzo Nobel Nv | Förfarande för att reducera metanbildningen från matspjälkningsaktiviteter hos djur |
EP1861490A4 (en) | 2005-03-23 | 2010-11-17 | Univ St Louis | USE OF ARRAYS TO MODULATE NUTRIENT CAPTURE FUNCTIONS BY THE GASTROINTESTINAL MICROBIOTE |
AR068551A1 (es) * | 2007-09-25 | 2009-11-18 | Pastoral Greenhouse Gas Res Lt | Peptidos y polipeptidos permeabilizantes celulares para celulas microbianas |
CN101434924A (zh) * | 2008-12-17 | 2009-05-20 | 中南大学 | 一种分离严格厌氧产甲烷古菌的方法 |
NZ795881A (en) * | 2009-08-27 | 2024-07-05 | Pastoral Greenhouse Gas Res Ltd | Complete genome sequence of the methanogen methanobrevibacter ruminantium |
CN101864362B (zh) * | 2010-05-19 | 2012-05-09 | 江苏加德绿色能源有限公司 | 一种复合微生物菌剂及其应用 |
DE102011119230B4 (de) * | 2011-11-23 | 2013-07-11 | Audi Ag | Kraftwagen-Blinkleuchte und Verfahren zum Betreiben einer Blinkleuchte |
JP2016511630A (ja) * | 2012-12-21 | 2016-04-21 | ダニスコ・ユーエス・インク | 代案の下流メバロン酸経路を使用するイソプレン、イソプレノイド、およびイソプレノイド前駆体の生成 |
-
2008
- 2008-09-25 AR ARP080104171A patent/AR068551A1/es unknown
- 2008-09-25 CN CN200880109156.6A patent/CN101932595B/zh active Active
- 2008-09-25 BR BR122020023381-8A patent/BR122020023381B1/pt active IP Right Grant
- 2008-09-25 BR BRPI0817299A patent/BRPI0817299A8/pt not_active Application Discontinuation
- 2008-09-25 CA CA2700162A patent/CA2700162C/en active Active
- 2008-09-25 DK DK08834203.5T patent/DK2203466T3/en active
- 2008-09-25 WO PCT/NZ2008/000247 patent/WO2009041830A2/en active Application Filing
- 2008-09-25 JP JP2010526841A patent/JP6067209B2/ja active Active
- 2008-09-25 CN CN200880109364.6A patent/CN101918431B/zh active Active
- 2008-09-25 MX MX2010003319A patent/MX340736B/es active IP Right Grant
- 2008-09-25 CA CA2700129A patent/CA2700129C/en active Active
- 2008-09-25 RU RU2010116163/10A patent/RU2528854C2/ru not_active IP Right Cessation
- 2008-09-25 BR BRPI0817312-5A patent/BRPI0817312B1/pt active IP Right Grant
- 2008-09-25 ES ES08834643.2T patent/ES2625144T3/es active Active
- 2008-09-25 ES ES17206527T patent/ES2895908T3/es active Active
- 2008-09-25 EP EP21181143.5A patent/EP3936516A1/en active Pending
- 2008-09-25 EP EP08834203.5A patent/EP2203466B1/en active Active
- 2008-09-25 DK DK08834643.2T patent/DK2203467T3/en active
- 2008-09-25 BR BR122021010729-7A patent/BR122021010729B1/pt active IP Right Grant
- 2008-09-25 CL CL2008002861A patent/CL2008002861A1/es unknown
- 2008-09-25 CL CL2008002860A patent/CL2008002860A1/es unknown
- 2008-09-25 CN CN2008801094507A patent/CN102015755A/zh active Pending
- 2008-09-25 JP JP2010526839A patent/JP5558356B2/ja not_active Expired - Fee Related
- 2008-09-25 EP EP17206527.8A patent/EP3327030B1/en active Active
- 2008-09-25 CA CA2700164A patent/CA2700164C/en active Active
- 2008-09-25 AR ARP080104172A patent/AR068552A1/es unknown
- 2008-09-25 EP EP08833501A patent/EP2203470A4/en not_active Ceased
- 2008-09-25 AU AU2008304019A patent/AU2008304019A1/en not_active Abandoned
- 2008-09-25 JP JP2010526840A patent/JP5552053B2/ja not_active Expired - Fee Related
- 2008-09-25 MX MX2010003321A patent/MX2010003321A/es active IP Right Grant
- 2008-09-25 NZ NZ780936A patent/NZ780936A/en unknown
- 2008-09-25 EP EP08834643.2A patent/EP2203467B1/en active Active
- 2008-09-25 UY UY31361A patent/UY31361A1/es active IP Right Grant
- 2008-09-25 US US12/678,925 patent/US8586709B2/en active Active
- 2008-09-25 MX MX2010003328A patent/MX2010003328A/es active IP Right Grant
- 2008-09-25 DK DK17206527.8T patent/DK3327030T3/da active
- 2008-09-25 UY UY31359A patent/UY31359A1/es not_active Application Discontinuation
- 2008-09-25 WO PCT/NZ2008/000248 patent/WO2009041831A1/en active Application Filing
- 2008-09-25 NZ NZ745324A patent/NZ745324A/en unknown
- 2008-09-25 US US12/678,976 patent/US9296789B2/en active Active
- 2008-09-25 UY UY31360A patent/UY31360A1/es not_active Application Discontinuation
- 2008-09-25 AR ARP080104173A patent/AR068553A1/es active IP Right Grant
- 2008-09-25 CL CL2008002859A patent/CL2008002859A1/es unknown
- 2008-09-25 ES ES08834203.5T patent/ES2587595T3/es active Active
- 2008-09-25 AU AU2008305846A patent/AU2008305846A1/en not_active Abandoned
- 2008-09-25 AU AU2008304018A patent/AU2008304018A1/en not_active Abandoned
- 2008-09-25 US US12/678,936 patent/US8592556B2/en active Active
- 2008-09-25 BR BR122021010737-8A patent/BR122021010737B1/pt active IP Right Grant
- 2008-09-25 CN CN201611216760.1A patent/CN107129524B/zh active Active
- 2008-09-25 WO PCT/NZ2008/000249 patent/WO2009041832A2/en active Application Filing
-
2010
- 2010-03-18 ZA ZA2010/01933A patent/ZA201001933B/en unknown
-
2013
- 2013-10-25 US US14/063,640 patent/US20140220636A1/en not_active Abandoned
-
2014
- 2014-07-04 JP JP2014139171A patent/JP2015042166A/ja active Pending
- 2014-08-08 AU AU2014210649A patent/AU2014210649B2/en active Active
-
2016
- 2016-03-28 US US15/082,373 patent/US10590170B2/en active Active
- 2016-10-05 JP JP2016197575A patent/JP2017046704A/ja active Pending
-
2020
- 2020-02-10 US US16/786,665 patent/US10995120B2/en active Active
-
2021
- 2021-04-08 US US17/226,028 patent/US11926647B2/en active Active
Non-Patent Citations (1)
Title |
---|
Analysis of the Methanobrevibacter ruminantium draft genome: understanding methanogen biology to inhibit their action in the rumen;Attwood, GT等;《Australian Journal of Experimental Agriculture》;20080102;第48卷(第2期);图2b,摘要 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101932595B (zh) | 噬菌体φmru多核苷酸和多肽及其应用 | |
US9441016B2 (en) | Complete genome sequence of the methanogen Methanobrevibacter ruminantium | |
RU2520738C2 (ru) | ПОЛИНУКЛЕОТИДЫ И ПОЛИПЕПТИДЫ ФАГА φ-mru, И ИХ ПРИМЕНЕНИЕ | |
AU2014210647A1 (en) | Phage phimru polynucleotides and polypeptides and uses thereof | |
ALTERMANN et al. | Patent 2700164 Summary | |
Class et al. | Patent application title: PHAGE &phgr; MRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF | |
AU2019203617A1 (en) | Vaccines and vaccine components for inhibition of microbial cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |